Funders › NY › The Leona M and Harry B Helmsley Charitable Trust › 2025
Grants paid by The Leona M and Harry B Helmsley Charitable Trust, tax year 2025
EIN 13-7184401 · New York, NY · Form 990-PF, Part XV · NTEE T20
In tax year 2025, The Leona M and Harry B Helmsley Charitable Trust (EIN 13-7184401) reported 570 grants paid totaling $440,927,206. Dataset version 2026.09.0, built 2026-09-03.
Every grant, 2025 · page 1 of 2
| Tax year | Recipient | Match | Amount | Type | Purpose | Source filing |
|---|---|---|---|---|---|---|
| 2025 | Ben-Gurion University of the Negev Beer Sheva | D | $10,542,857 | approved, future | CONSTRUCTION OF THE LEONA M. AND HARRY B. HELMSLEY CHARITABLE TRUST COMPUTER SCIENCE BUILDING | 202600369349100525 |
| 2025 | Mass General Brigham for the Brigham and Women's Hospital Boston, MA | U | $9,684,661 | approved, future | ACCELERATING PROGRESS AND PROMOTING QUALITY T1D CARE FOR THE POOREST BILLION THROUGH THE GLOBAL PEN-PLUS PARTNERSHIP | 202600369349100525 |
| 2025 | Mass General Brigham for the Brigham and Women's Hospital Boston, MA | U | $8,560,477 | approved, future | ACCELERATING PROGRESS AND PROMOTING QUALITY T1D CARE FOR THE POOREST BILLION THROUGH THE GLOBAL PEN-PLUS PARTNERSHIP | 202600369349100525 |
| 2025 | American Heart Association Inc Dallas, TX | B | $6,966,024 | paid | AMERICAN HEART ASSOCIATION CENTER FOR TELEHEALTH | 202600369349100525 |
| 2025 | Tel-Aviv University Tel Aviv | D | $6,828,500 | approved, future | HELMSLEY MEDICAL SIMULATION CENTER | 202600369349100525 |
| 2025 | Mass General Brigham for the Brigham and Women's Hospital Boston, MA | U | $6,753,638 | paid | ACCELERATING PROGRESS AND PROMOTING QUALITY T1D CARE FOR THE POOREST BILLION THROUGH THE GLOBAL PEN-PLUS PARTNERSHIP | 202600369349100525 |
| 2025 | Wilcox Health Foundation Lihue, HI | B | $6,273,000 | approved, future | WILCOX MEDICAL CENTER EQUIPMENT REVITALIZATION PROJECT | 202600369349100525 |
| 2025 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $5,917,762 | approved, future | THE GPPAD-05 STUDY ANTI-VIRAL ACTION AGAINST TYPE 1 DIABETES AUTOIMMUNITY (AVANT1A) | 202600369349100525 |
| 2025 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $5,917,761 | approved, future | THE GPPAD-05 STUDY ANTI-VIRAL ACTION AGAINST TYPE 1 DIABETES AUTOIMMUNITY (AVANT1A) | 202600369349100525 |
| 2025 | Corewell Health Grand Rapids, MI | U | $5,885,473 | approved, future | EXPANDING ACCESS TO ROBOTIC PCI AND ESTABLISHING A MULTI-STATE NETWORK TO STUDY THE FEASIBILITY OF TELEROBOTIC HEART ATTACK AND STROKE INTERVENTIONS | 202600369349100525 |
| 2025 | Ben-Gurion University of the Negev Beer Sheva | D | $5,785,714 | paid | CONSTRUCTION OF THE LEONA M. AND HARRY B. HELMSLEY CHARITABLE TRUST COMPUTER SCIENCE BUILDING | 202600369349100525 |
| 2025 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $5,755,302 | approved, future | THE GPPAD-05 STUDY ANTI-VIRAL ACTION AGAINST TYPE 1 DIABETES AUTOIMMUNITY (AVANT1A) | 202600369349100525 |
| 2025 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $5,755,301 | approved, future | THE GPPAD-05 STUDY ANTI-VIRAL ACTION AGAINST TYPE 1 DIABETES AUTOIMMUNITY (AVANT1A) | 202600369349100525 |
| 2025 | Hadassah Medical Organization Jerusalem | U | $5,265,160 | paid | EQUIPPING THE NEW HADASSAH - HELMSLEY MEDICAL CENTER, NETIVOT | 202600369349100525 |
| 2025 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $5,172,033 | approved, future | CONTINUATION 2 OF THE GPPAD-02-STUDY IDENTIFICATION OF INFANTS WITH INCREASED TYPE 1 DIABETES RISK FOR ENROLLMENT INTO PRIMARY PREVENTION TRIALS | 202600369349100525 |
| 2025 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $5,172,032 | approved, future | CONTINUATION 2 OF THE GPPAD-02-STUDY IDENTIFICATION OF INFANTS WITH INCREASED TYPE 1 DIABETES RISK FOR ENROLLMENT INTO PRIMARY PREVENTION TRIALS | 202600369349100525 |
| 2025 | Tel Aviv Sourasky Medical Center - Ichilov Hospital Tel Aviv | U | $5,120,490 | approved, future | CONSTRUCTION OF THE SHELTERED -5 FLOOR OF THE NORTH TOWER | 202600369349100525 |
| 2025 | Stichting the Ocean Cleanup Rotterdam | U | $5,000,000 | paid | DEVELOP AND SCALE TECHNOLOGIES TO RID THE OCEANS OF PLASTICS | 202600369349100525 |
| 2025 | Kapiolani Health Foundation Honolulu, HI | B | $5,000,000 | paid | MARTHA B. SMITH CANCER & INFUSION CENTER AT KAPIOLANI MEDICAL CENTER FOR WOMEN & CHILDREN | 202600369349100525 |
| 2025 | Billings Clinic Foundation Billings, MT | B | $5,000,000 | paid | BILLINGS CLINIC SURGICAL INTENSIVE CARE UNIT | 202600369349100525 |
| 2025 | Stichting the Ocean Cleanup Rotterdam | U | $5,000,000 | approved, future | DEVELOP AND SCALE TECHNOLOGIES TO RID THE OCEANS OF PLASTICS | 202600369349100525 |
| 2025 | The Queens Medical Center Honolulu, HI | B | $5,000,000 | paid | THE QUEEN'S MEDICAL CENTER - WEST OAHU CANCER CENTER EXPANSION | 202600369349100525 |
| 2025 | Tel Aviv Sourasky Medical Center - Ichilov Hospital Tel Aviv | U | $4,879,510 | paid | CONSTRUCTION OF THE SHELTERED -5 FLOOR OF THE NORTH TOWER | 202600369349100525 |
| 2025 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $4,829,040 | approved, future | THE GPPAD-05 STUDY ANTI-VIRAL ACTION AGAINST TYPE 1 DIABETES AUTOIMMUNITY (AVANT1A) | 202600369349100525 |
| 2025 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $4,829,040 | approved, future | THE GPPAD-05 STUDY ANTI-VIRAL ACTION AGAINST TYPE 1 DIABETES AUTOIMMUNITY (AVANT1A) | 202600369349100525 |
| 2025 | American Heart Association Inc Dallas, TX | B | $4,816,553 | approved, future | AMERICAN HEART ASSOCIATION CENTER FOR TELEHEALTH | 202600369349100525 |
| 2025 | St Luke Health Care Foundation West Chicago, IL | C | $4,790,316 | approved, future | HOPE CENTER FOR WOMEN AND CHILDREN | 202600369349100525 |
| 2025 | Baptist Medical Centre Nalerigu | U | $4,505,896 | paid | ELEVATING MATERNAL AND PEDIATRIC HEALTHCARE | 202600369349100525 |
| 2025 | Blue Circle Health Inc Wilmington, DE | U | $4,470,844 | paid | DEVELOPMENT OF BLUE CIRCLE HEALTH | 202600369349100525 |
| 2025 | Blue Circle Health Inc Wilmington, DE | U | $4,470,843 | paid | DEVELOPMENT OF BLUE CIRCLE HEALTH | 202600369349100525 |
| 2025 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $4,393,010 | approved, future | THE GPPAD-05 STUDY ANTI-VIRAL ACTION AGAINST TYPE 1 DIABETES AUTOIMMUNITY (AVANT1A) | 202600369349100525 |
| 2025 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $4,393,009 | approved, future | THE GPPAD-05 STUDY ANTI-VIRAL ACTION AGAINST TYPE 1 DIABETES AUTOIMMUNITY (AVANT1A) | 202600369349100525 |
| 2025 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $4,328,576 | approved, future | THE GPPAD-03 STUDY THE PRIMARY ORAL INSULIN TRIAL | 202600369349100525 |
| 2025 | Vayu Health Portola Valley, CA | B | $4,275,632 | approved, future | VAYU HEALTH PHASE 2 - SCALE AND SPREAD OF VALUE BASED PAYMENT ECOSYSTEM FOR MEDICAID BENEFICIARIES LIVING WITH TYPE 1 AND TYPE 2 DIABETES | 202600369349100525 |
| 2025 | Altru Health System Grand Forks, ND | B | $4,214,824 | paid | ALTRU HEALTH SYSTEM ULTRASOUND INITIATIVE | 202600369349100525 |
| 2025 | Blue Circle Health Inc Wilmington, DE | U | $3,975,887 | paid | DEVELOPMENT OF BLUE CIRCLE HEALTH | 202600369349100525 |
| 2025 | Wilcox Health Foundation Lihue, HI | B | $3,944,163 | paid | WILCOX MEDICAL CENTER EQUIPMENT REVITALIZATION PROJECT | 202600369349100525 |
| 2025 | St Alexius Medical Center Bismarck, ND | B | $3,799,563 | paid | CHI ST. ALEXIUS HEALTH ULTRASOUND INITIATIVE | 202600369349100525 |
| 2025 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $3,716,830 | approved, future | CONTINUATION 2 OF THE GPPAD-02-STUDY IDENTIFICATION OF INFANTS WITH INCREASED TYPE 1 DIABETES RISK FOR ENROLLMENT INTO PRIMARY PREVENTION TRIALS | 202600369349100525 |
| 2025 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $3,716,830 | approved, future | CONTINUATION 2 OF THE GPPAD-02-STUDY IDENTIFICATION OF INFANTS WITH INCREASED TYPE 1 DIABETES RISK FOR ENROLLMENT INTO PRIMARY PREVENTION TRIALS | 202600369349100525 |
| 2025 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $3,565,907 | approved, future | THE GPPAD-05 STUDY ANTI-VIRAL ACTION AGAINST TYPE 1 DIABETES AUTOIMMUNITY (AVANT1A) | 202600369349100525 |
| 2025 | Hillel Yaffe Medical Center Hadera | U | $3,536,258 | paid | CONSTRUCTION OF PET-CT INSTITUTE | 202600369349100525 |
| 2025 | Shaare Zedek Medical Center Jerusalem | D | $3,500,000 | approved, future | DEVELOPMENT OF THE HELMSLEY SURGICAL WING | 202600369349100525 |
| 2025 | State of Nevada Department of Division of State Parks Carson City, NV | U | $3,500,000 | paid | VALLEY OF FIRE VISITOR CENTER | 202600369349100525 |
| 2025 | The Broad Institute Inc Cambridge, MA | B | $3,499,051 | approved, future | NOVEL THERAPEUTIC APPROACHES FOR CROHNS DISEASE | 202600369349100525 |
| 2025 | The Broad Institute Inc Cambridge, MA | B | $3,497,605 | paid | NOVEL THERAPEUTIC APPROACHES FOR CROHNS DISEASE | 202600369349100525 |
| 2025 | The Broad Institute Inc Cambridge, MA | B | $3,477,159 | approved, future | NOVEL THERAPEUTIC APPROACHES FOR CROHNS DISEASE | 202600369349100525 |
| 2025 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $3,465,906 | approved, future | THE GPPAD-05 STUDY ANTI-VIRAL ACTION AGAINST TYPE 1 DIABETES AUTOIMMUNITY (AVANT1A) | 202600369349100525 |
| 2025 | Bar Ilan University in Israel Ramat Gan | D | $3,348,125 | paid | THE LEONA M. AND HARRY B. HELMSLEY ENERGY PROTOTYPE LAB AT BAR-ILAN UNIVERSITY | 202600369349100525 |
| 2025 | St Luke Health Care Foundation West Chicago, IL | C | $3,293,350 | paid | HOPE CENTER FOR WOMEN AND CHILDREN | 202600369349100525 |
| 2025 | The Academic College at Tel-Hai Upper Galilee | U | $3,225,321 | approved, future | THE HELMSLEY FELLOWSHIPS FOR SUSTAINABILITY AND HEALTH | 202600369349100525 |
| 2025 | Clinton Health Access Initiative Inc Boston, MA | B | $3,215,685 | approved, future | REACH EXPANDING ACCESS TO PRIMARY CARE FOR DIABETES AND HYPERTENSION (2024-2027) | 202600369349100525 |
| 2025 | Fairview Health Services Minneapolis, MN | B | $3,176,500 | paid | IMPROVING SURVIVAL OUTCOMES THROUGH UNIVERSITY OF MINNESOTA MEDICAL CENTER ECMO CENTER OF EXCELLENCE | 202600369349100525 |
| 2025 | Hillel Yaffe Medical Center Hadera | U | $3,158,400 | paid | EYE INSTITUTE AND AMBULATORY SURGERY CENTER | 202600369349100525 |
| 2025 | World Health Organization Geneva | U | $3,130,872 | approved, future | STRENGTHENING THE CAPACITY OF THE GLOBAL DIABETES COMPACT | 202600369349100525 |
| 2025 | World Health Organization Geneva | U | $3,129,504 | paid | STRENGTHENING THE CAPACITY OF THE GLOBAL DIABETES COMPACT | 202600369349100525 |
| 2025 | World Health Organization Geneva | U | $3,126,083 | paid | STRENGTHENING INTEGRATED PREVENTION AND CONTROL OF CHRONIC AND SEVERE NCDS IN THE WHO AFRICAN REGION, USING T1D, SCD, ARF, AND RHD AS ENTRY POINTS | 202600369349100525 |
| 2025 | Trinity Health Minot, ND | B | $3,020,087 | paid | TRINITY HEALTH ULTRASOUND INITIATIVE | 202600369349100525 |
| 2025 | World Health Organization Geneva | U | $3,010,445 | approved, future | STRENGTHENING INTEGRATED PREVENTION AND CONTROL OF CHRONIC AND SEVERE NCDS IN THE WHO AFRICAN REGION, USING T1D, SCD, ARF, AND RHD AS ENTRY POINTS | 202600369349100525 |
| 2025 | The Weizmann Institute of Science Rehovot | D | $3,000,000 | approved, future | EARLY CHILDHOOD DEVELOPMENT AND COMMUNITY CENTER AT THE WEIZMANN INSTITUTE OF SCIENCE | 202600369349100525 |
| 2025 | The Weizmann Institute of Science Rehovot | D | $3,000,000 | paid | EARLY CHILDHOOD DEVELOPMENT AND COMMUNITY CENTER AT THE WEIZMANN INSTITUTE OF SCIENCE | 202600369349100525 |
| 2025 | Mass General Brigham for the Brigham and Women's Hospital Boston, MA | U | $2,905,515 | paid | REAL-TIME POST-OP TOUCHLESS, REMOTE MONITORING IN CROHNS DISEASE THE SAPPHIRE TRIAL | 202600369349100525 |
| 2025 | Clinton Health Access Initiative Inc Boston, MA | B | $2,901,095 | approved, future | REACH EXPANDING ACCESS TO PRIMARY CARE FOR DIABETES AND HYPERTENSION (2024-2027) | 202600369349100525 |
| 2025 | Clinton Health Access Initiative Inc Boston, MA | B | $2,811,261 | paid | IMPROVING MEDICAL OXYGEN PRODUCTION AND UTILIZATION | 202600369349100525 |
| 2025 | Bnai Zion Medical Center Haifa | U | $2,764,483 | paid | DEVELOPMENT OF THE HELMSLEY CARDIOVASCULAR CARE UNIT | 202600369349100525 |
| 2025 | New York University New York, NY | B | $2,756,847 | paid | TAMALE EDUCATION AND INNOVATION CENTER FOR HEALTH | 202600369349100525 |
| 2025 | Anthos Home Inc Brooklyn, NY | C | $2,750,000 | approved, future | LAUNCHING ANTHOS HOME, WITH SPECIALIZED FOCUS ON HOUSING HIGH-NEED PATIENTS | 202600369349100525 |
| 2025 | Geoscience Australia Symonston | U | $2,737,545 | approved, future | DIGITAL EARTH AFRICA - SUSTAINABLE UPTAKE AND IMPACT | 202600369349100525 |
| 2025 | Holon Institute of Technology - Hit (ra) Holon | U | $2,725,000 | approved, future | MEDICAL TECHNOLOGIES BUILDING AT THE HOLON INSTITUTE OF TECHNOLOGY (HIT) | 202600369349100525 |
| 2025 | Clalit Health Services Tel Aviv | U | $2,658,835 | paid | A NEW NEONATAL CENTER FOR ISRAELS SOUTHERN PERIPHERY AT SOROKA MEDICAL CENTER | 202600369349100525 |
| 2025 | Water4 Inc Oklahoma City, OK | C | $2,647,448 | approved, future | SCALING NUMA IN NORTHERN GHANA | 202600369349100525 |
| 2025 | The Academic College at Tel-Hai Upper Galilee | U | $2,600,000 | paid | THE HELMSLEY RESEARCH AND INNOVATION WING IN THE TEL-HAI COMPUTER SCIENCE BUILDING. | 202600369349100525 |
| 2025 | Living Water International Stafford, TX | B | $2,574,349 | paid | SCALING INTEGRATED WASH SERVICES | 202600369349100525 |
| 2025 | T1d Exchange Inc Boston, MA | U | $2,567,417 | paid | EQUITABLE HEALTH AND PSYCHOSOCIAL OUTCOMES FOR INDIVIDUALS LIVING WITH T1D THROUGH THE T1D EXCHANGE QUALITY IMPROVEMENT COLLABORATIVE AND REGISTRY | 202600369349100525 |
| 2025 | Clalit Health Services Tel Aviv | U | $2,541,165 | paid | A NEW NEONATAL CENTER FOR ISRAELS SOUTHERN PERIPHERY AT SOROKA MEDICAL CENTER | 202600369349100525 |
| 2025 | Tel Aviv Sourasky Medical Center - Ichilov Hospital Tel Aviv | U | $2,538,786 | approved, future | GENETICS INSTITUTE AND GENOMICS CENTER | 202600369349100525 |
| 2025 | American Heart Association Inc Dallas, TX | B | $2,521,277 | paid | MISSION LIFELINE STROKE IOWA | 202600369349100525 |
| 2025 | Shaare Zedek Medical Center Jerusalem | D | $2,500,000 | paid | DEVELOPMENT OF THE HELMSLEY SURGICAL WING | 202600369349100525 |
| 2025 | Shaare Zedek Medical Center Jerusalem | D | $2,500,000 | paid | DEVELOPMENT OF THE HELMSLEY COMPREHENSIVE CARDIAC CARE CENTER | 202600369349100525 |
| 2025 | Int'l Bank for Reconstruction & Dev and Int'l Development Assoc Washington, DC | U | $2,500,000 | approved, future | HEALTH SYSTEM TRANSFORMATION AND RESILIENCE MULTI-DONOR TRUST FUND - NONCOMMUNICABLE DISEASE PARTNERSHIP GENERAL OPERATING SUPPORT | 202600369349100525 |
| 2025 | Int'l Bank for Reconstruction & Dev and Int'l Development Assoc Washington, DC | U | $2,500,000 | paid | HEALTH SYSTEM TRANSFORMATION AND RESILIENCE MULTI-DONOR TRUST FUND - NONCOMMUNICABLE DISEASE PARTNERSHIP GENERAL OPERATING SUPPORT | 202600369349100525 |
| 2025 | Shaare Zedek Medical Center Jerusalem | D | $2,500,000 | approved, future | DEVELOPMENT OF THE HELMSLEY SURGICAL WING | 202600369349100525 |
| 2025 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $2,482,836 | approved, future | CONTINUATION 2 OF THE GPPAD-02-STUDY IDENTIFICATION OF INFANTS WITH INCREASED TYPE 1 DIABETES RISK FOR ENROLLMENT INTO PRIMARY PREVENTION TRIALS | 202600369349100525 |
| 2025 | International Water Management Institute Battaramulla | D | $2,449,440 | paid | DIGITAL INNOVATIONS FOR A WATER SECURE AFRICA | 202600369349100525 |
| 2025 | Diabetes Australia Turner | U | $2,443,661 | approved, future | IMPROVEMENTS IN OUTCOMES FOR YOUNG PEOPLE WITH DIABETES IN LESS-RESOURCED COUNTRIES, THROUGH GEOGRAPHIC EXPANSION AND COUNTRY DATA-DRIVEN INITIATIVES. | 202600369349100525 |
| 2025 | Living Water International Stafford, TX | B | $2,432,337 | approved, future | SCALING INTEGRATED WASH SERVICES | 202600369349100525 |
| 2025 | Bridges to Prosperity Inc Denver, CO | D | $2,359,636 | approved, future | TRANSFORMATIVE CONNECTIVITY IN RURAL ZAMBIA | 202600369349100525 |
| 2025 | Ann & Robert H Lurie Childrens Hospital of Chicago Chicago, IL | B | $2,325,006 | paid | IMPLEMENTATION AND DISSEMINATION OF TOOLS TO HARNESS CGM DATA TO ACCELERATE ADOPTION OF POPULATION HEALTH IN T1D | 202600369349100525 |
| 2025 | Bridges to Prosperity Inc Denver, CO | D | $2,306,101 | paid | TRANSFORMATIVE CONNECTIVITY IN RURAL ZAMBIA | 202600369349100525 |
| 2025 | Icahn School of Medicine at Mount Sinai New York City, NY | B | $2,303,337 | paid | DEFINING THE PRE-DISEASE PHASE OF CROHNS DISEASE PREDICT AND PREVENT | 202600369349100525 |
| 2025 | Water4 Inc Oklahoma City, OK | C | $2,294,479 | approved, future | SCALING NUMA IN NORTHERN GHANA | 202600369349100525 |
| 2025 | Gay and Lesbian Community Center of Southern Nevada Inc Las Vegas, NV | B | $2,267,929 | paid | CAPITAL SUPPORT FOR THE CENTER | 202600369349100525 |
| 2025 | The Association for the Resident and Community in Ramat Hanegev Ramat Hanegev | U | $2,241,803 | paid | RAMAT HANEGEV SENIOR CITIZEN CENTER | 202600369349100525 |
| 2025 | American Heart Association Inc Dallas, TX | B | $2,220,899 | approved, future | MISSION LIFELINE STROKE HAWAII | 202600369349100525 |
| 2025 | Billings Clinic Foundation Billings, MT | B | $2,215,173 | paid | BILLINGS CLINIC TRANSFER CENTER | 202600369349100525 |
| 2025 | The Association for the Betterment of Eshkol Region Residents Kibbutz Magen | U | $2,203,283 | paid | BE'ERI AGRICULTURAL EQUIPMENT | 202600369349100525 |
| 2025 | Galilee Medical Center Nahariya | U | $2,200,000 | paid | RENOVATION OF TWO FLOORS OF THE INTERNAL MEDICINE BUILDING AT GALILEE MEDICAL CENTER | 202600369349100525 |
| 2025 | The End Fund Inc New York, NY | B | $2,132,360 | approved, future | TACKLING TRACHOMA SURGERY DISPARITIES | 202600369349100525 |
| 2025 | The End Fund Inc New York, NY | B | $2,124,880 | approved, future | TACKLING TRACHOMA SURGERY DISPARITIES | 202600369349100525 |
| 2025 | The End Fund Inc New York, NY | B | $2,117,400 | paid | TACKLING TRACHOMA SURGERY DISPARITIES | 202600369349100525 |
| 2025 | Engineering Ministries International USA Colorado Springs, CO | B | $2,112,745 | approved, future | MINGA MISSION HOSPITAL DEVELOPMENT | 202600369349100525 |
| 2025 | High Quality Medical Education Afton, MN | B | $2,112,639 | paid | POINT-OF-CARE ULTRASOUND (POCUS) TRAINING FOR MINNESOTA RURAL PROVIDERS | 202600369349100525 |
| 2025 | Ziv Medical Center Zefat Zefat | U | $2,100,000 | paid | NEW NEUROSURGERY DEPARTMENT | 202600369349100525 |
| 2025 | The Trevor Project Inc West Hollywood, CA | B | $2,081,072 | paid | LGBTQ YOUTH SUICIDE PREVENTION PROJECT | 202600369349100525 |
| 2025 | Essentia Health Duluth, MN | B | $2,065,413 | paid | ESSENTIA HEALTH ULTRASOUND INITIATIVE | 202600369349100525 |
| 2025 | Safe Water Network New York, NY | B | $2,064,000 | paid | SCALING SUSTAINABLE SAFE WATER ACCESS | 202600369349100525 |
| 2025 | Clalit Health Services Tel Aviv | U | $2,050,000 | paid | CT LINEAR ACCELERATOR FOR RABIN CANCER CENTER | 202600369349100525 |
| 2025 | Holon Institute of Technology - Hit Holon | U | $2,043,650 | approved, future | MEDICAL TECHNOLOGIES BUILDING AT THE HOLON INSTITUTE OF TECHNOLOGY (HIT) | 202600369349100525 |
| 2025 | Shaare Zedek Medical Center Jerusalem | D | $2,000,000 | approved, future | DEVELOPMENT OF THE HELMSLEY COMPREHENSIVE CARDIAC CARE CENTER | 202600369349100525 |
| 2025 | Billings Clinic Foundation Billings, MT | B | $2,000,000 | paid | BILLINGS CLINIC SURGICAL INTENSIVE CARE UNIT | 202600369349100525 |
| 2025 | Vayu Health Portola Valley, CA | B | $2,000,000 | approved, future | VAYU HEALTH PHASE 2 - SCALE AND SPREAD OF VALUE BASED PAYMENT ECOSYSTEM FOR MEDICAID BENEFICIARIES LIVING WITH TYPE 1 AND TYPE 2 DIABETES | 202600369349100525 |
| 2025 | American Heart Association Inc Dallas, TX | B | $1,988,020 | approved, future | MISSION LIFELINE STROKE HAWAII | 202600369349100525 |
| 2025 | Yitzhak Shamir Medical Center Tzrifin | U | $1,978,286 | paid | EXPANSION AND RENOVATION OF THE CANCER INSTITUTE AT SHAMIR MEDICAL CENTER | 202600369349100525 |
| 2025 | University of Glasgow Court Glasgow | U | $1,968,566 | approved, future | THE ROLE OF THE GUT MICROBIOME IN POSTOPERATIVE OUTCOMES AND DISEASE RECURRENCE IN SURGICAL ADULTS WITH CD TREATED WITH EXCLUSIVE ENTERAL NUTRITION. | 202600369349100525 |
| 2025 | Safe Water Network New York, NY | B | $1,932,000 | approved, future | SCALING SUSTAINABLE SAFE WATER ACCESS | 202600369349100525 |
| 2025 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $1,927,629 | paid | CONTINUATION OF THE GPPAD-02-STUDY IDENTIFICATION OF INFANTS WITH INCREASED TYPE 1 DIABETES RISK FOR ENROLLMENT INTO PRIMARY PREVENTION TRIALS | 202600369349100525 |
| 2025 | T1d Exchange Inc Boston, MA | U | $1,917,417 | paid | EQUITABLE HEALTH AND PSYCHOSOCIAL OUTCOMES FOR INDIVIDUALS LIVING WITH T1D THROUGH THE T1D EXCHANGE QUALITY IMPROVEMENT COLLABORATIVE AND REGISTRY | 202600369349100525 |
| 2025 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $1,913,981 | paid | THE GPPAD-05 STUDY ANTI-VIRAL ACTION AGAINST TYPE 1 DIABETES AUTOIMMUNITY (AVANT1A) | 202600369349100525 |
| 2025 | Vayu Health Portola Valley, CA | B | $1,913,552 | paid | VAYU HEALTH PHASE 2 - SCALE AND SPREAD OF VALUE BASED PAYMENT ECOSYSTEM FOR MEDICAID BENEFICIARIES LIVING WITH TYPE 1 AND TYPE 2 DIABETES | 202600369349100525 |
| 2025 | St Luke Health Care Foundation West Chicago, IL | C | $1,908,524 | approved, future | HOPE CENTER FOR WOMEN AND CHILDREN | 202600369349100525 |
| 2025 | Deutsche Welthungerhilfe Ev Bonn Bad Godesberg | U | $1,898,076 | paid | HOLISTICALLY ADDRESSING AGROBUSINESS | 202600369349100525 |
| 2025 | New Venture Fund Washington, DC | B | $1,894,037 | approved, future | TYPE 1 DIABETES CAMPS PROJECT (2025-2028) | 202600369349100525 |
| 2025 | New Venture Fund Washington, DC | B | $1,889,319 | paid | TYPE 1 DIABETES CAMPS PROJECT (2025-2028) | 202600369349100525 |
| 2025 | Vayu Health Portola Valley, CA | B | $1,865,381 | paid | VAYU HEALTH PHASE 2 - SCALE AND SPREAD OF VALUE BASED PAYMENT ECOSYSTEM FOR MEDICAID BENEFICIARIES LIVING WITH TYPE 1 AND TYPE 2 DIABETES | 202600369349100525 |
| 2025 | Diabetes Australia Turner | U | $1,855,504 | paid | IMPROVEMENTS IN OUTCOMES FOR YOUNG PEOPLE WITH DIABETES THROUGH GEOGRAPHIC EXPANSION AND COUNTRY-SPECIFIC DATA-DRIVEN INITIATIVES | 202600369349100525 |
| 2025 | New Venture Fund Washington, DC | B | $1,842,898 | approved, future | TYPE 1 DIABETES CAMPS PROJECT (2025-2028) | 202600369349100525 |
| 2025 | The Regents of the University of Colorado Denver Aurora, CO | D | $1,840,786 | approved, future | PREPARE 4 AID PRIMARY CARE PRAGMATIC, REAL WORLD EXPERIENCE FOR AUTOMATED INSULIN DELIVERY | 202600369349100525 |
| 2025 | American Heart Association Inc Dallas, TX | B | $1,836,354 | approved, future | MISSION LIFELINE STROKE SOUTH DAKOTA | 202600369349100525 |
| 2025 | The Scripps Research Institute La Jolla, CA | B | $1,836,022 | approved, future | GUT-RETAINED NRF2/ARE ACTIVATORS FOR IBD | 202600369349100525 |
| 2025 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $1,833,580 | paid | THE GPPAD-03 STUDY THE PRIMARY ORAL INSULIN TRIAL | 202600369349100525 |
| 2025 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $1,821,858 | approved, future | THE GPPAD-04 STUDY SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF TYPE 1 DIABETES AUTOIMMUNITY (SINT1A) | 202600369349100525 |
| 2025 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $1,821,858 | approved, future | THE GPPAD-04 STUDY SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF TYPE 1 DIABETES AUTOIMMUNITY (SINT1A) | 202600369349100525 |
| 2025 | Catholic Relief Services-Usccb Baltimore, MD | C | $1,808,630 | paid | EXPANDING COMMUNITY RECOVERY AND RESILIENCE | 202600369349100525 |
| 2025 | Oregon Health & Science University Portland, OR | U | $1,795,816 | paid | AN MDI DECISION SUPPORT SYSTEM WITH CDCES AND BEHAVIORAL HEALTH SUPPORT | 202600369349100525 |
| 2025 | Oregon Health & Science University Portland, OR | U | $1,783,316 | approved, future | AN MDI DECISION SUPPORT SYSTEM WITH CDCES AND BEHAVIORAL HEALTH SUPPORT | 202600369349100525 |
| 2025 | The Bionics Institute of Australia East Melbourne | U | $1,779,261 | paid | PATIENT-SPECIFIC ADAPTIVE, ELECTRIC THERAPY FOR CROHNS DISEASE | 202600369349100525 |
| 2025 | Ncd Alliance Geneva | U | $1,759,350 | approved, future | 2023-2025 PARTNERSHIP | 202600369349100525 |
| 2025 | Mass General Brigham for the Massachusetts General Hospital Boston, MA | U | $1,722,621 | paid | MICROBES, MOLECULES, AND CHEMISTRY DYSBIOSIS IN CROHNS DISEASE | 202600369349100525 |
| 2025 | High Quality Medical Education Afton, MN | B | $1,705,225 | approved, future | POINT-OF-CARE ULTRASOUND (POCUS) TRAINING FOR MINNESOTA RURAL PROVIDERS | 202600369349100525 |
| 2025 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $1,665,293 | approved, future | THE GPPAD-05 STUDY ANTI-VIRAL ACTION AGAINST TYPE 1 DIABETES AUTOIMMUNITY (AVANT1A) | 202600369349100525 |
| 2025 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $1,665,293 | approved, future | THE GPPAD-05 STUDY ANTI-VIRAL ACTION AGAINST TYPE 1 DIABETES AUTOIMMUNITY (AVANT1A) | 202600369349100525 |
| 2025 | Clinton Health Access Initiative Inc Boston, MA | B | $1,652,598 | paid | REACH EXPANDING ACCESS TO PRIMARY CARE FOR DIABETES AND HYPERTENSION (2024-2027) | 202600369349100525 |
| 2025 | Katholieke Universiteit Te Leuven Leuven | U | $1,644,973 | paid | EDENT1FI | 202600369349100525 |
| 2025 | The Queens Medical Center Honolulu, HI | B | $1,635,796 | paid | THE QUEENS MEDICAL CENTER & CLARENCE T.C. CHING ECMO PROGRAM EXCELLENCE AND VIABILITY APPRAISAL | 202600369349100525 |
| 2025 | Crohn's & Colitis Foundation Inc New York, NY | B | $1,632,470 | paid | ACHIEVING REMISSION IN IBD OPTIMIZING TREAT-TO-TARGET IN CLINICAL PRACTICE | 202600369349100525 |
| 2025 | Crohn's & Colitis Foundation Inc New York, NY | B | $1,622,595 | approved, future | ACHIEVING REMISSION IN IBD OPTIMIZING TREAT-TO-TARGET IN CLINICAL PRACTICE | 202600369349100525 |
| 2025 | Henry J Kaiser Family Foundation San Francisco, CA | B | $1,612,177 | approved, future | KFF HEALTH NEWS RURAL HEALTH DESK | 202600369349100525 |
| 2025 | American Heart Association Inc Dallas, TX | B | $1,606,124 | paid | MISSION LIFELINE STROKE HAWAII | 202600369349100525 |
| 2025 | American Heart Association Inc Dallas, TX | B | $1,592,190 | approved, future | MISSION LIFELINE STROKE SOUTH DAKOTA | 202600369349100525 |
| 2025 | Project Concern Zambia Limited Lusaka | U | $1,590,680 | approved, future | EMPOWERED CHILDREN AND ADOLESCENTS PROGRAM PLUS | 202600369349100525 |
| 2025 | Henry J Kaiser Family Foundation San Francisco, CA | B | $1,566,728 | approved, future | KFF HEALTH NEWS RURAL HEALTH DESK | 202600369349100525 |
| 2025 | American Heart Association Inc Dallas, TX | B | $1,563,575 | approved, future | EXPANDING THE SYSTEM OF STROKE CARE IN MINNESOTA | 202600369349100525 |
| 2025 | Katholieke Universiteit Te Leuven Leuven | U | $1,555,353 | approved, future | EDENT1FI | 202600369349100525 |
| 2025 | International Water Management Institute Battaramulla | D | $1,550,680 | approved, future | DIGITAL INNOVATIONS FOR A WATER SECURE AFRICA | 202600369349100525 |
| 2025 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $1,550,379 | approved, future | THE GPPAD-04 STUDY SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF TYPE 1 DIABETES AUTOIMMUNITY (SINT1A) | 202600369349100525 |
| 2025 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $1,550,379 | approved, future | THE GPPAD-04 STUDY SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF TYPE 1 DIABETES AUTOIMMUNITY (SINT1A) | 202600369349100525 |
| 2025 | American Heart Association Inc Dallas, TX | B | $1,546,123 | approved, future | EXPANDING THE SYSTEM OF STROKE CARE IN MINNESOTA | 202600369349100525 |
| 2025 | Ann & Robert H Lurie Childrens Hospital of Chicago Chicago, IL | B | $1,542,882 | approved, future | IMPLEMENTATION AND DISSEMINATION OF TOOLS TO HARNESS CGM DATA TO ACCELERATE ADOPTION OF POPULATION HEALTH IN T1D | 202600369349100525 |
| 2025 | Share Trust Inc Dover, MA | C | $1,540,658 | approved, future | BUILDING COMMUNITY DRIVEN COLLECTIVE ACTION | 202600369349100525 |
| 2025 | Share Trust Inc Dover, MA | C | $1,540,658 | paid | BUILDING COMMUNITY DRIVEN COLLECTIVE ACTION | 202600369349100525 |
| 2025 | The Trevor Project Inc West Hollywood, CA | B | $1,536,740 | approved, future | LGBTQ YOUTH SUICIDE PREVENTION PROJECT | 202600369349100525 |
| 2025 | Panorama Global Seattle, WA | B | $1,535,971 | approved, future | T1D COMMUNITY FUND STAGE II | 202600369349100525 |
| 2025 | Amsterdam Umc Research Bv Amsterdam | U | $1,532,103 | paid | A PROSPECTIVE RANDOMIZED STUDY OF TREATMENT SELECTION BASED ON EPIGENETIC MARKERS IN CROHNS DISEASE OMICROHN | 202600369349100525 |
| 2025 | Tel-Aviv University Tel Aviv | D | $1,524,350 | approved, future | HELMSLEY MEDICAL SIMULATION CENTER | 202600369349100525 |
| 2025 | Henry J Kaiser Family Foundation San Francisco, CA | B | $1,521,095 | paid | KFF HEALTH NEWS RURAL HEALTH DESK | 202600369349100525 |
| 2025 | The Academic College at Tel-Hai Upper Galilee | U | $1,517,781 | paid | THE HELMSLEY FELLOWSHIPS FOR SUSTAINABILITY AND HEALTH | 202600369349100525 |
| 2025 | The Chancellor Masters and Scholars of the University of Cambridge Cambridge | D | $1,510,641 | paid | NEW INSIGHTS INTO CROHN'S DISEASE FROM STUDYING NAKED MOLE RATS | 202600369349100525 |
| 2025 | The Jewish Agency for Israel Jerusalem | D | $1,500,000 | paid | THE SECURITY FUND SECURING AND SAFEGUARDING JEWISH COMMUNITIES WORLDWIDE | 202600369349100525 |
| 2025 | Shaare Zedek Medical Center Jerusalem | D | $1,500,000 | approved, future | DEVELOPMENT OF THE HELMSLEY COMPREHENSIVE CARDIAC CARE CENTER | 202600369349100525 |
| 2025 | Water4 Inc Oklahoma City, OK | C | $1,478,953 | paid | SCALING NUMA IN NORTHERN GHANA | 202600369349100525 |
| 2025 | Amsterdam Umc Research Bv Amsterdam | U | $1,476,985 | approved, future | A PROSPECTIVE RANDOMIZED STUDY OF TREATMENT SELECTION BASED ON EPIGENETIC MARKERS IN CROHNS DISEASE OMICROHN | 202600369349100525 |
| 2025 | Clalit Health Services Tel Aviv | U | $1,472,591 | paid | CLINICAL TRIAL TO EVALUATE A NOVEL MDI-BGM DECISION SUPPORT SYSTEM | 202600369349100525 |
| 2025 | Children's Hospital Corporation Boston, MA | C | $1,470,081 | paid | VERY EARLY ONSET INFLAMMATORY BOWEL DISEASE (VEOIBD) PRECISION MOLECULAR DIAGNOSES TO TARGETED THERAPIES BOSTON STUDIES | 202600369349100525 |
| 2025 | Panorama Global Seattle, WA | B | $1,469,142 | paid | T1D COMMUNITY FUND STAGE II | 202600369349100525 |
| 2025 | Katholieke Universiteit Te Leuven Leuven | U | $1,456,556 | paid | FAT AS A VILLAIN IN CROHN'S DISEASE. | 202600369349100525 |
| 2025 | Regents of the University of Minnesota Minneapolis, MN | U | $1,454,586 | approved, future | STANDARDIZED MICROBIOTA TRANSPLANT THERAPY IN CROHNS DISEASE. PILOT TRIAL. | 202600369349100525 |
| 2025 | A Glimmer of Hope Foundation Austin, TX | C | $1,446,574 | paid | EMPOWERING FAMILIES TO BUILD RESILIENCE AND REDUCE POVERTY | 202600369349100525 |
| 2025 | Mass General Brigham for the Brigham and Women's Hospital Boston, MA | U | $1,445,272 | approved, future | REAL-TIME POST-OP TOUCHLESS, REMOTE MONITORING IN CROHNS DISEASE THE SAPPHIRE TRIAL | 202600369349100525 |
| 2025 | Panorama Global Seattle, WA | B | $1,444,887 | approved, future | T1D COMMUNITY FUND STAGE II | 202600369349100525 |
| 2025 | Reachanother Foundation Bend, OR | U | $1,441,299 | paid | TRANSFORMING PEDIATRIC NEUROSURGERY SERVICES | 202600369349100525 |
| 2025 | Engineering Ministries International USA Colorado Springs, CO | B | $1,433,145 | paid | MINGA MISSION HOSPITAL DEVELOPMENT | 202600369349100525 |
| 2025 | Amici Di Adwa Ente del Terzo Settore Cento | U | $1,398,329 | paid | A HOSPITAL FOR ADWA, ETHIOPIA IN THE TIGRAY REGION | 202600369349100525 |
| 2025 | Weizmann Institute of Science Rehovot | D | $1,397,538 | approved, future | QUANTUM COMPUTING AND SENSING WITH ATOMS, ELECTRONS, AND PHOTONS | 202600369349100525 |
| 2025 | High Quality Medical Education Afton, MN | B | $1,384,586 | paid | POINT-OF-CARE ULTRASOUND (POCUS) TRAINING FOR NORTH DAKOTA RURAL PROVIDERS | 202600369349100525 |
| 2025 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $1,382,183 | approved, future | GPPAD COORDINATION CENTER CONTINUATION 2025-2029 | 202600369349100525 |
| 2025 | Children's Hospital Corporation Boston, MA | C | $1,378,160 | approved, future | ADVANCING THE DEVELOPMENT OF A NOVEL IMPLANTABLE GLUCOSE RESPONSIVE GLUCAGON (GRG) DELIVERY SYSTEM | 202600369349100525 |
| 2025 | Icahn School of Medicine at Mount Sinai New York City, NY | B | $1,367,190 | approved, future | THE REFLECTION STUDY PREDICTING OUTCOMES FOLLOWING ILEOCECAL RESECTION IN CROHNS DISEASE. | 202600369349100525 |
| 2025 | Rambam Health Corporation Haifa | D | $1,365,000 | paid | ANGIOGRAPHY SYSTEM FOR THE INTERVENTIONAL RADIOLOGY UNIT OF RAMBAM MEDICAL CENTER | 202600369349100525 |
| 2025 | Board of Trustees of the Leland Stanford Junior University Stanford, CA | B | $1,360,687 | approved, future | DEVELOPMENT OF A MOLECULAR SWITCH BASED CONTINUOUS INSULIN SENSOR | 202600369349100525 |
| 2025 | New York University New York, NY | B | $1,360,453 | approved, future | TAMALE EDUCATION AND INNOVATION CENTER FOR HEALTH | 202600369349100525 |
| 2025 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $1,353,865 | approved, future | THE GPPAD-04 STUDY SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF TYPE 1 DIABETES AUTOIMMUNITY (SINT1A) | 202600369349100525 |
| 2025 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $1,353,865 | approved, future | THE GPPAD-04 STUDY SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF TYPE 1 DIABETES AUTOIMMUNITY (SINT1A) | 202600369349100525 |
| 2025 | Mass General Brigham for the Massachusetts General Hospital Boston, MA | U | $1,352,242 | paid | VALIDATION OF WIRELESS THERMAL AND MICROSCOPIC IMAGING TECHNOLOGY FOR QUANTIFYING INFLAMMATION AND FIBROSIS IN CROHNS DISEASE | 202600369349100525 |
| 2025 | The Laniado Kiriat Sanz Hospital Nataniya | U | $1,350,000 | approved, future | NEW MATERNITY FLOOR C | 202600369349100525 |
| 2025 | Katholieke Universiteit Te Leuven Leuven | U | $1,344,948 | approved, future | FAT AS A VILLAIN IN CROHN'S DISEASE. | 202600369349100525 |
| 2025 | Jaeb Center for Health Research Foundation Inc Tampa, FL | C | $1,337,806 | paid | CGM FOR THE EARLY DETECTION AND MANAGEMENT OF DYSGLYCEMIA IN PREGNANCY (IMAGINE) | 202600369349100525 |
| 2025 | Catholic Relief Services-Usccb Baltimore, MD | C | $1,337,724 | paid | HELPING MOTHERS AND NEWBORNS SURVIVE AND THRIVE | 202600369349100525 |
| 2025 | American Samoa Dept of Health for American Samoa Community Health Ctr Pago Pago, AS | U | $1,335,622 | paid | IMAGING EQUIPMENT AT AMERICAN SAMOA COMMUNITY HEALTH CENTERS | 202600369349100525 |
| 2025 | American Pharmacists Association Foundation Washington, DC | B | $1,335,393 | paid | PROJECT IMPACT CGM EXPANDING ACCESS TO CGM THROUGH COMMUNITY PHARMACIES | 202600369349100525 |
| 2025 | Board of Trustees of the Leland Stanford Junior University Stanford, CA | B | $1,333,066 | approved, future | DEVELOPMENT OF A MOLECULAR SWITCH BASED CONTINUOUS INSULIN SENSOR | 202600369349100525 |
| 2025 | Children's Hospital Corporation Boston, MA | C | $1,332,312 | approved, future | ADVANCING THE DEVELOPMENT OF A NOVEL IMPLANTABLE GLUCOSE RESPONSIVE GLUCAGON (GRG) DELIVERY SYSTEM | 202600369349100525 |
| 2025 | King's College London London | U | $1,325,562 | approved, future | MULTIPEPT1DE PROOF-OF-CONCEPT STUDY STAGE III | 202600369349100525 |
| 2025 | Ziv Medical Center Zefat Zefat | U | $1,325,000 | paid | NEW THORACIC SURGERY UNIT | 202600369349100525 |
| 2025 | Tel-Aviv University Tel Aviv | D | $1,324,350 | approved, future | HELMSLEY MEDICAL SIMULATION CENTER | 202600369349100525 |
| 2025 | The Cleveland Clinic Foundation Cleveland, OH | C | $1,321,210 | paid | DEVELOPMENT OF A NEXT-GENERATION BIOMARKER TOOL TO ACCELERATE THE DEVELOPMENT OF EFFECTIVE ANTI-FIBROTIC THERAPIES | 202600369349100525 |
| 2025 | Washington University Saint Louis, MO | B | $1,319,373 | approved, future | PRECLINICAL DEVELOPMENT TO ADVANCE A T1D ANTIGEN-SPECIFIC IMMUNOTHERAPY CALLED SAGA-T1D | 202600369349100525 |
| 2025 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $1,310,183 | paid | CONTINUATION 2 OF THE GPPAD-02-STUDY IDENTIFICATION OF INFANTS WITH INCREASED TYPE 1 DIABETES RISK FOR ENROLLMENT INTO PRIMARY PREVENTION TRIALS | 202600369349100525 |
| 2025 | Board of Trustees of the Leland Stanford Junior University Stanford, CA | B | $1,306,247 | paid | DEVELOPMENT OF A MOLECULAR SWITCH BASED CONTINUOUS INSULIN SENSOR | 202600369349100525 |
| 2025 | University of North Carolina at Chapel Hill Chapel Hill, NC | B | $1,306,168 | approved, future | DEVELOPMENT OF A CONTINUOUS INSULIN SENSOR | 202600369349100525 |
| 2025 | The Weizmann Institute of Science Rehovot | D | $1,302,462 | approved, future | QUANTUM COMPUTING AND SENSING WITH ATOMS, ELECTRONS, AND PHOTONS | 202600369349100525 |
| 2025 | Stichting Health Action International Amsterdam | U | $1,300,026 | approved, future | ADDRESSING THE CHALLENGE AND CONSTRAINTS OF INSULIN SOURCES AND SUPPLY (ACCISS) STUDY PHASE IV | 202600369349100525 |
| 2025 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $1,299,716 | approved, future | GPPAD COORDINATION CENTER CONTINUATION 2025-2029 | 202600369349100525 |
| 2025 | Regents of the University of Minnesota Minneapolis, MN | U | $1,296,918 | paid | MINNESOTA FIRST RESPONDER AED PROJECT | 202600369349100525 |
| 2025 | Children's Hospital Corporation Boston, MA | C | $1,296,628 | paid | ADVANCING THE DEVELOPMENT OF A NOVEL IMPLANTABLE GLUCOSE RESPONSIVE GLUCAGON (GRG) DELIVERY SYSTEM | 202600369349100525 |
| 2025 | King's College London London | U | $1,296,483 | approved, future | MULTIPEPT1DE PROOF-OF-CONCEPT STUDY STAGE III | 202600369349100525 |
| 2025 | North Dakota State University Fargo, ND | B | $1,295,711 | approved, future | EXPANDING RURAL SONOGRAPHY EXPERTISE IN NORTH DAKOTA | 202600369349100525 |
| 2025 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $1,282,899 | paid | THE GPPAD-04 STUDY SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF TYPE 1 DIABETES AUTOIMMUNITY (SINT1A) | 202600369349100525 |
| 2025 | The Trevor Project Inc West Hollywood, CA | B | $1,282,735 | approved, future | LGBTQ YOUTH SUICIDE PREVENTION PROJECT | 202600369349100525 |
| 2025 | Catholic Relief Services-Usccb Baltimore, MD | C | $1,273,764 | approved, future | HELPING MOTHERS AND NEWBORNS SURVIVE AND THRIVE | 202600369349100525 |
| 2025 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $1,272,469 | approved, future | GPPAD COORDINATION CENTER CONTINUATION 2025-2029 | 202600369349100525 |
| 2025 | Washington University Saint Louis, MO | B | $1,271,885 | paid | PRECLINICAL DEVELOPMENT TO ADVANCE A T1D ANTIGEN-SPECIFIC IMMUNOTHERAPY CALLED SAGA-T1D | 202600369349100525 |
| 2025 | Vayu Health Portola Valley, CA | B | $1,260,384 | paid | VAYU HEALTH PHASE 2 - SCALE AND SPREAD OF VALUE BASED PAYMENT ECOSYSTEM FOR MEDICAID BENEFICIARIES LIVING WITH TYPE 1 AND TYPE 2 DIABETES | 202600369349100525 |
| 2025 | Jaeb Center for Health Research Foundation Inc Tampa, FL | C | $1,256,044 | approved, future | PREGNANCY DATA REPOSITORY TO ASSESS MANAGEMENT OF TYPE 1 DIABETES WITH DIABETES TECHNOLOGY (PRAM-T1D) | 202600369349100525 |
| 2025 | Snv Netherlands Development Organisation Den Haag | U | $1,246,508 | paid | SCALING THE HEALTHY FUTURE FOR ALL MODEL | 202600369349100525 |
| 2025 | Ann & Robert H Lurie Childrens Hospital of Chicago Chicago, IL | B | $1,245,216 | approved, future | IMPLEMENTATION AND DISSEMINATION OF TOOLS TO HARNESS CGM DATA TO ACCELERATE ADOPTION OF POPULATION HEALTH IN T1D | 202600369349100525 |
| 2025 | Vayu Health Portola Valley, CA | B | $1,242,777 | approved, future | VAYU HEALTH PHASE 2 - SCALE AND SPREAD OF VALUE BASED PAYMENT ECOSYSTEM FOR MEDICAID BENEFICIARIES LIVING WITH TYPE 1 AND TYPE 2 DIABETES | 202600369349100525 |
| 2025 | Nevada Department of Health and Human Services Carson City, NV | U | $1,239,092 | paid | NEVADA VIRTUAL CRISIS CARE | 202600369349100525 |
| 2025 | Icahn School of Medicine at Mount Sinai New York City, NY | B | $1,232,170 | approved, future | THE USE OF GLP-1R AGONISTS TO PROMOTE EPITHELIAL HEALING IN CROHNS DISEASE | 202600369349100525 |
| 2025 | Jaeb Center for Health Research Foundation Inc Tampa, FL | C | $1,223,066 | approved, future | PREGNANCY DATA REPOSITORY TO ASSESS MANAGEMENT OF TYPE 1 DIABETES WITH DIABETES TECHNOLOGY (PRAM-T1D) | 202600369349100525 |
| 2025 | The Regents of the University of Colorado Denver Aurora, CO | D | $1,215,803 | approved, future | IMPACT OF MENSTRUATION ON GLYCEMIC RESPONSE AND EXERCISE | 202600369349100525 |
| 2025 | Michigan State University East Lansing, MI | U | $1,215,611 | paid | A C-PEPTIDE COMPLEX FOR IMPROVED GLUCOSE METABOLISM IN PEOPLE WITH TYPE 1 DIABETES | 202600369349100525 |
| 2025 | High Quality Medical Education Afton, MN | B | $1,213,318 | approved, future | POINT-OF-CARE ULTRASOUND (POCUS) TRAINING FOR NORTH DAKOTA RURAL PROVIDERS | 202600369349100525 |
| 2025 | Convergent Impact Inc Boulder, CO | B | $1,212,300 | approved, future | COLLABORATIVE ON HOUSING FOR HEALTH | 202600369349100525 |
| 2025 | Stichting Health Action International Amsterdam | U | $1,200,977 | paid | ADDRESSING THE CHALLENGE AND CONSTRAINTS OF INSULIN SOURCES AND SUPPLY (ACCISS) STUDY PHASE IV | 202600369349100525 |
| 2025 | American College of Diabetology Inc Fayetteville, NC | B | $1,200,436 | paid | IMPROVE THE DIABETES TRAINING OPPORTUNITIES FOR PCPS | 202600369349100525 |
| 2025 | Geoscience Australia Symonston | U | $1,195,336 | paid | DIGITAL EARTH AFRICA - SUSTAINABLE UPTAKE AND IMPACT | 202600369349100525 |
| 2025 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $1,184,939 | paid | CONTINUATION 2 OF THE GPPAD-02-STUDY IDENTIFICATION OF INFANTS WITH INCREASED TYPE 1 DIABETES RISK FOR ENROLLMENT INTO PRIMARY PREVENTION TRIALS | 202600369349100525 |
| 2025 | High Quality Medical Education Afton, MN | B | $1,183,489 | approved, future | POINT-OF-CARE ULTRASOUND (POCUS) TRAINING FOR NORTH DAKOTA RURAL PROVIDERS | 202600369349100525 |
| 2025 | Crohn's & Colitis Foundation Inc New York, NY | B | $1,180,400 | paid | IBD VENTURES ACADEMIC INCUBATOR | 202600369349100525 |
| 2025 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $1,176,451 | approved, future | GPPAD COORDINATION CENTER CONTINUATION | 202600369349100525 |
| 2025 | International Bowel Ultrasound Group Ev Munster | U | $1,168,344 | paid | DEVELOPMENT OF AN INTESTINAL ULTRASOUND SCORE TO EVALUATE INFLAMMATION AND TREATMENT RESPONSE IN CROHNS DISEASE. | 202600369349100525 |
| 2025 | Clinton Health Access Initiative Inc Boston, MA | B | $1,166,919 | approved, future | IMPROVING MEDICAL OXYGEN PRODUCTION AND UTILIZATION | 202600369349100525 |
| 2025 | King's College London London | U | $1,147,254 | approved, future | MULTIPEPT1DE PROOF-OF-CONCEPT STUDY STAGE III | 202600369349100525 |
| 2025 | Snv Netherlands Development Organisation Den Haag | U | $1,144,205 | approved, future | SCALING THE HEALTHY FUTURE FOR ALL MODEL | 202600369349100525 |
| 2025 | Oakland University Rochester, MI | B | $1,139,629 | approved, future | A COMPREHENSIVE STUDY OF T1D EXOMES (PHASE 2) | 202600369349100525 |
| 2025 | Uppsala University Hospital Uppsala | U | $1,139,284 | paid | IMMUNE-EVASIVE ISLETS FOR TRANSPLANTATION | 202600369349100525 |
| 2025 | Jaeb Center for Health Research Foundation Inc Tampa, FL | C | $1,131,140 | approved, future | CGM FOR THE EARLY DETECTION AND MANAGEMENT OF DYSGLYCEMIA IN PREGNANCY (IMAGINE) | 202600369349100525 |
| 2025 | The Broad Institute Inc Cambridge, MA | B | $1,129,976 | approved, future | UNCOVERING CROHN'S GENETIC RISK IN AFRICAN-AMERICAN AND HISPANIC/LATINO POPULATIONS | 202600369349100525 |
| 2025 | Oakland University Rochester, MI | B | $1,129,765 | paid | A COMPREHENSIVE STUDY OF T1D EXOMES (PHASE 2) | 202600369349100525 |
| 2025 | Reachanother Foundation Bend, OR | U | $1,119,929 | approved, future | TRANSFORMING PEDIATRIC NEUROSURGERY SERVICES | 202600369349100525 |
| 2025 | Foundation for Innovative New Diagnostics Find Le Grandsaconnex | D | $1,118,735 | paid | ACESS TO CGMS FOR EQUITY IN DIABETES MANAGEMENT - THE ACCEDE PROJECT | 202600369349100525 |
| 2025 | The Regents of the University of California Santa Barbara Santa Barbara, CA | U | $1,116,996 | approved, future | EXERCISE SPECIFIC AID ALGORITHM FOR TYPE 1 DIABETES | 202600369349100525 |
| 2025 | Universite de Geneve Geneve | U | $1,112,238 | paid | PRECLINICAL TESTING OF S100A9 TO IMPROVE GLYCEMIC CONTROL IN TYPE 1 DIABETES | 202600369349100525 |
| 2025 | National Association of School Nurses Inc Silver Spring, MD | B | $1,110,787 | approved, future | PROVIDING COORDINATED CARE AND CAPTURING OUTCOMES FOR STUDENTS WITH T1D SCHOOL NURSE-LED PILOT PROJECT | 202600369349100525 |
| 2025 | Research Triangle Institute Durham, NC | C | $1,110,288 | paid | USING GENOME SEQUENCING AND GENETIC RISK SCORES TO IDENTIFY NEWBORNS WITH SERIOUS HEALTH CONDITIONS A STATEWIDE IMPLEMENTATION STUDY | 202600369349100525 |
| 2025 | The Association for the Resident and Community in Ramat Hanegev Ramat Hanegev | U | $1,109,829 | approved, future | RAMAT HANEGEV CENTRAL AUDITORIUM | 202600369349100525 |
| 2025 | The Regents of the University of California at Irvine Irvine, CA | C | $1,108,867 | paid | DEVELOPMENT OF A MULTI-ANALYTE SENSOR - GLUCOSE, LACTATE, OXYGEN, KETONES, INSULIN FOR PEOPLE WITH T1D | 202600369349100525 |
| 2025 | Jaeb Center for Health Research Foundation Inc Tampa, FL | C | $1,108,482 | approved, future | CGM FOR THE EARLY DETECTION AND MANAGEMENT OF DYSGLYCEMIA IN PREGNANCY (IMAGINE) | 202600369349100525 |
| 2025 | Children's Hospital Medical Center Cincinnati, OH | B | $1,093,319 | paid | ARTIFICIAL INTELLIGENCE PREDICTION OF MEANINGFUL OUTCOMES IN NEWLY DIAGNOSED SMALL BOWEL CROHNS DISEASE | 202600369349100525 |
| 2025 | Sanford Research Sioux Falls, SD | C | $1,093,143 | approved, future | PLEDGE PHASE 3 | 202600369349100525 |
| 2025 | The Regents of the University of California San Diego La Jolla, CA | C | $1,092,733 | approved, future | THE DRUGGABLE GPCROME IN CROHNS DISEASE | 202600369349100525 |
| 2025 | Renown Health Foundation Reno, NV | B | $1,091,987 | paid | RENOWN HEALTH TO BRING EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) TO NORTHERN NEVADA | 202600369349100525 |
| 2025 | The Regents of the University of California San Diego La Jolla, CA | C | $1,091,471 | paid | THE DRUGGABLE GPCROME IN CROHNS DISEASE | 202600369349100525 |
| 2025 | Engineering Ministries International USA Colorado Springs, CO | B | $1,089,542 | approved, future | MINGA MISSION HOSPITAL DEVELOPMENT | 202600369349100525 |
| 2025 | The Imperial College of Science Technology and Medicine London | U | $1,081,289 | approved, future | UNRAVELING THE IMMUNOPATHOLOGY OF PERIANAL FISTULIZING CROHNS DISEASE | 202600369349100525 |
| 2025 | King's College London London | U | $1,079,926 | approved, future | MULTIPEPT1DE PROOF-OF-CONCEPT STUDY STAGE III | 202600369349100525 |
| 2025 | Deutsche Welthungerhilfe Ev Bonn Bad Godesberg | U | $1,079,659 | approved, future | HOLISTICALLY ADDRESSING AGROBUSINESS | 202600369349100525 |
| 2025 | Catholic Relief Services-Usccb Baltimore, MD | C | $1,073,759 | approved, future | EXPANDING COMMUNITY RECOVERY AND RESILIENCE | 202600369349100525 |
| 2025 | King's College London London | U | $1,069,889 | approved, future | MULTIPEPT1DE PROOF-OF-CONCEPT STUDY STAGE III | 202600369349100525 |
| 2025 | Board of Trustees of the Leland Stanford Junior University Stanford, CA | B | $1,069,498 | approved, future | DEVELOPMENT OF PERSONALIZED DECISION SUPPORT TOOL USING NETIOB TO HELP MANAGE EXERCISE FOR PEOPLE WITH T1D | 202600369349100525 |
| 2025 | University of North Carolina at Chapel Hill Chapel Hill, NC | B | $1,058,738 | approved, future | PILOTING INTEGRATION OF PORTABLE ULTRASOUNDS | 202600369349100525 |
| 2025 | Regents of University of California Berkeley Berkeley, CA | D | $1,054,179 | paid | DEVELOPING MICROBIOME EDITING TOOLS TO ADVANCE UNDERSTANDING OF THE MICROBIAL INFLUENCE ON CROHN'S DISEASE | 202600369349100525 |
| 2025 | University of North Carolina at Chapel Hill Chapel Hill, NC | B | $1,038,654 | paid | PILOTING INTEGRATION OF PORTABLE ULTRASOUNDS | 202600369349100525 |
| 2025 | The Regents of the University of Colorado Denver Aurora, CO | D | $1,036,513 | approved, future | IMPLEMENTATION OF EARLY STAGE T1D EDUCATION AND SUPPORT (ESTES) | 202600369349100525 |
| 2025 | Lander County Hospital District Battle Mountain, NV | U | $1,035,000 | paid | BATTLE MOUNTAIN GENERAL HOSPITAL HOSPITAL EQUIPMENT REVITALIZATION | 202600369349100525 |
| 2025 | The Imperial College of Science Technology and Medicine London | U | $1,032,574 | paid | UNRAVELING THE IMMUNOPATHOLOGY OF PERIANAL FISTULIZING CROHNS DISEASE | 202600369349100525 |
| 2025 | Association of Diabetes Care & Education Specialists Chicago, IL | B | $1,030,062 | paid | DANATECH DIABETES TECHNOLOGY PLATFORM EXPANSION & MAINTENANCE | 202600369349100525 |
| 2025 | The Regents of the University of California Santa Barbara Santa Barbara, CA | U | $1,027,327 | paid | EXERCISE SPECIFIC AID ALGORITHM FOR TYPE 1 DIABETES | 202600369349100525 |
| 2025 | Jaeb Center for Health Research Foundation Inc Tampa, FL | C | $1,025,846 | paid | TECHNOSPHERE INSULIN VERSUS RAPID ACTING ANALOGUE INSULIN ON EXERCISE-INDUCED HYPOGLYCEMIA IN ADULTS WITH T1D USING AUTOMATED INSULIN DELIVERY | 202600369349100525 |
| 2025 | Oakland University Rochester, MI | B | $1,019,181 | approved, future | A COMPREHENSIVE STUDY OF T1D EXOMES (PHASE 2) | 202600369349100525 |
| 2025 | Children's Hospital Medical Center Cincinnati, OH | B | $1,016,595 | approved, future | COMPARISON OF STANDARD-OF-CARE VS. A PATIENT-CENTRIC NONCONTRAST ABBREVIATED MR ENTEROGRAPHY PROTOCOL | 202600369349100525 |
| 2025 | Board of Trustees of the Leland Stanford Junior University Stanford, CA | B | $1,006,687 | approved, future | MICROBIOME-BASED THERAPEUTICS FOR CROHNS DISEASE | 202600369349100525 |
| 2025 | Project Concern Zambia Limited Lusaka | U | $1,004,026 | paid | EMPOWERED CHILDREN AND ADOLESCENTS PROGRAM PLUS | 202600369349100525 |
| 2025 | Center for Health Care Strategies Inc Hamilton, NJ | B | $1,002,514 | paid | CGM MEDICAID ACCESS ACCELERATOR - TARGETED RESOURCES AND TECHNICAL ASSISTANCE TO IMPROVE CARE FOR PEOPLE LIVING WITH DIABETES WHO USE INSULIN | 202600369349100525 |
| 2025 | Stichting Access to Medicine Foundation Amsterdam | U | $1,000,000 | paid | EXPANDING ACCESS TO DIABETES CARE | 202600369349100525 |
| 2025 | Stichting Access to Medicine Foundation Amsterdam | U | $1,000,000 | approved, future | EXPANDING ACCESS TO DIABETES CARE | 202600369349100525 |
| 2025 | Fjc New York, NY | B | $1,000,000 | approved, future | THE WELLNESS CLASSROOM, A PROJECT OF FJC - A FOUNDATION OF PHILANTHROPIC FUNDS | 202600369349100525 |
| 2025 | Anthos Home Inc Brooklyn, NY | C | $1,000,000 | paid | LAUNCHING ANTHOS HOME, WITH SPECIALIZED FOCUS ON HOUSING HIGH-NEED PATIENTS | 202600369349100525 |
| 2025 | Gates Philanthropy Partners City of Industry, CA | U | $1,000,000 | approved, future | POLIO ERADICATION FUND SUPPORT | 202600369349100525 |
| 2025 | Stichting Access to Medicine Foundation Amsterdam | U | $1,000,000 | approved, future | EXPANDING ACCESS TO DIABETES CARE | 202600369349100525 |
| 2025 | Fjc New York, NY | B | $1,000,000 | paid | THE WELLNESS CLASSROOM, A PROJECT OF FJC - A FOUNDATION OF PHILANTHROPIC FUNDS | 202600369349100525 |
| 2025 | Gates Philanthropy Partners City of Industry, CA | U | $1,000,000 | paid | POLIO ERADICATION FUND SUPPORT | 202600369349100525 |
| 2025 | Pennington County Health and Human Services Rapid City, SD | U | $1,000,000 | paid | PENNINGTON COUNTY CRISIS STABILIZATION UNIT | 202600369349100525 |
| 2025 | Stichting Health Action International Amsterdam | U | $998,988 | approved, future | ADDRESSING THE CHALLENGE AND CONSTRAINTS OF INSULIN SOURCES AND SUPPLY (ACCISS) STUDY PHASE IV | 202600369349100525 |
| 2025 | Safe Water Network New York, NY | B | $998,000 | approved, future | SCALING SUSTAINABLE SAFE WATER ACCESS | 202600369349100525 |
| 2025 | The Regents of the University of Colorado Denver Aurora, CO | D | $996,486 | approved, future | PREPARE 4 AID PRIMARY CARE PRAGMATIC, REAL WORLD EXPERIENCE FOR AUTOMATED INSULIN DELIVERY | 202600369349100525 |
| 2025 | The Sderot Development Foundation Sderot | U | $993,626 | approved, future | SDEROT MEDICAL CENTER | 202600369349100525 |
| 2025 | Icahn School of Medicine at Mount Sinai New York City, NY | B | $993,497 | paid | THE USE OF GLP-1R AGONISTS TO PROMOTE EPITHELIAL HEALING IN CROHNS DISEASE | 202600369349100525 |
| 2025 | Crohn's Colitis Cure Pyrmont Nsw | U | $991,768 | approved, future | ENHANCING INFLAMMATORY BOWEL DISEASE CARE CONSUMER-CENTRIC PORTAL FOR BETTER COMMUNICATION & REDUCED NAVIGATION STRESS | 202600369349100525 |
| 2025 | Shaare Zedek Medical Center Jerusalem | D | $989,083 | paid | ISRAELI IBD RESEARCH NUCLEUS (IIRN) CONSORTIUM COMBINING MULTI-TIER ADMINISTRATIVE DATA FOR FACILITATING DISEASE FREE MANAGEMENT | 202600369349100525 |
| 2025 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $988,211 | paid | GPPAD COORDINATION CENTER CONTINUATION | 202600369349100525 |
| 2025 | International Alliance for Diabetes Action Inc Boston, MA | B | $971,684 | approved, future | SEED FUNDING SUPPORT | 202600369349100525 |
| 2025 | The Broad Institute Inc Cambridge, MA | B | $971,014 | paid | UNCOVERING CROHN'S GENETIC RISK IN AFRICAN-AMERICAN AND HISPANIC/LATINO POPULATIONS | 202600369349100525 |
| 2025 | Children's Hospital Medical Center Cincinnati, OH | B | $963,282 | paid | COMPARISON OF STANDARD-OF-CARE VS. A PATIENT-CENTRIC NONCONTRAST ABBREVIATED MR ENTEROGRAPHY PROTOCOL | 202600369349100525 |
| 2025 | Trustees and Friends of Agricultural Research at the Volcani Center Rishon Lezion | U | $962,990 | paid | PROTECTING FARMERS AND AGRICULTURAL WORKERS ACROSS NORTHERN ISRAEL | 202600369349100525 |
| 2025 | American Heart Association Inc Dallas, TX | B | $957,913 | paid | MISSION LIFELINE STROKE SOUTH DAKOTA | 202600369349100525 |
| 2025 | Reachanother Foundation Bend, OR | U | $952,406 | paid | EXPANDING PEDIATRIC NEUROSURGERY CAPACITY IN ETHIOPIA | 202600369349100525 |
| 2025 | Hadassah Medical Organization Jerusalem | U | $950,450 | paid | RECRUITMENT OF TOP MEDICAL TALENT FOR THE NEW HADASSAH-HELMSLEY MEDICAL CENTER, NETIVOT | 202600369349100525 |
| 2025 | Klinikum Der Ludwig-Maximilians-Universitat Munchen Munchen | U | $949,869 | approved, future | FECAL MICROBIOTA TRANSFER FOR MAINTENANCE OF REMISSION AFTER INDUCTION TREATMENT WITH EXCLUSIVE ENTERAL NUTRITION IN CROHNS DISEASE | 202600369349100525 |
| 2025 | Katholieke Universiteit Te Leuven Leuven | U | $944,656 | approved, future | EDENT1FI | 202600369349100525 |
| 2025 | Cork University Foundation Cork | U | $941,943 | approved, future | ENDOSCOPIC MULTIMODAL ASSESSMENT USING ADVANCED IMAGING INTEGRATED AI TO PREDICT RECURRENCE IN POST-OPERATIVE CROHNS DISEASE - PROSPERS | 202600369349100525 |
| 2025 | The Regents of the University of Colorado Denver Aurora, CO | D | $935,698 | paid | IMPLEMENTATION OF EARLY STAGE T1D EDUCATION AND SUPPORT (ESTES) | 202600369349100525 |
| 2025 | The Bionics Institute of Australia East Melbourne | U | $932,181 | approved, future | PATIENT-SPECIFIC ADAPTIVE, ELECTRIC THERAPY FOR CROHNS DISEASE | 202600369349100525 |
| 2025 | Improvecarenow Inc Essex Junction, VT | B | $931,101 | paid | IMPLEMENTING THE COMBINE TRIAL RESULTS IN THE IMPROVECARENOW (ICN) LEARNING HEALTH NETWORK | 202600369349100525 |
| 2025 | Jdrf Australia Sydney | U | $929,309 | paid | ENDIA FOLLOW UP 2023-2025 SAMPLES ANALYSIS RFA | 202600369349100525 |
| 2025 | Association of Diabetes Care & Education Specialists Chicago, IL | B | $928,645 | approved, future | DANATECH DIABETES TECHNOLOGY PLATFORM EXPANSION & MAINTENANCE | 202600369349100525 |
| 2025 | Icahn School of Medicine at Mount Sinai New York City, NY | B | $920,802 | paid | SPATIAL MAPPING OF FIBROMUSCULAR CROHNS DISEASE FROM GENETIC TO SENESCENT SIGNALS | 202600369349100525 |
| 2025 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $920,486 | paid | GPPAD COORDINATION CENTER CONTINUATION | 202600369349100525 |
| 2025 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $912,618 | approved, future | GPPAD BIOSAMPLE RFP | 202600369349100525 |
| 2025 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $912,527 | approved, future | GPPAD COORDINATION CENTER CONTINUATION 2025-2029 | 202600369349100525 |
| 2025 | American Heart Association Inc Dallas, TX | B | $908,680 | paid | EXPANDING THE SYSTEM OF STROKE CARE IN MINNESOTA | 202600369349100525 |
| 2025 | Klinikum Der Ludwig-Maximilians-Universitt Mnchen Munchen | U | $907,027 | approved, future | FECAL MICROBIOTA TRANSFER FOR MAINTENANCE OF REMISSION AFTER INDUCTION TREATMENT WITH EXCLUSIVE ENTERAL NUTRITION IN CROHNS DISEASE | 202600369349100525 |
| 2025 | Chi Health Foundation Omaha, NE | U | $903,993 | paid | CHI HEALTH ND ULTRASOUND INITIATIVE | 202600369349100525 |
| 2025 | Michigan State University East Lansing, MI | U | $896,270 | approved, future | A C-PEPTIDE COMPLEX FOR IMPROVED GLUCOSE METABOLISM IN PEOPLE WITH TYPE 1 DIABETES | 202600369349100525 |
| 2025 | Tzafon Medical Center Tiberias | U | $895,000 | paid | SECURING TZAFON MEDICAL CENTER'S ELECTRICAL CONNECTION TO ISRAEL'S POWER GRID | 202600369349100525 |
| 2025 | International Alliance for Diabetes Action Inc Boston, MA | B | $893,663 | paid | SEED FUNDING SUPPORT | 202600369349100525 |
| 2025 | Deutsche Welthungerhilfe Ev Bonn Bad Godesberg | U | $892,391 | approved, future | HOLISTICALLY ADDRESSING AGROBUSINESS | 202600369349100525 |
| 2025 | Billings Clinic Foundation Billings, MT | B | $880,233 | approved, future | BILLINGS CLINIC TRANSFER CENTER | 202600369349100525 |
| 2025 | Improvecarenow Inc Essex Junction, VT | B | $872,406 | approved, future | IMPLEMENTING THE COMBINE TRIAL RESULTS IN THE IMPROVECARENOW (ICN) LEARNING HEALTH NETWORK | 202600369349100525 |
| 2025 | Crohn's Colitis Cure Pyrmont Nsw | U | $871,250 | paid | ENHANCING INFLAMMATORY BOWEL DISEASE CARE CONSUMER-CENTRIC PORTAL FOR BETTER COMMUNICATION & REDUCED NAVIGATION STRESS | 202600369349100525 |
| 2025 | American Heart Association Inc Dallas, TX | B | $871,217 | paid | HEARTCORPS AHA'S RURAL PUBLIC HEALTH WORKFORCE DEVELOPMENT INITIATIVE | 202600369349100525 |
| 2025 | Path Seattle, WA | B | $871,123 | paid | THE DIABETES CAREPAK PROJECT ENABLING HIGH-QUALITY DIABETES SELF-CARE | 202600369349100525 |
| 2025 | The Cleveland Clinic Foundation Cleveland, OH | C | $869,476 | paid | ENDPOINT DEVELOPMENT FOR OSTOMY CLINICAL TRIALS (ENDO-TRIAL) CONSORTIUM | 202600369349100525 |
| 2025 | United States Fund for Unicef New York, NY | U | $869,232 | paid | ACCELERATING GLOBAL FOCUS ON NCDS AND PEN-PLUS COUNTRY PROGRAMS | 202600369349100525 |
| 2025 | University Hospitals Health System Inc Cleveland, OH | U | $866,199 | paid | TYPE 1 DIABETES FINANCIAL TOOLKIT FOR EMERGING ADULTS | 202600369349100525 |
| 2025 | Cornell University for the Joan & Sanford I Weill Medical College New York, NY | U | $863,618 | paid | TARGETING THE MYCOBIOME IN PATIENTS WITH CROHNS DISEASE | 202600369349100525 |
| 2025 | The Chancellor Masters and Scholars of the University of Cambridge Cambridge | D | $851,645 | approved, future | DOES BIOCHEMISTRY AT THE CENTRE OF LIFE DRIVE CROHN'S DISEASE? | 202600369349100525 |
| 2025 | Wyoming Association of Sheriffs and Chiefs of Police Douglas, WY | B | $851,113 | approved, future | WYOMING VIRTUAL CRISIS CARE PILOT PROGRAM | 202600369349100525 |
| 2025 | American Heart Association Inc Dallas, TX | B | $850,098 | approved, future | HEARTCORPS AHA'S RURAL PUBLIC HEALTH WORKFORCE DEVELOPMENT INITIATIVE | 202600369349100525 |
| 2025 | Baptist Medical Centre Nalerigu | U | $848,730 | paid | CT SCANNER FOR BAPTIST MEDICAL CENTRE | 202600369349100525 |
| 2025 | The Association for the Resident and Community in Ramat Hanegev Ramat Hanegev | U | $843,988 | paid | RAMAT HANEGEV CENTRAL AUDITORIUM | 202600369349100525 |
| 2025 | University of North Carolina at Chapel Hill Chapel Hill, NC | B | $837,846 | paid | DEVELOPMENT OF A CONTINUOUS INSULIN SENSOR | 202600369349100525 |
| 2025 | Board of Trustees of the Leland Stanford Junior University Stanford, CA | B | $835,639 | paid | DIABETESWISE FOR EXERCISE | 202600369349100525 |
| 2025 | Research Triangle Institute Durham, NC | C | $826,376 | approved, future | USING GENOME SEQUENCING AND GENETIC RISK SCORES TO IDENTIFY NEWBORNS WITH SERIOUS HEALTH CONDITIONS A STATEWIDE IMPLEMENTATION STUDY | 202600369349100525 |
| 2025 | The Chancellor Masters and Scholars of the University of Cambridge Cambridge | D | $820,911 | approved, future | DOES BIOCHEMISTRY AT THE CENTRE OF LIFE DRIVE CROHN'S DISEASE? | 202600369349100525 |
| 2025 | Southcentral Foundation Anchorage, AK | B | $818,171 | paid | FWWI NU'IJU TRANSFORMATIONAL LIVING COMMUNITY PROGRAM | 202600369349100525 |
| 2025 | Jdrf Australia Sydney | U | $816,628 | paid | ENDIA FOLLOW UP 2023-2025 SAMPLES ANALYSIS RFA | 202600369349100525 |
| 2025 | Icahn School of Medicine at Mount Sinai New York City, NY | B | $809,899 | approved, future | THE USE OF GLP-1R AGONISTS TO PROMOTE EPITHELIAL HEALING IN CROHNS DISEASE | 202600369349100525 |
| 2025 | The Chancellor Masters and Scholars of the University of Cambridge Cambridge | D | $808,734 | paid | DOES THE WESTERN DIET TRIGGER CROHN'S DISEASE VIA OSMOTIC STRESS? | 202600369349100525 |
| 2025 | The Regents of the University of Colorado Denver Aurora, CO | D | $807,989 | approved, future | PRENATAL AND OBSTETRIC MATERNAL EXPOSURES AND ISLET AUTOIMMUNITY IN EARLY LIFE (PROMISE) | 202600369349100525 |
| 2025 | Jaeb Center for Health Research Foundation Inc Tampa, FL | C | $805,385 | approved, future | EDUCATIONAL INTERVENTION TO SUPPORT DIABETES GUIDANCE FOR EXERCISE (EDGE) | 202600369349100525 |
| 2025 | American Diabetes Association Inc Arlington, VA | B | $805,382 | approved, future | TRAINING AND MENTORSHIP PROGRAMS | 202600369349100525 |
| 2025 | King's College London London | U | $805,337 | approved, future | PRENATAL DRIVERS OF INFANT ISLET AUTOIMMUNITY (PISA STUDY) | 202600369349100525 |
| 2025 | New York City Health and Hospitals Corporation New York, NY | B | $800,000 | approved, future | PROJECT ASAP BUILDING CAPACITY FOR SUPPORTIVE HOUSING FACILITATION AND BRIDGE CARE IN NYC'S PUBLIC HOSPITALS | 202600369349100525 |
| 2025 | Corporation for Supportive Housing New York City, NY | B | $800,000 | approved, future | HEALTH-ENRICHED SERVICES PILOTS FOR SUPPORTIVE HOUSING | 202600369349100525 |
| 2025 | New York City Health and Hospitals Corporation New York, NY | B | $800,000 | approved, future | PROJECT ASAP BUILDING CAPACITY FOR SUPPORTIVE HOUSING FACILITATION AND BRIDGE CARE IN NYC'S PUBLIC HOSPITALS | 202600369349100525 |
| 2025 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $800,000 | paid | THE GPPAD-03 STUDY THE PRIMARY ORAL INSULIN TRIAL | 202600369349100525 |
| 2025 | Wyoming Association of Sheriffs and Chiefs of Police Douglas, WY | B | $798,469 | paid | WYOMING VIRTUAL CRISIS CARE PILOT PROGRAM | 202600369349100525 |
| 2025 | Beth Israel Deaconess Medical Center Inc Boston, MA | B | $797,851 | approved, future | PROACTIVE OPTIMIZATION OF INFLIXIMAB USING A PHARMACOKINETIC DASHBOARD VERSUS STANDARD OF CARE IN PATIENTS WITH CROHNS DISEASE THE OPTIMIZE TRIAL | 202600369349100525 |
| 2025 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $794,714 | paid | THE GPPAD-04 STUDY SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF TYPE 1 DIABETES AUTOIMMUNITY (SINT1A) | 202600369349100525 |
| 2025 | Mass General Brigham for the Massachusetts General Hospital Boston, MA | U | $781,613 | approved, future | VALIDATION OF WIRELESS THERMAL AND MICROSCOPIC IMAGING TECHNOLOGY FOR QUANTIFYING INFLAMMATION AND FIBROSIS IN CROHNS DISEASE | 202600369349100525 |
| 2025 | Icahn School of Medicine at Mount Sinai New York City, NY | B | $779,716 | paid | PROMOTE BIRTH EQUITY THROUGH COMMUNITY-BASED DOULA CARE, HOMELESS AND JUSTICE-INVOLVED PREGNANT PERSONS. | 202600369349100525 |
| 2025 | King's College London London | U | $778,535 | approved, future | MULTIPEPT1DE PROOF-OF-CONCEPT STUDY STAGE III | 202600369349100525 |
| 2025 | New York City Health and Hospitals Corporation New York, NY | B | $777,607 | paid | PROJECT ASAP BUILDING CAPACITY FOR SUPPORTIVE HOUSING FACILITATION AND BRIDGE CARE IN NYC'S PUBLIC HOSPITALS | 202600369349100525 |
| 2025 | Board of Trustees of the Leland Stanford Junior University Stanford, CA | B | $775,549 | approved, future | DETERMINING THE THERAPEUTIC POTENTIAL OF STATINS ON STRICTURING CROHNS DISEASE | 202600369349100525 |
| 2025 | Improvecarenow Inc Essex Junction, VT | B | $771,948 | approved, future | IMPLEMENTING THE COMBINE TRIAL RESULTS IN THE IMPROVECARENOW (ICN) LEARNING HEALTH NETWORK | 202600369349100525 |
| 2025 | Mass General Brigham for the Brigham and Women's Hospital Boston, MA | U | $767,141 | approved, future | REAL-TIME POST-OP TOUCHLESS, REMOTE MONITORING IN CROHNS DISEASE THE SAPPHIRE TRIAL | 202600369349100525 |
| 2025 | Ben-Gurion University of the Negev Beer Sheva | D | $765,436 | paid | ISRAELI IBD RESEARCH NUCLEUS (IIRN) CONSORTIUM COBMINDEX GOES FORWARD- A SMARTPHONE APPLICATION FOR ADDED PSYCHOLOGICAL WELLBEING IN CD. | 202600369349100525 |
| 2025 | National Association of School Nurses Inc Silver Spring, MD | B | $763,279 | paid | PROVIDING COORDINATED CARE AND CAPTURING OUTCOMES FOR STUDENTS WITH T1D SCHOOL NURSE-LED PILOT PROJECT | 202600369349100525 |
| 2025 | Board of Trustees of the Leland Stanford Junior University Stanford, CA | B | $758,218 | paid | DEVELOPMENT OF PERSONALIZED DECISION SUPPORT TOOL USING NETIOB TO HELP MANAGE EXERCISE FOR PEOPLE WITH T1D | 202600369349100525 |
| 2025 | Mckenzie County Healthcare Systems Inc Watford City, ND | B | $757,493 | paid | MCKENZIE HEALTH ULTRASOUND INITIATIVE | 202600369349100525 |
| 2025 | University of Western Ontario London | D | $756,873 | approved, future | ENDPOINT DEVELOPMENT FOR OSTOMY CLINICAL TRIALS (ENDO-TRIAL) CONSORTIUM | 202600369349100525 |
| 2025 | The Sheba Fund for Health Services and Research Ramat Gan | U | $756,699 | paid | ISRAEL IBD RESEARCH NUCLEUS (IIRN) CONSORTIUM CAPSULE & OMICS FOR PREDICTING EXACERBATION OF CROHNS DISEASE (CORE-CD) | 202600369349100525 |
| 2025 | National Committee for Quality Assurance Washington, DC | B | $753,478 | paid | NCQA DIABETES RECOGNITION PROGRAM REFRESH & DIABETES MEASURE DEVELOPMENT | 202600369349100525 |
| 2025 | The Max Stern Academic College of Emek Yezreel Ltd Yezreel Valley | U | $751,269 | paid | NURSING SIMULATION CENTER UPGRADES | 202600369349100525 |
| 2025 | Galilee Medical Center Nahariya | U | $750,000 | paid | RENOVATION OF ONE FLOOR OF THE INTERNAL MEDICINE BUILDING AT GALILEE MEDICAL CENTER | 202600369349100525 |
| 2025 | Galilee Medical Center Nahariya | U | $750,000 | approved, future | RENOVATION OF ONE FLOOR OF THE INTERNAL MEDICINE BUILDING AT GALILEE MEDICAL CENTER | 202600369349100525 |
| 2025 | Johns Hopkins University Baltimore, MD | U | $750,000 | paid | ENGINEERED CYTOKINE/ANTIBODY FUSION PROTEIN TO TREAT CROHNS DISEASE | 202600369349100525 |
| 2025 | Anthos Home Inc Brooklyn, NY | C | $750,000 | approved, future | LAUNCHING ANTHOS HOME, WITH SPECIALIZED FOCUS ON HOUSING HIGH-NEED PATIENTS | 202600369349100525 |
| 2025 | City Parks Foundation Inc New York, NY | B | $750,000 | paid | NYC GREEN FUND | 202600369349100525 |
| 2025 | The Jewish Agency for Israel Jerusalem | D | $750,000 | paid | BAYIT PROJECT, COMMUNAL MULTI-FAMILY SHELTERS AT THE SHOSHANA ABSORPTION CENTER IN KIRYAT GAT | 202600369349100525 |
| 2025 | Institute for Community Living Inc New York City, NY | B | $749,790 | paid | PILOTING A THREE-YEAR IMT/ACT STEP-DOWN PROJECT | 202600369349100525 |
| 2025 | Institute for Community Living Inc New York City, NY | B | $749,790 | approved, future | PILOTING A THREE-YEAR IMT/ACT STEP-DOWN PROJECT | 202600369349100525 |
| 2025 | Alimentiv Inc London | U | $749,412 | approved, future | VALIDATION OF THE PRO SYMPTOMS AND IMPACTS QUESTIONNAIRE FOR CROHNS DISEASE | 202600369349100525 |
| 2025 | Rambam Health Corporation Haifa | D | $746,990 | approved, future | ISRAELI IBD RESEARCH NUCLEUS (IIRN) CONSORTIUM MICROBIAL AND DIETARY EFFECTS ON IMMUNE COMPOSITION AND FUNCTION IN PATIENTS WITH CD. | 202600369349100525 |
| 2025 | Wyoming Association of Sheriffs and Chiefs of Police Douglas, WY | B | $746,408 | approved, future | WYOMING VIRTUAL CRISIS CARE PILOT PROGRAM | 202600369349100525 |
| 2025 | Crohn's & Colitis Foundation Inc New York, NY | B | $744,245 | paid | ACCELERATING ENROLLMENT IN IBD CLINICAL TRIALS | 202600369349100525 |
| 2025 | Mercy Hospital of Devils Lake Devils Lake, ND | U | $743,309 | paid | CHI ST. ALEXIUS HEALTH DEVILS LAKE ULTRASOUND INITIATIVE | 202600369349100525 |
| 2025 | Johns Hopkins University Baltimore, MD | U | $742,901 | paid | DEVELOPMENT OF AN APTAMER-BASED BIOSENSOR FOR CONTINUOUS INSULIN MONITORING | 202600369349100525 |
| 2025 | Crohn's & Colitis Foundation Inc New York, NY | B | $739,745 | approved, future | ACHIEVING REMISSION IN IBD OPTIMIZING TREAT-TO-TARGET IN CLINICAL PRACTICE | 202600369349100525 |
| 2025 | Mass General Brigham for the Massachusetts General Hospital Boston, MA | U | $734,202 | approved, future | VALIDATION OF WIRELESS THERMAL AND MICROSCOPIC IMAGING TECHNOLOGY FOR QUANTIFYING INFLAMMATION AND FIBROSIS IN CROHNS DISEASE | 202600369349100525 |
| 2025 | Cedars-Sinai Medical Center Los Angeles, CA | B | $733,694 | paid | THE ADVANCED DIETARY IBD EDUCATION AND TRAINING (DIET) PROGRAM BEYOND MALNUTRITION | 202600369349100525 |
| 2025 | Children's Hospital Medical Center Cincinnati, OH | B | $733,121 | approved, future | VALIDATION OF A PERIPHERAL BLOOD BIOMARKER SIGNATURE FOR ANTI-TNF RESPONSE IN PATIENTS WITH CROHNS DISEASE (ATPBIOS) | 202600369349100525 |
| 2025 | Children's Hospital Corporation Boston, MA | C | $732,284 | paid | NOVEL GLUCOSE BINDERS FOR THE DEVELOPMENT OF GLUCOSE RESPONSIVE INSULIN (GRI) | 202600369349100525 |
| 2025 | The Chancellor Masters and Scholars of the University of Cambridge Cambridge | D | $726,752 | approved, future | DOES THE WESTERN DIET TRIGGER CROHN'S DISEASE VIA OSMOTIC STRESS? | 202600369349100525 |
| 2025 | Children's Hospital Medical Center Cincinnati, OH | B | $725,157 | paid | DELIVERY SYSTEM REDESIGN TO IMPROVE CARE FOR LOW-INCOME YOUTH WITH T1D | 202600369349100525 |
| 2025 | The Cleveland Clinic Foundation Cleveland, OH | C | $719,051 | approved, future | ENDPOINT DEVELOPMENT FOR OSTOMY CLINICAL TRIALS (ENDO-TRIAL) CONSORTIUM | 202600369349100525 |
| 2025 | The Chancellor Masters and Scholars of the University of Cambridge Cambridge | D | $718,215 | approved, future | EPIGENETIC REGULATION OF INTESTINAL EPITHELIAL MHC CLASS 1 SIGNALLING - A NOVEL MECHANISM IN THE PATHOGENESIS OF CROHNS DISEASE | 202600369349100525 |
| 2025 | University of Iowa Iowa City, IA | U | $714,411 | paid | SIMULATION IN MOTION IOWA (SIM-IA) | 202600369349100525 |
| 2025 | The Regents of the University of Colorado Denver Aurora, CO | D | $706,939 | approved, future | PRENATAL AND OBSTETRIC MATERNAL EXPOSURES AND ISLET AUTOIMMUNITY IN EARLY LIFE (PROMISE) | 202600369349100525 |
| 2025 | Dartmouth- Hitchcock Clinic Lebanon, NH | B | $706,219 | paid | CAPACITY BUILDING FOR DARTMOUTH-HITCHCOCK'S VIRTUAL IBD TELEMEDICINE NETWORK PROGRAM | 202600369349100525 |
| 2025 | University of Notre Dame du Lac Notre Dame, ID | U | $705,510 | paid | DEVELOPMENT OF A NOVEL GLUCOSE-RESPONSIVE GLUCAGON DELIVERY SYSTEM | 202600369349100525 |
| 2025 | Clalit Health Services Tel Aviv | U | $700,000 | paid | A NEW NEONATAL CENTER FOR ISRAELS SOUTHERN PERIPHERY AT SOROKA MEDICAL CENTER | 202600369349100525 |
| 2025 | The Association for the Resident and Community in Ramat Hanegev Ramat Hanegev | U | $699,190 | approved, future | RAMAT HANEGEV SENIOR CITIZEN CENTER | 202600369349100525 |
| 2025 | Lutheran Charity Association Jamestown, ND | B | $693,723 | paid | JAMESTOWN REGIONAL MEDICAL CENTER ULTRASOUND INITIATIVE | 202600369349100525 |
| 2025 | The University of Manchester Manchester | U | $692,839 | approved, future | A MAP OF THE INTESTINE FOLLOWING REGULATORY T CELL INFUSION INTO PATIENTS WITH ACTIVE CROHNS DISEASE AT SINGLE-CELL AND SPATIAL RESOLUTION | 202600369349100525 |
| 2025 | University of Exeter Exeter | U | $692,073 | approved, future | UNCOVERING NEW GENETIC MECHANISMS UNDERLYING EXTREME EARLY-ONSET TYPE 1 DIABETES | 202600369349100525 |
| 2025 | International Bowel Ultrasound Group Ev Munster | U | $688,466 | approved, future | THE EXTENT STUDY (CALCULATING THE LEMANN INDEX USING INTESTINAL ULTRASOUND) | 202600369349100525 |
| 2025 | The Regents of the University of Colorado Denver Aurora, CO | D | $686,820 | paid | SEEDS PATHWAY SHARED EMPOWERMENT FOR EARLY DEVICE SUCCESS OF DIABETES TECHNOLOGY | 202600369349100525 |
| 2025 | Stichting Pharmaccess International Amsterdam | U | $686,565 | paid | SAFECARE A BUSINESS MODEL FOR HEALTHCARE QUALITY | 202600369349100525 |
| 2025 | The University of Edinburgh Edinburgh | U | $682,311 | paid | MITOCHONDRIAL DAMPS AS MECHANISTIC BIOMARKERS OF MUCOSAL INFLAMMATION IN CROHNS DISEASE (MUSIC) | 202600369349100525 |
| 2025 | Holon Institute of Technology - Hit Holon | U | $681,350 | paid | MEDICAL TECHNOLOGIES BUILDING AT THE HOLON INSTITUTE OF TECHNOLOGY (HIT) | 202600369349100525 |
| 2025 | University Hospitals Health System Inc Cleveland, OH | U | $677,700 | approved, future | TYPE 1 DIABETES FINANCIAL TOOLKIT FOR EMERGING ADULTS | 202600369349100525 |
| 2025 | Board of Trustees of the Leland Stanford Junior University Stanford, CA | B | $667,666 | paid | DETERMINING THE THERAPEUTIC POTENTIAL OF STATINS ON STRICTURING CROHNS DISEASE | 202600369349100525 |
| 2025 | Care-for-Rare Foundation Munich | U | $667,252 | paid | VERY EARLY ONSET INFLAMMATORY BOWEL DISEASE (VEOIBD) PRECISION MOLECULAR DIAGNOSES TO TARGETED THERAPIES MUNICH STUDIES | 202600369349100525 |
| 2025 | Icahn School of Medicine at Mount Sinai New York City, NY | B | $663,610 | approved, future | EARLY LIFE EXPOSOME BIOMARKERS AND CROHN'S DISEASE RISK THE EARLY-CD PROJECT | 202600369349100525 |
| 2025 | Cork University Foundation Cork | U | $663,503 | approved, future | ENDOSCOPIC MULTIMODAL ASSESSMENT USING ADVANCED IMAGING INTEGRATED AI TO PREDICT RECURRENCE IN POST-OPERATIVE CROHNS DISEASE - PROSPERS | 202600369349100525 |
| 2025 | Bipartisan Policy Center Inc Washington, DC | B | $658,783 | paid | STRENGTHENING RURAL HEALTH CARE DELIVERY AND SERVICES | 202600369349100525 |
| 2025 | Cambridge University Hospitals Nhs Foundation Trust Cambridge | U | $657,605 | approved, future | THE UK IBD BIORESOURCE TRANSLATING TODAYS SCIENCE INTO TOMORROWS TREATMENTS IN CROHNS DISEASE | 202600369349100525 |
| 2025 | T1d Exchange Inc Boston, MA | U | $650,000 | paid | EQUITABLE HEALTH AND PSYCHOSOCIAL OUTCOMES FOR INDIVIDUALS LIVING WITH T1D THROUGH THE T1D EXCHANGE QUALITY IMPROVEMENT COLLABORATIVE AND REGISTRY | 202600369349100525 |
| 2025 | Christian Unity Hospital Corporation Grafton, ND | B | $646,571 | paid | NORTH DAKOTA ULTRASOUND INITIATIVE | 202600369349100525 |
| 2025 | The University of Edinburgh Edinburgh | U | $646,292 | approved, future | REPURPOSING POSITIVE ALLOSTERIC MODULATORS OF GLUTAMATE RECEPTORS TO PREVENT HYPOGLYCEMIA IN TYPE 1 DIABETES A PILOT CLINICAL STUDY | 202600369349100525 |
| 2025 | International Bowel Ultrasound Group Ev Munster | U | $645,000 | paid | DEVELOPMENT OF ELEARNING PLATFORM FOR STANDARDIZATION AND DISSEMINATION OF INTESTINAL ULTRASOUND EDUCATION GLOBALLY (IBUS EIUS ED) | 202600369349100525 |
| 2025 | Beyond Type 1 San Mateo, CA | D | $645,000 | approved, future | CAPACITY BUILDING SUPPORT | 202600369349100525 |
| 2025 | Association of Diabetes Care & Education Specialists Chicago, IL | B | $640,509 | approved, future | DANATECH DIABETES TECHNOLOGY PLATFORM EXPANSION & MAINTENANCE | 202600369349100525 |
| 2025 | T1d Exchange Inc Boston, MA | U | $633,709 | paid | EQUITABLE HEALTH AND PSYCHOSOCIAL OUTCOMES FOR INDIVIDUALS LIVING WITH T1D THROUGH THE T1D EXCHANGE QUALITY IMPROVEMENT COLLABORATIVE AND REGISTRY | 202600369349100525 |
| 2025 | St Josephs Hospital and Health Center Dickinson, ND | U | $632,439 | paid | CHI ST. ALEXIUS HEALTH DICKINSON ULTRASOUND INITIATIVE | 202600369349100525 |
| 2025 | Crohn's & Colitis Foundation Inc New York, NY | B | $626,728 | approved, future | APPLICATION OF MACHINE LEARNING TO PRECISION NUTRITION IN CROHNS DISEASE | 202600369349100525 |
| 2025 | Center for Health Care Strategies Inc Hamilton, NJ | B | $626,707 | approved, future | CGM MEDICAID ACCESS ACCELERATOR - TARGETED RESOURCES AND TECHNICAL ASSISTANCE TO IMPROVE CARE FOR PEOPLE LIVING WITH DIABETES WHO USE INSULIN | 202600369349100525 |
| 2025 | Snv Netherlands Development Organisation Den Haag | U | $626,684 | approved, future | SCALING THE HEALTHY FUTURE FOR ALL MODEL | 202600369349100525 |
| 2025 | Chancellor Masters & Scholars of the University of Oxford Oxford | D | $625,660 | approved, future | DEFINING THE SIGNALING CIRCUITS AND REGULONS MEDIATING CROHNS FIBROSIS. | 202600369349100525 |
| 2025 | National Committee for Quality Assurance Washington, DC | B | $621,487 | paid | NCQA DIABETES RECOGNITION PROGRAM REFRESH & DIABETES MEASURE DEVELOPMENT | 202600369349100525 |
| 2025 | The Regents of the University of California at Irvine Irvine, CA | C | $620,649 | approved, future | DEVELOPMENT OF A MULTI-ANALYTE SENSOR - GLUCOSE, LACTATE, OXYGEN, KETONES, INSULIN FOR PEOPLE WITH T1D | 202600369349100525 |
| 2025 | Mercy Medical Center Williston, ND | U | $619,183 | paid | CHI ST. ALEXIUS HEALTH WILLISTON ULTRASOUND INITIATIVE | 202600369349100525 |
| 2025 | Icahn School of Medicine at Mount Sinai New York City, NY | B | $618,257 | paid | EARLY LIFE EXPOSOME BIOMARKERS AND CROHN'S DISEASE RISK THE EARLY-CD PROJECT | 202600369349100525 |
| 2025 | Seattle Children's Hospital Seattle, WA | U | $616,923 | approved, future | EXPANDING USE OF ENGINEERED TREGS IN T1D THERAPY (PHASE 4) | 202600369349100525 |
| 2025 | New York City Health and Hospitals Corporation New York, NY | B | $614,668 | paid | EXPRESSCARE TELE-BEHAVIORAL HEALTH SERVICE LAUNCH AND TAILORED SERVICE STRATEGIES FOR HIGH NEEDS PATIENTS IN NYC | 202600369349100525 |
| 2025 | Chancellor Masters & Scholars of the University of Oxford Oxford | D | $612,471 | paid | DEFINING THE SIGNALING CIRCUITS AND REGULONS MEDIATING CROHNS FIBROSIS. | 202600369349100525 |
| 2025 | Seattle Children's Hospital Seattle, WA | U | $609,141 | paid | EXPANDING USE OF ENGINEERED TREGS IN T1D THERAPY (PHASE 4) | 202600369349100525 |
| 2025 | Saint Louis University Saint Louis, MO | B | $608,523 | paid | IDENTIFY AND VALIDATE POTENTIAL THERAPEUTIC TARGETS TO PREVENT HYPOGLYCEMIA IN TYPE 1 DIABETES | 202600369349100525 |
| 2025 | Chancellor Masters & Scholars of the University of Oxford Oxford | D | $607,072 | approved, future | DEFINING THE SIGNALING CIRCUITS AND REGULONS MEDIATING CROHNS FIBROSIS. | 202600369349100525 |
| 2025 | University of Western Ontario London | D | $606,448 | approved, future | ENDPOINT DEVELOPMENT FOR OSTOMY CLINICAL TRIALS (ENDO-TRIAL) CONSORTIUM | 202600369349100525 |
| 2025 | Yale University New Haven, CT | U | $605,522 | approved, future | TARGETING NEWLY DISCOVERED HOST-MICROBIOTA INTERACTION NODES TO TREAT OR PREVENT CROHNS DISEASE | 202600369349100525 |
| 2025 | Beyond Type 1 San Mateo, CA | D | $600,000 | paid | CAPACITY BUILDING SUPPORT | 202600369349100525 |
| 2025 | Beyond Type 1 San Mateo, CA | D | $600,000 | paid | CAPACITY BUILDING SUPPORT | 202600369349100525 |
| 2025 | Yale University New Haven, CT | U | $599,035 | paid | TARGETING NEWLY DISCOVERED HOST-MICROBIOTA INTERACTION NODES TO TREAT OR PREVENT CROHNS DISEASE | 202600369349100525 |
| 2025 | The Regents of the University of Colorado Denver Aurora, CO | D | $598,309 | paid | SEEDS PATHWAY SHARED EMPOWERMENT FOR EARLY DEVICE SUCCESS OF DIABETES TECHNOLOGY | 202600369349100525 |
| 2025 | Icahn School of Medicine at Mount Sinai New York City, NY | B | $597,244 | approved, future | THE WOMEN WITH INFLAMMATORY BOWEL DISEASE AND MOTHERHOOD (WISDOM) REGISTRY A PROSPECTIVE STUDY OF FEMALE FERTILITY IN IBD | 202600369349100525 |
| 2025 | Board of Trustees of the Leland Stanford Junior University Stanford, CA | B | $591,775 | approved, future | DETERMINING THE THERAPEUTIC POTENTIAL OF STATINS ON STRICTURING CROHNS DISEASE | 202600369349100525 |
| 2025 | Association Sante Diabete Grenoble | U | $587,221 | paid | STRENGTHEN THE CARE AND SUPPORT OF PATIENTS WITH TYPE 1 DIABETES IN MALI, BURKINA FASO, AND THE UNION OF THE COMOROS | 202600369349100525 |
| 2025 | Association Sante Diabete Grenoble | U | $587,221 | approved, future | STRENGTHEN THE CARE AND SUPPORT OF PATIENTS WITH TYPE 1 DIABETES IN MALI, BURKINA FASO, AND THE UNION OF THE COMOROS | 202600369349100525 |
| 2025 | Icahn School of Medicine at Mount Sinai New York City, NY | B | $587,152 | approved, future | DEFINING THE PRE-DISEASE PHASE OF CROHNS DISEASE PREDICT AND PREVENT | 202600369349100525 |
| 2025 | University of Florida Gainesville, FL | U | $586,219 | approved, future | HUMAN ATLAS OF NEONATAL DEVELOPMENT AND EARLY LIFE-IMMUNITY (HANDEL-I) CONTINUATION | 202600369349100525 |
| 2025 | Breaking Ground Housing Development Fund Corporation New York, NY | B | $585,924 | approved, future | PILOTING AND EVALUATING THE HEALTH EFFECTS OF ACCELERATED PLACEMENTS INTO PERMANENT SUPPORTIVE HOUSING | 202600369349100525 |
| 2025 | Regents of the University of Minnesota Minneapolis, MN | U | $585,172 | approved, future | STANDARDIZED MICROBIOTA TRANSPLANT THERAPY IN CROHNS DISEASE. PILOT TRIAL. | 202600369349100525 |
| 2025 | Bipartisan Policy Center Inc Washington, DC | B | $584,923 | approved, future | STRENGTHENING RURAL HEALTH CARE DELIVERY AND SERVICES | 202600369349100525 |
| 2025 | Icahn School of Medicine at Mount Sinai New York City, NY | B | $583,881 | paid | DEVELOPMENT OF NOVEL LRRK2 INHIBITORS TO TREAT CROHNS DISEASE | 202600369349100525 |
| 2025 | Icahn School of Medicine at Mount Sinai New York City, NY | B | $583,880 | approved, future | DEVELOPMENT OF NOVEL LRRK2 INHIBITORS TO TREAT CROHNS DISEASE | 202600369349100525 |
| 2025 | Sanford Research Sioux Falls, SD | C | $583,363 | approved, future | PLEDGE PHASE 3 | 202600369349100525 |
| 2025 | Children's Hospital Medical Center Cincinnati, OH | B | $583,113 | paid | VALIDATION OF A PERIPHERAL BLOOD BIOMARKER SIGNATURE FOR ANTI-TNF RESPONSE IN PATIENTS WITH CROHNS DISEASE (ATPBIOS) | 202600369349100525 |
| 2025 | Icahn School of Medicine at Mount Sinai New York City, NY | B | $580,306 | approved, future | THE WOMEN WITH INFLAMMATORY BOWEL DISEASE AND MOTHERHOOD (WISDOM) REGISTRY A PROSPECTIVE STUDY OF FEMALE FERTILITY IN IBD | 202600369349100525 |
| 2025 | King's College London London | U | $579,408 | approved, future | PRENATAL DRIVERS OF INFANT ISLET AUTOIMMUNITY (PISA STUDY) | 202600369349100525 |
| 2025 | The Sonia Nabeta Foundation Inc Long Island City, NY | C | $578,470 | approved, future | WORLD OF WARRIORS | 202600369349100525 |
| 2025 | Fundacio de Recerca Clinic Barcelona Institut D'investigacions Biomed Barcelona | U | $576,960 | paid | EARLY DETECTION OF PERIANAL FISTULIZING DISEASE- PATHOPHYSIOLOGY AND IMAGING | 202600369349100525 |
| 2025 | Icahn School of Medicine at Mount Sinai New York City, NY | B | $574,537 | paid | THE WOMEN WITH INFLAMMATORY BOWEL DISEASE AND MOTHERHOOD (WISDOM) REGISTRY A PROSPECTIVE STUDY OF FEMALE FERTILITY IN IBD | 202600369349100525 |
| 2025 | Johns Hopkins University Baltimore, MD | U | $571,287 | approved, future | TARGETED, SUSTAINED RELEASE ANTIFIBROTIC THERAPIES FOR CROHNS DISEASE PATIENTS | 202600369349100525 |
| 2025 | Joslin Diabetes Center Inc Boston, MA | B | $569,990 | paid | AN INTEGRATED CARE MODEL FOR OLDER ADULTS WITH INSULIN-TREATED DIABETES | 202600369349100525 |
| 2025 | Breaking Ground Housing Development Fund Corporation New York, NY | B | $567,155 | paid | PILOTING AND EVALUATING THE HEALTH EFFECTS OF ACCELERATED PLACEMENTS INTO PERMANENT SUPPORTIVE HOUSING | 202600369349100525 |
| 2025 | Children's Hospital Medical Center Cincinnati, OH | B | $560,242 | approved, future | VALIDATION OF A PERIPHERAL BLOOD BIOMARKER SIGNATURE FOR ANTI-TNF RESPONSE IN PATIENTS WITH CROHNS DISEASE (ATPBIOS) | 202600369349100525 |
| 2025 | The Hospital for Sick Children Toronto | U | $555,480 | paid | VERY EARLY ONSET INFLAMMATORY BOWEL DISEASE (VEOIBD) PRECISION MOLECULAR DIAGNOSES TO TARGETED THERAPIES-TORONTO STUDIES | 202600369349100525 |
| 2025 | Beyond Type 1 San Mateo, CA | D | $555,000 | paid | CAPACITY BUILDING SUPPORT | 202600369349100525 |
| 2025 | The Regents of the University of Colorado Denver Aurora, CO | D | $552,433 | approved, future | IMPLEMENTATION OF EARLY STAGE T1D EDUCATION AND SUPPORT (ESTES) | 202600369349100525 |
| 2025 | University of Florida Gainesville, FL | U | $548,565 | paid | UNDERSTANDING T1D AND INSULIN-REQUIRING DIABETES IN FEDERALLY QUALIFIED HEALTH CENTERS (FQHC) A NATIONAL NEEDS ASSESSMENT | 202600369349100525 |
| 2025 | Mass General Brigham for the Brigham and Women's Hospital Boston, MA | U | $543,037 | paid | U.S. PREVENTIVE TYPE 1 DIABETES COALITION | 202600369349100525 |
| 2025 | Alliance of Community Health Plans Foundation Inc Washington, DC | B | $539,349 | paid | COLLABORATING WITH HEALTH PLANS TO OVERCOME BARRIERS TO COVERAGE AND UTILIZATION OF CONTINUOUS GLUCOSE MONITORING : LAYING THE FOUNDATION | 202600369349100525 |
| 2025 | Stichting Pharmaccess International Amsterdam | U | $538,692 | approved, future | SAFECARE A BUSINESS MODEL FOR HEALTHCARE QUALITY | 202600369349100525 |
| 2025 | Montana Pediatrics Missoula, MT | C | $536,186 | approved, future | CREATING A STATEWIDE MODEL OF CARE FOR CHILDREN WITH T1D | 202600369349100525 |
| 2025 | Icahn School of Medicine at Mount Sinai New York City, NY | B | $535,412 | approved, future | THE REFLECTION STUDY PREDICTING OUTCOMES FOLLOWING ILEOCECAL RESECTION IN CROHNS DISEASE. | 202600369349100525 |
| 2025 | Icahn School of Medicine at Mount Sinai New York City, NY | B | $531,966 | approved, future | COMBINATION THERAPY OF RESILIENCE INTERVENTION WITH BIOLOGICS IN CROHNS DISEASE [CATHARSIS TRIAL] | 202600369349100525 |
| 2025 | Jaeb Center for Health Research Foundation Inc Tampa, FL | C | $531,921 | approved, future | EVALUATION OF THE RELATIONSHIP OF GLUCOSE METRICS VIA CONTINUOUS GLUCOSE MONITORING WITH DIABETIC RETINOPATHY | 202600369349100525 |
| 2025 | Children's Hospital Los Angeles Los Angeles, CA | U | $531,630 | approved, future | BEYOND COYOT1 EXPANSION OF PATIENT-CENTERED VIRTUAL CARE | 202600369349100525 |
| 2025 | Sanford Research Sioux Falls, SD | C | $528,559 | paid | PLEDGE PHASE 3 | 202600369349100525 |
| 2025 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $526,471 | approved, future | THE GPPAD-04 STUDY SUPPLEMENTATION WITH B. INFANTIS FOR MITIGATION OF TYPE 1 DIABETES AUTOIMMUNITY (SINT1A) | 202600369349100525 |
| 2025 | Cardiff University Wales | U | $525,638 | approved, future | T1D-PLUS AN ADAPTIVE TRIAL PLATFORM FOR THE STUDY OF COMBINATION THERAPIES IN NEW-ONSET T1D | 202600369349100525 |
| 2025 | Cardiff University Wales | U | $525,638 | approved, future | T1D-PLUS AN ADAPTIVE TRIAL PLATFORM FOR THE STUDY OF COMBINATION THERAPIES IN NEW-ONSET T1D | 202600369349100525 |
| 2025 | University of Melbourne Victoria | D | $524,787 | approved, future | USE OF WHEY PROTEIN TO REDUCE RISK OF HYPOGLYCEMIA DURING EXERCISE FOR PEOPLE WITH T1D | 202600369349100525 |
| 2025 | Icahn School of Medicine at Mount Sinai New York City, NY | B | $523,716 | paid | COMBINATION THERAPY OF RESILIENCE INTERVENTION WITH BIOLOGICS IN CROHNS DISEASE [CATHARSIS TRIAL] | 202600369349100525 |
| 2025 | Icahn School of Medicine at Mount Sinai New York City, NY | B | $520,141 | approved, future | COMBINATION THERAPY OF RESILIENCE INTERVENTION WITH BIOLOGICS IN CROHNS DISEASE [CATHARSIS TRIAL] | 202600369349100525 |
| 2025 | Cedars-Sinai Medical Center Los Angeles, CA | B | $519,768 | paid | THE ADVANCED DIETARY IBD EDUCATION AND TRAINING (DIET) PROGRAM BEYOND MALNUTRITION | 202600369349100525 |
| 2025 | Chancellor Masters & Scholars of the University of Oxford Oxford | D | $515,981 | approved, future | ALPHA CELL FUNCTION IN PEOPLE WITH TYPE 1 DIABETES WITH AND WITHOUT SEVERE HYPOGLYCEMIA | 202600369349100525 |
| 2025 | The Sonia Nabeta Foundation Inc Long Island City, NY | C | $514,210 | approved, future | WORLD OF WARRIORS | 202600369349100525 |
| 2025 | The Regents of the University of Colorado Denver Aurora, CO | D | $513,331 | paid | IMPACT OF MENSTRUATION ON GLYCEMIC RESPONSE AND EXERCISE | 202600369349100525 |
| 2025 | Regents of the University of Minnesota Minneapolis, MN | U | $502,750 | approved, future | ENGINEERING ANTIGEN-SPECIFIC REGULATORY T CELLS FOR USE IN TYPE 1 DIABETES (PHASE 3) | 202600369349100525 |
| 2025 | Regents of the University of Minnesota Minneapolis, MN | U | $502,750 | paid | ENGINEERING ANTIGEN-SPECIFIC REGULATORY T CELLS FOR USE IN TYPE 1 DIABETES (PHASE 3) | 202600369349100525 |
| 2025 | The Regents of the University of Colorado Denver Aurora, CO | D | $501,000 | paid | T AND B CELL RECEPTOR ATLAS ACROSS TISSUES AND STAGES OF TYPE 1 DIABETES | 202600369349100525 |
| 2025 | The Regents of the University of Colorado Denver Aurora, CO | D | $501,000 | approved, future | T AND B CELL RECEPTOR ATLAS ACROSS TISSUES AND STAGES OF TYPE 1 DIABETES | 202600369349100525 |
| 2025 | Convergent Impact Inc Boulder, CO | B | $500,000 | paid | COLLABORATIVE ON HOUSING FOR HEALTH | 202600369349100525 |
| 2025 | The Regents of the University of Colorado Denver Aurora, CO | D | $500,000 | paid | ASK THE EXPERTS 2024 | 202600369349100525 |
| 2025 | Alliance of Community Health Plans Foundation Inc Washington, DC | B | $500,000 | paid | COLLABORATING WITH HEALTH PLANS TO OVERCOME BARRIERS TO COVERAGE AND UTILIZATION OF CONTINUOUS GLUCOSE MONITORING : LAYING THE FOUNDATION | 202600369349100525 |
| 2025 | Corporation for Supportive Housing New York City, NY | B | $500,000 | paid | HEALTH-ENRICHED SERVICES PILOTS FOR SUPPORTIVE HOUSING | 202600369349100525 |
| 2025 | Nuru International Washington, CA | U | $500,000 | paid | EXPANSION OF AGRIBUSINESS | 202600369349100525 |
| 2025 | Breakthrough T1d New York, NY | B | $500,000 | approved, future | JOINING FORCES BUILDING A SHARED 'GRAND ACCESS STRATEGY' FOR SAVING T1D LIVES | 202600369349100525 |
| 2025 | City Parks Foundation Inc New York, NY | B | $500,000 | approved, future | NYC GREEN FUND | 202600369349100525 |
| 2025 | Corporation for Supportive Housing New York City, NY | B | $500,000 | approved, future | HEALTH-ENRICHED SERVICES PILOTS FOR SUPPORTIVE HOUSING | 202600369349100525 |
| 2025 | Critical Path Institute Tucson, AZ | B | $500,000 | paid | TRANSLATIONAL THERAPEUTICS ACCELERATOR DEVELOPING KINASE INHIBITORS OF THE UNFOLDED PROTEIN RESPONSE TO TREAT T1D | 202600369349100525 |
| 2025 | Jerusalem Foundation Inc New York, NY | C | $500,000 | approved, future | BUILDING A NEW HOME FOR TSAD KADIMA | 202600369349100525 |
| 2025 | Jerusalem Foundation Inc New York, NY | C | $500,000 | paid | BUILDING A NEW HOME FOR TSAD KADIMA | 202600369349100525 |
| 2025 | Anthos Home Inc Brooklyn, NY | C | $500,000 | paid | LAUNCHING ANTHOS HOME, WITH SPECIALIZED FOCUS ON HOUSING HIGH-NEED PATIENTS | 202600369349100525 |
| 2025 | Healing Hands of Joy Charlotte, NC | B | $500,000 | paid | ELIMINATION OF OBSTETRIC FISTULA | 202600369349100525 |
| 2025 | The Regents of the University of Colorado Denver Aurora, CO | D | $499,998 | approved, future | ASK THE EXPERTS 2024 | 202600369349100525 |
| 2025 | The Regents of the University of Colorado Denver Aurora, CO | D | $499,995 | approved, future | ASK THE EXPERTS 2024 | 202600369349100525 |
| 2025 | Kyler Cares Foundation New Orleans, LA | C | $495,000 | approved, future | CAPACITY BUILDING SUPPORT | 202600369349100525 |
| 2025 | North Dakota State University Fargo, ND | B | $494,155 | approved, future | EXPANDING RURAL SONOGRAPHY EXPERTISE IN NORTH DAKOTA | 202600369349100525 |
| 2025 | Convergent Impact Inc Boulder, CO | B | $492,300 | approved, future | COLLABORATIVE ON HOUSING FOR HEALTH | 202600369349100525 |
| 2025 | Katholieke Universiteit Te Leuven Leuven | U | $490,041 | approved, future | COMBINATION THERAPY OF DIET WITH BIOLOGICALS FOR CROHNS DISEASE THE OATS STUDY | 202600369349100525 |
| 2025 | International Bowel Ultrasound Group Ev Munster | U | $488,553 | paid | THE EXTENT STUDY (CALCULATING THE LEMANN INDEX USING INTESTINAL ULTRASOUND) | 202600369349100525 |
| 2025 | Washington University Saint Louis, MO | B | $488,300 | paid | CELLULAR BIOMARKERS FOR PEDIATRIC CROHNS DISEASE | 202600369349100525 |
| 2025 | Billings Clinic Foundation Billings, MT | B | $485,826 | approved, future | EXPANDING ECMO SERVICES AT BILLINGS CLINIC | 202600369349100525 |
| 2025 | Georgia Tech Research Corporation Atlanta, GA | C | $485,616 | paid | LONGITUDINAL TRACKING AND REFERENCE-BASED INTERPRETATION OF SINGLE-CELL CHARACTERISTICS IN TREATMENT NAVE PATIENTS WITH CROHNS DISEASE | 202600369349100525 |
| 2025 | University of Notre Dame du Lac Notre Dame, ID | U | $483,726 | paid | GLUCOSE-BINDING MOTIFS FROM DYNAMIC COMBINATORIAL LANDSCAPES | 202600369349100525 |
| 2025 | The Sonia Nabeta Foundation Inc Long Island City, NY | C | $482,110 | paid | WORLD OF WARRIORS | 202600369349100525 |
| 2025 | American Diabetes Association Inc Arlington, VA | B | $480,260 | approved, future | 2025-2027 TYPE 1 DIABETES CAMP INITIATIVE | 202600369349100525 |
| 2025 | American Diabetes Association Inc Arlington, VA | B | $480,260 | approved, future | 2025-2027 TYPE 1 DIABETES CAMP INITIATIVE | 202600369349100525 |
| 2025 | American Diabetes Association Inc Arlington, VA | B | $480,260 | paid | 2025-2027 TYPE 1 DIABETES CAMP INITIATIVE | 202600369349100525 |
| 2025 | University of Birmingham Birmingham | U | $479,888 | approved, future | CREATING AN OPTIMISED ANTIGEN-SPECIFIC IMMUNOTHERAPY FOR TYPE 1 DIABETES | 202600369349100525 |
| 2025 | The Bionics Institute of Australia East Melbourne | U | $477,568 | approved, future | PATIENT-SPECIFIC ADAPTIVE, ELECTRIC THERAPY FOR CROHNS DISEASE | 202600369349100525 |
| 2025 | Trustees of Indiana University Bloomington, ID | U | $475,212 | approved, future | THE FINDING IMMUNE NASCENT DIABETES (FIND-T1D) | 202600369349100525 |
| 2025 | University of Massachusetts Medical School Worcester, MA | U | $473,409 | paid | DIETA ANTI-INFLAMATORIA A CROHNS DISEASE MANAGEMENT STRATEGY TAILORED FOR PUERTO RICANS | 202600369349100525 |
| 2025 | The Regents of the University of California San Diego La Jolla, CA | C | $471,131 | approved, future | MECHANISM OF ACTION AND SAFETY STUDY OF LIVER TARGETED INSULIN | 202600369349100525 |
| 2025 | Alimentiv Inc London | U | $469,915 | paid | VALIDATION OF THE PRO SYMPTOMS AND IMPACTS QUESTIONNAIRE FOR CROHNS DISEASE | 202600369349100525 |
| 2025 | Mass General Brigham for the Brigham and Women's Hospital Boston, MA | U | $469,406 | approved, future | U.S. PREVENTIVE TYPE 1 DIABETES COALITION | 202600369349100525 |
| 2025 | Good Samaritan Hospital Association Rugby, ND | B | $468,841 | paid | HEART OF AMERICA MEDICAL CENTER ULTRASOUND INITIATIVE | 202600369349100525 |
| 2025 | Solidaridad Network Foundation Limited Lusaka | U | $468,562 | paid | HOOVES FOR SUSTAINABILITY (H4S) | 202600369349100525 |
| 2025 | Crohn's and Colitis Uk Hatfield | U | $467,726 | paid | IMPLEMENTATION OF A LOWER GI DIAGNOSTIC PATHWAY IN PRIMARY HEALTHCARE AND DEVELOPMENT AND DISSEMINATION OF A LOWER GI PATIENT TOOLKIT | 202600369349100525 |
| 2025 | City Parks Foundation Inc New York, NY | B | $466,100 | paid | STRENGTHENING NYCS URBAN FOREST PLAN PUBLIC PARK LANDS | 202600369349100525 |
| 2025 | University of Exeter Exeter | U | $465,868 | approved, future | EXTREMELY EARLY ONSET TYPE 1 DIABETES (EXE T1D) PHASE 2 FROM OBSERVATION TO MECHANISM | 202600369349100525 |
| 2025 | Clalit Health Services Tel Aviv | U | $463,512 | paid | ISRAELI IBD RESEARCH NUCLEUS (IIRN) CONSORTIUM BIOMARKER-BASED MULTIDISCIPLINARY TEAM APPROACH TO IMPROVE EARLY CROHN'S DISEASE OUTCOMES | 202600369349100525 |
| 2025 | The Regents of the University of Colorado Denver Aurora, CO | D | $459,401 | approved, future | EPIGENOMIC BIOMARKERS OF THE INCOMPLETE MATERNAL PROTECTION IN TYPE 1 DIABETES | 202600369349100525 |
| 2025 | Chi Health Foundation Omaha, NE | U | $458,920 | paid | ECMO SUPPORT AT CHI HEALTH CREIGHTON UNIVERSITY MEDICAL CENTER-BERGAN MERCY | 202600369349100525 |
| 2025 | University of Wyoming Foundation Laramie, WY | B | $458,857 | approved, future | ULTRASOUND TRAINING INITIATIVE IN WYOMING | 202600369349100525 |
| 2025 | University of Wyoming Foundation Laramie, WY | B | $458,857 | approved, future | ULTRASOUND TRAINING INITIATIVE IN WYOMING | 202600369349100525 |
| 2025 | The Regents of the University of California San Francisco San Francisco, CA | U | $458,242 | approved, future | IDENTIFICATION AND ANALYSIS OF EXTREME FORMS OF TYPE 1 DIABETES, ESTABLISHMENT OF A DATA COMMONS | 202600369349100525 |
| 2025 | The Regents of the University of Colorado Denver Aurora, CO | D | $457,178 | paid | EPITHELIAL MITOCHONDRIAL DYSFUNCTION AND EXTRACELLULAR VESICLES IN CROHNS DISEASE FIBROSTENOSIS. | 202600369349100525 |
| 2025 | American Diabetes Association Inc Arlington, VA | B | $455,274 | paid | TRAINING AND MENTORSHIP PROGRAMS | 202600369349100525 |
| 2025 | Yehuda Abarbanel Government Hospital Bat Yam | U | $454,960 | approved, future | MODERNIZATION OF ABARBANELS INFORMATION TECHNOLOGY AND SECURITY SYSTEMS | 202600369349100525 |
| 2025 | Trustees of Indiana University Bloomington, ID | U | $452,575 | approved, future | THE FINDING IMMUNE NASCENT DIABETES (FIND-T1D) | 202600369349100525 |
| 2025 | Supportive Housing Network of New York Inc New York City, NY | C | $450,000 | paid | TRAINING ACADEMY AND COMMUNITY OF PRACTICE FOR SUPPORTIVE HOUSING PROVIDERS | 202600369349100525 |
| 2025 | Billings Clinic Foundation Billings, MT | B | $449,629 | paid | EXPANDING ECMO SERVICES AT BILLINGS CLINIC | 202600369349100525 |
| 2025 | Jdrf Australia Sydney | U | $448,818 | approved, future | ENDIA FOLLOW UP 2023-2025 SAMPLES ANALYSIS RFA | 202600369349100525 |
| 2025 | Children's Hospital Medical Center Cincinnati, OH | B | $439,601 | paid | ROLE OF PPAR-ALPHA IN PROMOTING BRUSH BORDER MATURITY OF INTESTINAL ENTEROCYTES | 202600369349100525 |
| 2025 | The Regents of the University of California Los Angeles Los Angeles, CA | U | $439,378 | paid | GLUCOSE RESPONSIVE GLUCAGON (GRG) FOR THE REDUCTION OF HYPOGLYCEMIA FOR PEOPLE WITH T1D | 202600369349100525 |
| 2025 | University of Florida Gainesville, FL | U | $435,671 | approved, future | HUMAN ATLAS OF NEONATAL DEVELOPMENT AND EARLY LIFE-IMMUNITY (HANDEL-I) CONTINUATION | 202600369349100525 |
| 2025 | Georgetown University Washington, DC | B | $432,998 | paid | ADVANCING ACCESS TO HIGH QUALITY, AFFORDABLE DIABETES CARE THROUGH PRIVATE HEALTH INSURANCE REGULATION | 202600369349100525 |
| 2025 | Association of Diabetes Care & Education Specialists Chicago, IL | B | $432,057 | paid | EXPANSION OF THE DANATECH PLATFORM | 202600369349100525 |
| 2025 | University of Bristol Bristol | U | $431,779 | paid | TYPE 1 DIABETES RISK IN ADULTS (T1DRA) A GENERAL POPULATION STUDY | 202600369349100525 |
| 2025 | The Regents of the University of Colorado Denver Aurora, CO | D | $431,482 | approved, future | EPITHELIAL MITOCHONDRIAL DYSFUNCTION AND EXTRACELLULAR VESICLES IN CROHNS DISEASE FIBROSTENOSIS. | 202600369349100525 |
| 2025 | The Governors of the University of Calgary Calgary | D | $430,190 | approved, future | A DRUG-WIDE SCAN TO IDENTIFY REPURPOSED MEDICATIONS FOR CROHN'S DISEASE | 202600369349100525 |
| 2025 | University of Cincinnati Cincinnati, OH | B | $429,700 | approved, future | STUDIES ON THE ROLE OF C-PEPTIDE TO REGULATE BLOOD GLUCOSE DURING SLEEP AND EXERCISE | 202600369349100525 |
| 2025 | The Trustees of Columbia University in the City of New York New York, NY | U | $429,646 | paid | COMBINATORIAL PERTURBATION OF CELLULAR NETWORK IN CROHNS DISEASE | 202600369349100525 |
| 2025 | Mass General Brigham for the Brigham and Women's Hospital Boston, MA | U | $429,475 | approved, future | U.S. PREVENTIVE TYPE 1 DIABETES COALITION | 202600369349100525 |
| 2025 | Katholieke Universiteit Te Leuven Leuven | U | $426,571 | paid | TARGETING CHRONIC INFLAMMATION AND TISSUE REMODELLING IN CROHN'S DISEASE WITH ENGINEERED T CELLS | 202600369349100525 |
| 2025 | The University of Edinburgh Edinburgh | U | $426,524 | approved, future | REPURPOSING POSITIVE ALLOSTERIC MODULATORS OF GLUTAMATE RECEPTORS TO PREVENT HYPOGLYCEMIA IN TYPE 1 DIABETES A PILOT CLINICAL STUDY | 202600369349100525 |
| 2025 | University of Glasgow Court Glasgow | U | $426,282 | approved, future | THE ROLE OF THE GUT MICROBIOME IN POSTOPERATIVE OUTCOMES AND DISEASE RECURRENCE IN SURGICAL ADULTS WITH CD TREATED WITH EXCLUSIVE ENTERAL NUTRITION. | 202600369349100525 |
| 2025 | Innodia Leuven | U | $426,278 | approved, future | INNODIA NONPROFIT LAUNCH | 202600369349100525 |
| 2025 | University of Glasgow Court Glasgow | U | $425,075 | approved, future | THE ROLE OF THE GUT MICROBIOME IN POSTOPERATIVE OUTCOMES AND DISEASE RECURRENCE IN SURGICAL ADULTS WITH CD TREATED WITH EXCLUSIVE ENTERAL NUTRITION. | 202600369349100525 |
| 2025 | The Governors of the University of Calgary Calgary | D | $424,253 | approved, future | A DRUG-WIDE SCAN TO IDENTIFY REPURPOSED MEDICATIONS FOR CROHN'S DISEASE | 202600369349100525 |
| 2025 | Association of Diabetes Care & Education Specialists Chicago, IL | B | $423,489 | paid | EXPANSION OF THE DANATECH PLATFORM | 202600369349100525 |
| 2025 | Aphp St Antoine Hospital Paris | U | $421,681 | approved, future | FECAL MICROBIOTA TRANSPLANTATION IN CROHN'S DISEASE AS RELAY AFTER ANTI-TNF WITHDRAWAL (MIRACLE) | 202600369349100525 |
| 2025 | Federal Institute of Technology Zurich Ethz Zurich | U | $421,278 | paid | SPATIAL BIOLOGY OF CROHNS COLITIS | 202600369349100525 |
| 2025 | Tampere University Foundation Sr Tampere | U | $419,684 | approved, future | ENTEROVIRUS-INDUCED TYPE 1 DIABETES MECHANISMS AND BIOMARKERS FOR RISK | 202600369349100525 |
| 2025 | University at Buffalo Pediatric Associates P C Buffalo, NY | D | $419,662 | paid | FINANCIAL VIABILITY OF TELEHEALTH SERVICES FOR UNDERSERVED T1D PEDIATRIC POPULATIONS | 202600369349100525 |
| 2025 | University of Cincinnati Cincinnati, OH | B | $416,500 | paid | STUDIES ON THE ROLE OF C-PEPTIDE TO REGULATE BLOOD GLUCOSE DURING SLEEP AND EXERCISE | 202600369349100525 |
| 2025 | The Trustees of Columbia University in the City of New York New York, NY | U | $413,263 | paid | COMBINATORIAL PERTURBATION OF CELLULAR NETWORK IN CROHNS DISEASE | 202600369349100525 |
| 2025 | Yale University New Haven, CT | U | $413,016 | paid | EXPOSOMICS FOR EARLY LIFE CROHNS DISEASE | 202600369349100525 |
| 2025 | Wilcox Health Foundation Lihue, HI | B | $409,000 | approved, future | WILCOX MEDICAL CENTER EQUIPMENT REVITALIZATION PROJECT | 202600369349100525 |
| 2025 | Cavalier County Memorial Hospital Association Langdon, ND | B | $408,100 | paid | NORTH DAKOTA ULTRASOUND INITIATIVE | 202600369349100525 |
| 2025 | Children's Hospital Medical Center Cincinnati, OH | B | $407,932 | approved, future | COMPARISON OF STANDARD-OF-CARE VS. A PATIENT-CENTRIC NONCONTRAST ABBREVIATED MR ENTEROGRAPHY PROTOCOL | 202600369349100525 |
| 2025 | Trustees of the University of Pennsylvania Philadelphia, PA | B | $407,000 | paid | ENGINEERING CAR REGULATORY T CELLS TO PROVIDE DURABLE TOLERANCE TO ALLOGENIC ISLET TRANSPLANTS | 202600369349100525 |
| 2025 | Genome Research Limited for the Wellcome Sanger Institute Cambridge | U | $402,672 | paid | SCIBD-RESPONSE MASSIVE-SCALE SINGLE-CELL RNA-SEQUENCING TO IDENTIFY TRANSCRIPTOMIC PREDICTORS OF RESPONSE TO BIOLOGIC THERAPIES IN CROHNS DISEASE | 202600369349100525 |
| 2025 | Pulitzer Center On Crisis Reporting Washington, DC | C | $400,371 | approved, future | INSIGHT AND CONNECTION THROUGH JOURNALISM AND EDUCATION | 202600369349100525 |
| 2025 | Northern Westchester Hospital Association Mount Kisco, NY | C | $400,000 | paid | EMERGENCY DEPARTMENT RAPID ACCESS EXPANSION | 202600369349100525 |
| 2025 | American Diabetes Association Inc Arlington, VA | B | $399,368 | paid | 2022-2024 TYPE 1 DIABETES CAMP INITIATIVE | 202600369349100525 |
| 2025 | Board of Trustees of the Leland Stanford Junior University Stanford, CA | B | $395,280 | approved, future | DIABDOCS NATIONAL K12 SUPPLEMENT | 202600369349100525 |
| 2025 | The Governors of the University of Calgary Calgary | D | $394,365 | paid | A DRUG-WIDE SCAN TO IDENTIFY REPURPOSED MEDICATIONS FOR CROHN'S DISEASE | 202600369349100525 |
| 2025 | Pulitzer Center On Crisis Reporting Washington, DC | C | $393,053 | paid | INSIGHT AND CONNECTION THROUGH JOURNALISM AND EDUCATION | 202600369349100525 |
| 2025 | Katholieke Universiteit Te Leuven Leuven | U | $389,044 | approved, future | TARGETING CHRONIC INFLAMMATION AND TISSUE REMODELLING IN CROHN'S DISEASE WITH ENGINEERED T CELLS | 202600369349100525 |
| 2025 | The Cleveland Clinic Foundation Cleveland, OH | C | $387,615 | paid | MECHANOBIOLOGY OF THE INTESTINAL EPITHELIAL BARRIER DISRUPTION IN CROHNS DISEASE | 202600369349100525 |
| 2025 | University of Washington Seattle, WA | B | $387,576 | paid | DESIGN OF ISLET TARGETED AGONISTS OF PD1 AND CTLA4 | 202600369349100525 |
| 2025 | University Medical Center of Southern Nevada Las Vegas, NV | U | $387,094 | paid | DEVELOPMENT OF AN EXTRACORPOREAL LIFE SUPPORT (ECLS) PROGRAM AT UNIVERSITY MEDICAL CENTER OF SOUTHERN NEVADA | 202600369349100525 |
| 2025 | University of Washington Seattle, WA | B | $385,000 | approved, future | PATHOGENIC ACTION OF AUTOANTIBODIES ON ISLET FUNCTION AND VIABILITY IN TYPE 1 DIABETES | 202600369349100525 |
| 2025 | University of Washington Seattle, WA | B | $385,000 | paid | PATHOGENIC ACTION OF AUTOANTIBODIES ON ISLET FUNCTION AND VIABILITY IN TYPE 1 DIABETES | 202600369349100525 |
| 2025 | Medical University of South Carolina Charleston, SD | U | $384,392 | approved, future | ENGINEERED DENDRITIC CELL BASED ROBUST ANTIGEN SPECIFIC THERAPY FOR TYPE 1 DIABETES | 202600369349100525 |
| 2025 | King's College London London | U | $384,292 | paid | RESOLVING HARMFUL ACCUMULATION OF INNATE LYMPHOID CELLS DURING CROHNS DISEASE. | 202600369349100525 |
| 2025 | Hawai'i Health Systems Corp Kaua'i Region for Veterans Memorial Hosp Waimea, HI | U | $381,278 | paid | MEDICAL SIMULATION AT KAUA'I VETERANS MEMORIAL HOSPITAL | 202600369349100525 |
| 2025 | American Heart Association Inc Dallas, TX | B | $379,458 | paid | POST-ACUTE STROKE CARE IMPLEMENTING QUALITY STANDARDS IN MONTANA, NEBRASKA AND NORTH DAKOTA | 202600369349100525 |
| 2025 | Benaroya Research Institute at Virginia Mason Seattle, WA | B | $379,135 | paid | MECHANISMS OF AUTOANTIBODY REVERSION IN AT-RISK SUBJECTS | 202600369349100525 |
| 2025 | Minnesota Rural Health Association Henning, MN | C | $378,700 | approved, future | SONOGRAPHER AND TECHNOLOGIST TRAINING FOR RURAL MINNESOTA | 202600369349100525 |
| 2025 | Crohn's & Colitis Foundation Inc New York, NY | B | $375,484 | approved, future | ACCELERATING ENROLLMENT IN IBD CLINICAL TRIALS | 202600369349100525 |
| 2025 | Region Hovedstaden Hillerod | U | $375,228 | paid | CAN MICROCHIMERISM EXPLAIN DIFFERENCES IN PARENTAL TYPE 1 DIABETES CONFERRED RISK OF OFFSPRING TYPE 1 DIABETES? | 202600369349100525 |
| 2025 | New Venture Fund Washington, DC | B | $374,930 | paid | TYPE 1 DIABETES CAMPS PROJECT (2025-2028) | 202600369349100525 |
| 2025 | Crohn's and Colitis Canada Toronto | U | $374,912 | paid | IMPLEMENTATION OF NATIONWIDE TELEMEDICINE NETWORK TO MITIGATE GEOGRAPHIC DISPARITIES IN ACCESS TO HEALTHCARE FOR CD PATIENTS LIVING IN CANADA | 202600369349100525 |
| 2025 | The City of Hope Duarte, CA | U | $371,800 | approved, future | CD318 MEDIATED REGULATION OF ISLET AUTOANTIGEN SPECIFIC T CELL IMMUNITY | 202600369349100525 |
| 2025 | University of Melbourne Carlton | D | $371,201 | paid | USE OF WHEY PROTEIN TO REDUCE RISK OF HYPOGLYCEMIA DURING EXERCISE FOR PEOPLE WITH T1D | 202600369349100525 |
| 2025 | King's College London London | U | $369,984 | approved, future | MULTIPEPT1DE PROOF-OF-CONCEPT STUDY STAGE III | 202600369349100525 |
| 2025 | The City of Hope Duarte, CA | U | $368,500 | paid | CD318 MEDIATED REGULATION OF ISLET AUTOANTIGEN SPECIFIC T CELL IMMUNITY | 202600369349100525 |
| 2025 | University of Glasgow Court Glasgow | U | $367,104 | paid | UNRAVELING THE ROLE OF THE GUT MICROBIOME IN POSTOPERATIVE OUTCOMES AND DISEASE RECURRENCE IN ADULTS WITH CD TREATED WITH EXCLUSIVE ENTERAL NUTRITION. | 202600369349100525 |
| 2025 | Vanderbilt University Medical Center Nashville, TN | C | $364,886 | paid | EXPANSION OF PANCREATLAS CONNECTIVITY PLATFORM AND PHENOTYPING OF HANDEL SAMPLES BY CUTTING-EDGE SINGLE CELL MULTIOME TECHNOLOGY | 202600369349100525 |
| 2025 | Mineral County Hospital District Hawthorne, NV | U | $364,679 | paid | USDA COMMUNITY FACILITY DIRECT LOAN PROGRAM APPLICATION | 202600369349100525 |
| 2025 | Natural Areas Conservancy Inc New York, NY | B | $363,328 | paid | ACTIVATING AND SUSTAINING NYC NATURE TRAIL NETWORK (PHASE 3) | 202600369349100525 |
| 2025 | Institut National de la Sante Et de la Recherche Medicale Paris | U | $362,460 | paid | FROM BENIGN ISLET AUTOIMMUNITY TO TYPE 1 DIABETES HLA-A- VS. HLA-B-RESTRICTED CD8 T-CELL BIOMARKERS OF PROGRESSION | 202600369349100525 |
| 2025 | Uppsala University Hospital Uppsala | U | $360,374 | approved, future | IMMUNE-EVASIVE ISLETS FOR TRANSPLANTATION | 202600369349100525 |
| 2025 | Chi Health Foundation Omaha, NE | U | $359,722 | paid | ECMO SUPPORT AT CHI HEALTH CREIGHTON UNIVERSITY MEDICAL CENTER-BERGAN MERCY | 202600369349100525 |
| 2025 | University of Bristol Bristol | U | $358,900 | approved, future | TYPE 1 DIABETES RISK IN ADULTS (T1DRA) A GENERAL POPULATION STUDY | 202600369349100525 |
| 2025 | Parker Institute for Cancer Immunotherapy San Francisco, CA | B | $358,140 | approved, future | UNDERSTANDING AUTOIMMUNE DIABETES FOLLOWING CERTAIN CANCER IMMUNOTHERAPIES. | 202600369349100525 |
| 2025 | The Chancellor Masters and Scholars of the University of Cambridge Cambridge | D | $353,223 | approved, future | CLOSED LOOP INSULIN DELIVERY IN NEWLY DIAGNOSED YOUTH WITH TYPE 1 DIABETES AGES 10 TO 18 YEARS (PART 2) | 202600369349100525 |
| 2025 | Benaroya Research Institute at Virginia Mason Seattle, WA | B | $350,194 | approved, future | MECHANISMS OF AUTOANTIBODY REVERSION IN AT-RISK SUBJECTS | 202600369349100525 |
| 2025 | American Diabetes Association Inc Arlington, VA | B | $350,108 | paid | TRAINING AND MENTORSHIP PROGRAMS | 202600369349100525 |
| 2025 | The Binyamin Fund Inc Cedarhurst, NY | C | $350,000 | paid | EMERGENCY GENERATORS FOR COMMUNITIES IN THE BINYAMIN REGIONAL COUNCIL | 202600369349100525 |
| 2025 | Zaka - Search and Rescue Jerusalem | U | $350,000 | paid | EMERGENCY AND DISASTER PREPAREDNESS IN ISRAEL | 202600369349100525 |
| 2025 | Israel Antiquities Authority Jerusalem | U | $350,000 | paid | REVIVAL EXHIBITION AT BEN GURION AIRPORT | 202600369349100525 |
| 2025 | Benaroya Research Institute at Virginia Mason Seattle, WA | B | $348,874 | approved, future | MECHANISMS OF AUTOANTIBODY REVERSION IN AT-RISK SUBJECTS | 202600369349100525 |
| 2025 | Billings Clinic Foundation Billings, MT | B | $348,798 | approved, future | BILLINGS CLINIC TRANSFER CENTER | 202600369349100525 |
| 2025 | Massachusetts Institute of Technology Cambridge, MA | B | $348,553 | paid | COMPUTATIONAL MODELING TO IMPROVE GLUCOSE-RESPONSIVE GLUCAGON DESIGNS | 202600369349100525 |
| 2025 | The Nature Conservancy Arlington, VA | B | $347,804 | paid | FUTURE FOREST NYC PHASE III | 202600369349100525 |
| 2025 | The Chancellor Masters and Scholars of the University of Cambridge Cambridge | D | $347,219 | approved, future | NEW INSIGHTS INTO CROHN'S DISEASE FROM STUDYING NAKED MOLE RATS | 202600369349100525 |
| 2025 | Reachanother Foundation Bend, OR | U | $346,974 | paid | EXPANDING PEDIATRIC NEUROSURGERY CAPACITY IN ETHIOPIA | 202600369349100525 |
| 2025 | The Cleveland Clinic Foundation Cleveland, OH | C | $342,955 | approved, future | MECHANOBIOLOGY OF THE INTESTINAL EPITHELIAL BARRIER DISRUPTION IN CROHNS DISEASE | 202600369349100525 |
| 2025 | Crohn's & Colitis Foundation Inc New York, NY | B | $342,493 | paid | APPLICATION OF MACHINE LEARNING TO PRECISION NUTRITION IN CROHNS DISEASE | 202600369349100525 |
| 2025 | The Imperial College of Science Technology and Medicine London | U | $340,788 | approved, future | IMMUNOLOGICAL MECHANISMS UNDERLYING THE GENETIC BASIS FOR NATURAL T1D PROTECTION | 202600369349100525 |
| 2025 | Tzafon Medical Center Tiberias | U | $340,000 | paid | SHELTERED HOSPITALIZATION AREA | 202600369349100525 |
| 2025 | Kyler Cares Foundation New Orleans, LA | C | $339,900 | paid | CAPACITY BUILDING SUPPORT | 202600369349100525 |
| 2025 | Kyler Cares Foundation New Orleans, LA | C | $339,900 | paid | CAPACITY BUILDING SUPPORT | 202600369349100525 |
| 2025 | University of North Carolina at Chapel Hill Chapel Hill, NC | B | $336,550 | approved, future | FREQUENCY AND TITER OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AUTO-ANTIBODIES IN PATIENTS WITH CD-LIKE DISEASE OF THE POUCH | 202600369349100525 |
| 2025 | Social Science Research Council Brooklyn, NY | B | $336,025 | paid | DATA2GO.NYC REVAMP AND DATA CLINIC | 202600369349100525 |
| 2025 | Healing Hands of Joy Charlotte, NC | B | $335,000 | approved, future | ELIMINATION OF OBSTETRIC FISTULA | 202600369349100525 |
| 2025 | The University of Chicago Chicago, IL | U | $333,042 | paid | DEVELOPMENT AND DISSEMINATION OF AN IBD MONITORING AND PREVENTION PROGRAM WITH A FOCUS ON INTESTINAL ULTRASOUND | 202600369349100525 |
| 2025 | The Regents of the University of Colorado Denver Aurora, CO | D | $332,512 | paid | CGM IN PRIMARY CARE - REFER OR LEARN IMPLEMENTATION AND EVALUATION | 202600369349100525 |
| 2025 | Washington University Saint Louis, MO | B | $330,000 | paid | RESTORATION OF NORMAL GLUCAGON SECRETORY DYNAMICS BY DIRECT MANIPULATION OF ALPHA CELL SIGNALING | 202600369349100525 |
| 2025 | Vanderbilt University Medical Center Nashville, TN | C | $330,000 | paid | SCREENING HUMAN ISLETS TO IDENTIFY SMALL MOLECULES ENHANCING GLUCAGON SECRETION UNDER HYPOGLYCEMIA | 202600369349100525 |
| 2025 | The Regents of the University of Colorado Denver Aurora, CO | D | $329,695 | approved, future | EPIGENOMIC BIOMARKERS OF THE INCOMPLETE MATERNAL PROTECTION IN TYPE 1 DIABETES | 202600369349100525 |
| 2025 | Tioga Medical Center Tioga, ND | B | $326,201 | paid | TIOGA MEDICAL CENTER ULTRASOUND INITIATIVE | 202600369349100525 |
| 2025 | Association Sante Diabete Grenoble | U | $325,558 | approved, future | STRENGTHEN THE CARE AND SUPPORT OF PATIENTS WITH TYPE 1 DIABETES IN MALI, BURKINA FASO, AND THE UNION OF THE COMOROS | 202600369349100525 |
| 2025 | King's College London London | U | $325,389 | approved, future | RESOLVING HARMFUL ACCUMULATION OF INNATE LYMPHOID CELLS DURING CROHNS DISEASE. | 202600369349100525 |
| 2025 | Medicines for Humanity Inc Rockland, MA | B | $322,909 | paid | MAI MBELEKI II EXPANSION | 202600369349100525 |
| 2025 | Universit Degli Studi Di Milano Milan | U | $321,749 | approved, future | UNRAVELING THE ROLE OF CD45RACCR7 CD4 T CELLS IN THE PATHOGENESIS OF TYPE 1 DIABETES | 202600369349100525 |
| 2025 | Mass General Brigham for the Brigham and Women's Hospital Boston, MA | U | $320,341 | approved, future | U.S. PREVENTIVE TYPE 1 DIABETES COALITION | 202600369349100525 |
| 2025 | The Regents of the University of Colorado Denver Aurora, CO | D | $319,937 | approved, future | IMPACT OF MENSTRUATION ON GLYCEMIC RESPONSE AND EXERCISE | 202600369349100525 |
| 2025 | Palo Alto Veterans Institute for Research Palo Alto, CA | B | $318,978 | paid | CELL ATLAS OF HUMAN INTESTINAL LYMPHOID TISSUES AND CHANGES IN CROHN'S DISEASE | 202600369349100525 |
| 2025 | Minnesota Rural Health Association Henning, MN | C | $318,700 | paid | SONOGRAPHER AND TECHNOLOGIST TRAINING FOR RURAL MINNESOTA | 202600369349100525 |
| 2025 | Vayu Health Portola Valley, CA | B | $318,000 | approved, future | PILOT TO DESIGN A VALUE BASED PAYMENT ECOSYSTEM TO IMPROVE HEALTH AND EQUITY FOR MEDICAID BENEFICIARIES LIVING WITH TYPE 1 AND TYPE 2 DIABETES | 202600369349100525 |
| 2025 | The Regents of the University of Colorado Denver Aurora, CO | D | $315,557 | paid | PRENATAL AND OBSTETRIC MATERNAL EXPOSURES AND ISLET AUTOIMMUNITY IN EARLY LIFE (PROMISE) | 202600369349100525 |
| 2025 | Australasian Gastro Intestinal Research Foundation Ltd Fitzroy | U | $315,421 | paid | FECAL MICROBIOTA TRANSPLANTATION (FMT) IN CROHN'S DISEASE THE MIRO (MICROBIOTA RESTORATION) STUDY. | 202600369349100525 |
| 2025 | Australasian Gastro Intestinal Research Foundation Ltd Fitzroy | U | $315,421 | approved, future | FECAL MICROBIOTA TRANSPLANTATION (FMT) IN CROHN'S DISEASE THE MIRO (MICROBIOTA RESTORATION) STUDY. | 202600369349100525 |
| 2025 | Ballad Research Institute San Diego, CA | B | $315,380 | paid | CD127-HIGH T-CELL POPULATIONS IN AUTOANTIBODY POSITIVE CHILDREN | 202600369349100525 |
| 2025 | Pembina County Memorial Hospital Association Cavalier, ND | B | $312,733 | paid | NORTH DAKOTA ULTRASOUND INITIATIVE | 202600369349100525 |
| 2025 | Crohn's & Colitis Foundation Inc New York, NY | B | $310,748 | paid | INTERNATIONAL CONSORTIUM ON MEDICAL NUTRITION IN IBD | 202600369349100525 |
| 2025 | Jaeb Center for Health Research Foundation Inc Tampa, FL | C | $309,895 | approved, future | EVALUATION OF THE RELATIONSHIP OF GLUCOSE METRICS VIA CONTINUOUS GLUCOSE MONITORING WITH DIABETIC RETINOPATHY | 202600369349100525 |
| 2025 | University of Pittsburgh Pittsburgh, PA | B | $307,891 | approved, future | ANALOGUE VS HUMAN INSULIN FOR YOUTH WITH TYPE 1 DIABETES IN LOW-RESOURCE SETTINGS A RANDOMIZED CONTROLLED TRIAL (ANHUT1D TRIAL) | 202600369349100525 |
| 2025 | King's College London London | U | $307,779 | approved, future | HYPO - RESOLVE - EVALUATION OF BIOLOGICAL, SOCIAL AND ECONOMIC IMPACT OF HYPOGLYCEMIA | 202600369349100525 |
| 2025 | Amsterdam Umc Research Bv Amsterdam | U | $306,900 | paid | IDENTIFICATION OF BIOMARKERS FOR PATIENT STRATIFICATION IN PERIANAL FISTULIZING DISEASE | 202600369349100525 |
| 2025 | New York Restoration Project New York, NY | B | $306,464 | approved, future | NYC URBAN REFORESTATION & EXPANSION | 202600369349100525 |
| 2025 | Universite Catholique de Louvain Louvainlaneuve | U | $304,033 | approved, future | SEARCH FOR MECHANISMS RESPONSIBLE FOR THE IMPAIRED GLUCAGON SECRETION IN T1D AND FOR STRATEGIES TO CORRECT THEM | 202600369349100525 |
| 2025 | Sapir Academic College Gevim | U | $303,000 | paid | PLANNING FOR SAPIR ACADEMIC COLLEGE LAW SCHOOL BUILDING | 202600369349100525 |
| 2025 | Emory University Atlanta, GA | U | $302,430 | paid | CARDIAC ARREST REGISTRY TO ENHANCE SURVIVAL (CARES) HELMSLEY STATE EXPANSION | 202600369349100525 |
| 2025 | The Weizmann Institute of Science Rehovot | D | $300,000 | paid | QUANTUM COMPUTING AND SENSING WITH ATOMS, ELECTRONS, AND PHOTONS | 202600369349100525 |
| 2025 | The City of Hope Duarte, CA | U | $300,000 | paid | THE HELMSLEY CHARITABLE TRUST GEORGE S. EISENBARTH NPOD AWARD FOR TEAM SCIENCE | 202600369349100525 |
| 2025 | Fjc New York, NY | B | $300,000 | approved, future | NYC FUND TO END YOUTH & FAMILY HOMELESSNESS, A PROJECT OF FJC. | 202600369349100525 |
| 2025 | The Regents of the University of Colorado Denver Aurora, CO | D | $300,000 | paid | MAPPING THE B CELL HETEROGENEITY IN TYPE 1 DIABETES AT THE SINGLE-CELL LEVEL | 202600369349100525 |
| 2025 | Middle East Media and Research Institute Inc Washington, DC | B | $300,000 | paid | THE INTERCONNECTED IRAN -RUSSIA-CHINA AXIS | 202600369349100525 |
| 2025 | Jaeb Center for Health Research Foundation Inc Tampa, FL | C | $299,921 | approved, future | EVALUATION OF THE RELATIONSHIP OF GLUCOSE METRICS VIA CONTINUOUS GLUCOSE MONITORING WITH DIABETIC RETINOPATHY | 202600369349100525 |
| 2025 | Sustainable Coastlines Hawaii Honolulu, HI | B | $299,213 | paid | SCALING SUSTAINABLE COASTLINES HAWAII BUILDING LEADERSHIP FOR LONG-TERM GROWTH AND IMPACT | 202600369349100525 |
| 2025 | St Vincent's Institute of Medical Research Melbourne | U | $298,224 | paid | WHICH CHECKPOINTS MAINTAIN IMMUNE TOLERANCE TO BETA-CELLS IN GENETICALLY AT-RISK PEOPLE WHO DONT HAVE T1D? | 202600369349100525 |
| 2025 | Crohn's and Colitis Canada Toronto | U | $297,612 | paid | IMPLEMENTING A MULTIMODAL RCT INTERVENTION TO IMPROVE THE TRANSITION OF PATIENTS WITH CROHNS DISEASE FROM PEDIATRIC TO ADULT CARE | 202600369349100525 |
| 2025 | International Bowel Ultrasound Group Ev Munster | U | $296,500 | approved, future | DEVELOPMENT OF ELEARNING PLATFORM FOR STANDARDIZATION AND DISSEMINATION OF INTESTINAL ULTRASOUND EDUCATION GLOBALLY (IBUS EIUS ED) | 202600369349100525 |
| 2025 | The Regents of the University of Colorado Denver Aurora, CO | D | $291,029 | paid | DEFINING HUMAN ISLET MYELOID CELL POPULATIONS THROUGH PROGRESSION OF TYPE 1 DIABETES | 202600369349100525 |
| 2025 | University of Utah Salt Lake City, UT | B | $290,806 | paid | INDUCTION OF PERIPHERAL TOLERANCE TO BETA CELL ANTIGENS BY SPECIFIC TARGETING OF LANGERIN DENDRITIC CELLS | 202600369349100525 |
| 2025 | Benaroya Research Institute at Virginia Mason Seattle, WA | B | $288,200 | approved, future | LINKING DISEASE MECHANISM AND CLINICAL TRIAL DESIGN VIA RAPIDLY CONDUCTED IMMUNOTHERAPY TRIALS IN T1D | 202600369349100525 |
| 2025 | Joslin Diabetes Center Inc Boston, MA | B | $287,280 | approved, future | AN INTEGRATED CARE MODEL FOR OLDER ADULTS WITH INSULIN-TREATED DIABETES | 202600369349100525 |
| 2025 | Action4diabetes Taunton | U | $284,390 | approved, future | PHILIPPINES T1D TASK FORCE | 202600369349100525 |
| 2025 | Tampere University Foundation Sr Tampere | U | $283,718 | approved, future | ENTEROVIRUS-INDUCED TYPE 1 DIABETES MECHANISMS AND BIOMARKERS FOR RISK | 202600369349100525 |
| 2025 | Emory University Atlanta, GA | U | $283,099 | approved, future | CARDIAC ARREST REGISTRY TO ENHANCE SURVIVAL (CARES) HELMSLEY STATE EXPANSION | 202600369349100525 |
| 2025 | Baylor College of Medicine Houston, TX | B | $282,140 | approved, future | PREDICTIVE ANALYTICS AND TARGETED INTERVENTIONS SHIFTING THE PARADIGM FROM REACTIVE TO PROACTIVE DIABETES CARE | 202600369349100525 |
| 2025 | University of Miami Coral Gables, FL | U | $282,000 | approved, future | DEVELOP A NEW METHOD OF STUDYING ALPHA CELL FUNCTION IN PANCREATIC SLICES | 202600369349100525 |
| 2025 | Institut National de la Sante Et de la Recherche Medicale Paris | U | $278,787 | approved, future | FROM BENIGN ISLET AUTOIMMUNITY TO TYPE 1 DIABETES HLA-A- VS. HLA-B-RESTRICTED CD8 T-CELL BIOMARKERS OF PROGRESSION | 202600369349100525 |
| 2025 | Duke University Durham, NC | B | $275,861 | paid | NOVEL ASSAYS FOR PROGLUCAGON PEPTIDES TO UNDERSTAND ALPHA CELL FUNCTION IN HEALTH AND DIABETES | 202600369349100525 |
| 2025 | Duke University Durham, NC | B | $275,096 | approved, future | NOVEL ASSAYS FOR PROGLUCAGON PEPTIDES TO UNDERSTAND ALPHA CELL FUNCTION IN HEALTH AND DIABETES | 202600369349100525 |
| 2025 | Vanderbilt University Nashville, TN | C | $275,000 | paid | NORMALIZING HYPOGLYCEMIA-INDUCED GLUCAGON SECRETION IN T1D THROUGH PHARMACOLOGICAL RESTORATION OF ALPHA-CELL CALCIUM HANDLING | 202600369349100525 |
| 2025 | Vanderbilt University Medical Center Nashville, TN | C | $275,000 | paid | DEFINING MOLECULAR MECHANISMS OF CELL DYSFUNCTION IN TYPE 1 DIABETES TO DEVELOP NEW APPROACHES TO PREVENT HYPOGLYCEMIA | 202600369349100525 |
| 2025 | Sustainable Coastlines Hawaii Honolulu, HI | B | $274,787 | approved, future | SCALING SUSTAINABLE COASTLINES HAWAII BUILDING LEADERSHIP FOR LONG-TERM GROWTH AND IMPACT | 202600369349100525 |
| 2025 | University of Oulu Oulu | U | $274,391 | paid | MATERNAL AND PATERNAL TYPE 1 DIABETES MECHANISMS FOR THE DISTINCT RECURRENCE RISK IN THE OFFSPRING | 202600369349100525 |
| 2025 | Jaeb Center for Health Research Foundation Inc Tampa, FL | C | $273,882 | approved, future | VIRTUAL DIABETES SPECIALTY CLINIC (VDISC) - A STUDY EVALUATING REMOTE INITIATION OF CONTINUOUS GLUCOSE MONITORING | 202600369349100525 |
| 2025 | Regents of the University of Minnesota Minneapolis, MN | U | $273,689 | paid | CONTINUING DEVELOPMENT OF OXYGEN SUPER-SATURATED SALINE FOR DEPLOYMENT IN MEDICAL EMERGENCIES | 202600369349100525 |
| 2025 | Solidaridad Network Foundation Limited Lusaka | U | $273,384 | approved, future | HOOVES FOR SUSTAINABILITY (H4S) | 202600369349100525 |
| 2025 | The Regents of the University of Colorado Denver Aurora, CO | D | $269,500 | paid | PREPARE 4 AID PRIMARY CARE PRAGMATIC, REAL WORLD EXPERIENCE FOR AUTOMATED INSULIN DELIVERY | 202600369349100525 |
| 2025 | The Regents of the University of California San Francisco San Francisco, CA | U | $269,368 | paid | PREGNANCY IN INFLAMMATORY BOWEL DISEASE AND NEONATAL OUTCOMES (PIANO) | 202600369349100525 |
| 2025 | The Regents of the University of California San Francisco San Francisco, CA | U | $269,368 | paid | PREGNANCY IN INFLAMMATORY BOWEL DISEASE AND NEONATAL OUTCOMES (PIANO) | 202600369349100525 |
| 2025 | Regents of the University of Minnesota Minneapolis, MN | U | $269,189 | approved, future | CONTINUING DEVELOPMENT OF OXYGEN SUPER-SATURATED SALINE FOR DEPLOYMENT IN MEDICAL EMERGENCIES | 202600369349100525 |
| 2025 | Dartmouth- Hitchcock Clinic Lebanon, NH | B | $268,958 | approved, future | CAPACITY BUILDING FOR DARTMOUTH-HITCHCOCK'S VIRTUAL IBD TELEMEDICINE NETWORK PROGRAM | 202600369349100525 |
| 2025 | Tel Aviv Sourasky Medical Center - Ichilov Hospital Tel Aviv | U | $268,340 | paid | IBD GENETICS RESEARCH ROLE OF PROTEASE-ACTIVATED RECEPTOR 2 (PAR2) IN INFLAMMATORY GASTROINTESTINAL DISORDERS | 202600369349100525 |
| 2025 | Papahanaumokuakea Marine Debris Project Inc Kailua, HI | B | $268,067 | approved, future | PAPAHANAUMOKUAKEA MARINE DEBRIS PROJECT CAPACITY-BUILDING | 202600369349100525 |
| 2025 | Critical Path Institute Tucson, AZ | B | $266,741 | paid | T1D CONSORTIUM 2.0 | 202600369349100525 |
| 2025 | The Tel Aviv Jaffa Academic College Tel Aviv Yaffo | U | $266,667 | paid | NEED-BASED SCHOLARSHIPS FOR NURSING STUDENTS | 202600369349100525 |
| 2025 | The Tel Aviv Jaffa Academic College Tel Aviv Yaffo | U | $266,666 | approved, future | NEED-BASED SCHOLARSHIPS FOR NURSING STUDENTS | 202600369349100525 |
| 2025 | Insulin for Life USA Inc Gainesville, FL | B | $265,700 | approved, future | STRENGTHENING ORGANIZATIONAL CAPACITY II | 202600369349100525 |
| 2025 | Baylor College of Medicine Houston, TX | B | $265,400 | paid | PREDICTIVE ANALYTICS AND TARGETED INTERVENTIONS SHIFTING THE PARADIGM FROM REACTIVE TO PROACTIVE DIABETES CARE | 202600369349100525 |
| 2025 | Cardiff University Wales | U | $262,543 | approved, future | T1D-PLUS AN ADAPTIVE TRIAL PLATFORM FOR THE STUDY OF COMBINATION THERAPIES IN NEW-ONSET T1D | 202600369349100525 |
| 2025 | King's College London London | U | $260,566 | approved, future | CHARACTERISING NOGO AUTOIMMUNITY IN GENETICALLY PROTECTED (HLA-DQ6) SUBJECTS | 202600369349100525 |
| 2025 | University of Exeter Exeter | U | $260,351 | approved, future | B CELL SIGNATURES IN TYPE 1 DIABETES | 202600369349100525 |
| 2025 | Alimentiv Inc London | U | $259,951 | paid | DEVELOPMENT OF A NEXT GENERATION BIOMARKER TOOL TO ACCELERATE THE DEVELOPMENT OF EFFECTIVE ANTI-FIBROTIC THERAPIES | 202600369349100525 |
| 2025 | Boston Medical Center Corporation Boston, MA | B | $257,191 | approved, future | SUPPLEMENTAL FUNDING FOR AN EFFECTIVENESS TRIAL TO SUPPORT ADOPTION OF AID IN UNDERSERVED ADULTS WITH T1D | 202600369349100525 |
| 2025 | Boston Medical Center Corporation Boston, MA | B | $257,191 | approved, future | SUPPLEMENTAL FUNDING FOR AN EFFECTIVENESS TRIAL TO SUPPORT ADOPTION OF AID IN UNDERSERVED ADULTS WITH T1D | 202600369349100525 |
| 2025 | Boston Medical Center Corporation Boston, MA | B | $257,191 | approved, future | SUPPLEMENTAL FUNDING FOR AN EFFECTIVENESS TRIAL TO SUPPORT ADOPTION OF AID IN UNDERSERVED ADULTS WITH T1D | 202600369349100525 |
| 2025 | St Aloisius Hospital Inc Harvey, ND | B | $256,572 | paid | SMP HEALTH - ST. ALOISIUS ULTRASOUND PROJECT | 202600369349100525 |
| 2025 | Papahanaumokuakea Marine Debris Project Inc Kailua, HI | B | $256,540 | paid | PAPAHANAUMOKUAKEA MARINE DEBRIS PROJECT CAPACITY-BUILDING | 202600369349100525 |
| 2025 | St Vincent's Institute of Medical Research Melbourne | U | $255,857 | approved, future | WHICH CHECKPOINTS MAINTAIN IMMUNE TOLERANCE TO BETA-CELLS IN GENETICALLY AT-RISK PEOPLE WHO DONT HAVE T1D? | 202600369349100525 |
| 2025 | St Mark's Hospital Foundation London | U | $254,998 | paid | SUPPORT FOR THE ONGOING DEVELOPMENT OF THE TOPCLASS PERIANAL CD CONSORTIUM | 202600369349100525 |
| 2025 | Kyler Cares Foundation New Orleans, LA | C | $251,700 | approved, future | CAPACITY BUILDING SUPPORT | 202600369349100525 |
| 2025 | Supportive Housing Network of New York Inc New York City, NY | C | $251,200 | approved, future | TRAINING ACADEMY AND COMMUNITY OF PRACTICE FOR SUPPORTIVE HOUSING PROVIDERS | 202600369349100525 |
| 2025 | The Hospital for Sick Children Toronto | U | $250,415 | approved, future | IMMUNE RESPONSES TO GUT MICROBES ASSOCIATED WITH T1D RISK AND PROGRESSION | 202600369349100525 |
| 2025 | The Milken Institute Santa Monica, CA | B | $250,000 | paid | FASTERCURES LEADERSLINK PROGRAM EXPANSION | 202600369349100525 |
| 2025 | Genetic Alliance Inc Damascus, MD | B | $250,000 | approved, future | IHOPE GENETIC HEALTH | 202600369349100525 |
| 2025 | Hawai'i Health Systems Corp Kaua'i Region for Veterans Memorial Hosp Waimea, HI | U | $250,000 | approved, future | MEDICAL SIMULATION AT KAUA'I VETERANS MEMORIAL HOSPITAL | 202600369349100525 |
| 2025 | Genetic Alliance Inc Damascus, MD | B | $250,000 | paid | IHOPE GENETIC HEALTH | 202600369349100525 |
| 2025 | New York Restoration Project New York, NY | B | $250,000 | approved, future | NYC URBAN REFORESTATION & EXPANSION | 202600369349100525 |
| 2025 | Mayo Clinic Rochester, MN | U | $249,920 | approved, future | MILITARY SCIENCES MEDICAL TRAINING 2024-2026 | 202600369349100525 |
| 2025 | The Hospital for Sick Children Toronto | U | $248,621 | paid | IMMUNE RESPONSES TO GUT MICROBES ASSOCIATED WITH T1D RISK AND PROGRESSION | 202600369349100525 |
| 2025 | University of Exeter Exeter | U | $247,813 | paid | B CELL SIGNATURES IN TYPE 1 DIABETES | 202600369349100525 |
| 2025 | University of Miami Coral Gables, FL | U | $247,023 | paid | DEVELOP A NEW METHOD OF STUDYING ALPHA CELL FUNCTION IN PANCREATIC SLICES | 202600369349100525 |
| 2025 | Adi Negev-Nahalat Eran Ra Ofakim | U | $244,998 | paid | REHABILITATION EQUIPMENT | 202600369349100525 |
| 2025 | Chancellor Masters & Scholars of the University of Oxford Oxford | D | $244,860 | paid | THE CELLULAR LANDSCAPE OF MONOGENIC INFLAMMATORY BOWEL DISEASE IN VEOIBD | 202600369349100525 |
| 2025 | Ballad Research Institute San Diego, CA | B | $243,390 | approved, future | CD127-HIGH T-CELL POPULATIONS IN AUTOANTIBODY POSITIVE CHILDREN | 202600369349100525 |
| 2025 | Renown Health Foundation Reno, NV | B | $243,019 | approved, future | RENOWN HEALTH TO BRING EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO) TO NORTHERN NEVADA | 202600369349100525 |
| 2025 | Towner County Medical Center Inc Cando, ND | B | $241,563 | paid | TOWNER COUNTY MEDICAL CENTER ULTRASOUND INITIATIVE | 202600369349100525 |
| 2025 | The Regents of the University of Colorado Denver Aurora, CO | D | $239,819 | approved, future | DEFINING HUMAN ISLET MYELOID CELL POPULATIONS THROUGH PROGRESSION OF TYPE 1 DIABETES | 202600369349100525 |
| 2025 | Academisch Ziekenhuis Leiden Leiden | U | $238,910 | approved, future | SAFETY AND EFFICACY OF IMMUNE INTERVENTION WITH TOLEROGENIC DENDRITIC CELLS IN PATIENTS WITH EARLY T1D (D-SENSE II) | 202600369349100525 |
| 2025 | Mountrail County Medical Center Inc Stanley, ND | B | $238,556 | paid | NORTH DAKOTA ULTRASOUND INITIATIVE | 202600369349100525 |
| 2025 | University of Pittsburgh Pittsburgh, PA | B | $237,102 | paid | SINGLE CELL MULTIMODAL OMICS ANALYSIS OF COLONOSCOPIC BIOPSY-DERIVED IMMUNE CELLS IN CROHNS DISEASE | 202600369349100525 |
| 2025 | The Cleveland Clinic Foundation Cleveland, OH | C | $236,313 | paid | THE MILESTONE INITIATIVE EDUCATION INNOVATION FOR ADVANCED IBD FELLOWS IN THE USA | 202600369349100525 |
| 2025 | The City of Hope Duarte, CA | U | $235,681 | paid | GENETIC PROTECTION BY HLA-DQ6 IN T1D | 202600369349100525 |
| 2025 | Crohn's & Colitis Foundation Inc New York, NY | B | $235,000 | paid | SPONSORSHIP FOR THE 2025 CROHNS & COLITIS CONGRESS PRESENTED BY THE CROHNS & COLITIS FOUNDATION AND THE AMERICAN GASTROENTEROLOGICAL ASSOCIATION | 202600369349100525 |
| 2025 | The Imperial College of Science Technology and Medicine London | U | $234,854 | approved, future | IMMUNOLOGICAL MECHANISMS UNDERLYING THE GENETIC BASIS FOR NATURAL T1D PROTECTION | 202600369349100525 |
| 2025 | Regents of the University of Michigan Ann Arbor, MI | C | $232,662 | approved, future | HEALTH ECONOMIC ANALYSIS OF AUTOMATED INSULIN DELIVERY SYSTEMS | 202600369349100525 |
| 2025 | Vanderbilt University Medical Center Nashville, TN | C | $232,525 | approved, future | ADAPTING FAMS TO OPTIMIZE CGM USE AMONG EMERGING ADULTS WITH TYPE 1 DIABETES | 202600369349100525 |
| 2025 | Chi Health Foundation Omaha, NE | U | $229,460 | approved, future | ECMO SUPPORT AT CHI HEALTH CREIGHTON UNIVERSITY MEDICAL CENTER-BERGAN MERCY | 202600369349100525 |
| 2025 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $229,162 | paid | GPPAD BIOSAMPLE RFP | 202600369349100525 |
| 2025 | Tampere University Foundation Sr Tampere | U | $227,066 | paid | ENTEROVIRUS-INDUCED TYPE 1 DIABETES MECHANISMS AND BIOMARKERS FOR RISK | 202600369349100525 |
| 2025 | The Regents of the University of Colorado Denver Aurora, CO | D | $226,229 | approved, future | DEFINING HUMAN ISLET MYELOID CELL POPULATIONS THROUGH PROGRESSION OF TYPE 1 DIABETES | 202600369349100525 |
| 2025 | Regents of the University of Michigan Ann Arbor, MI | C | $226,169 | paid | HEALTH ECONOMIC ANALYSIS OF AUTOMATED INSULIN DELIVERY SYSTEMS | 202600369349100525 |
| 2025 | Southwest Healthcare Corporation Bowman, ND | B | $225,517 | paid | NORTH DAKOTA ULTRASOUND INITIATIVE | 202600369349100525 |
| 2025 | Amsterdam Umc Research Bv Amsterdam | U | $225,500 | paid | IDENTIFICATION OF BIOMARKERS FOR PATIENT STRATIFICATION IN PERIANAL FISTULIZING DISEASE | 202600369349100525 |
| 2025 | Papahanaumokuakea Marine Debris Project Inc Kailua, HI | B | $225,393 | approved, future | PAPAHANAUMOKUAKEA MARINE DEBRIS PROJECT CAPACITY-BUILDING | 202600369349100525 |
| 2025 | Action4diabetes Taunton | U | $222,500 | paid | PHILIPPINES T1D TASK FORCE | 202600369349100525 |
| 2025 | King's College London London | U | $221,552 | paid | PRENATAL DRIVERS OF INFANT ISLET AUTOIMMUNITY (PISA STUDY) | 202600369349100525 |
| 2025 | Hebrew University of Jerusalem Jerusalem | D | $221,500 | paid | METHYLATION PATTERNS OF CELL-FREE DNA AS A NOVEL BIOMARKER IN CROHNS DISEASE | 202600369349100525 |
| 2025 | Katholieke Universiteit Te Leuven Leuven | U | $221,407 | paid | EMBODY EFFECTS OF A MINDFULNESS BASED INTERVENTION ON IBD DISABILITY | 202600369349100525 |
| 2025 | Regents of the University of Minnesota Minneapolis, MN | U | $220,565 | approved, future | THERAPEUTIC USE OF PEPTIDEMHC MABS FOR T1D | 202600369349100525 |
| 2025 | Icahn School of Medicine at Mount Sinai New York City, NY | B | $220,000 | paid | VERY EARLY ONSET INFLAMMATORY BOWEL DISEASE (VEOIBD) PRECISION MOLECULAR DIAGNOSES TO TARGETED THERAPIES MOUNT SINAI STUDIES | 202600369349100525 |
| 2025 | Cedars-Sinai Medical Center Los Angeles, CA | B | $219,514 | paid | A MULTIDISCIPLINARY PREHABILITATION PROGRAM FOR PATIENTS WITH IBD UNDERGOING ABDOMINAL SURGERY | 202600369349100525 |
| 2025 | King's College London London | U | $218,298 | approved, future | CHARACTERISING NOGO AUTOIMMUNITY IN GENETICALLY PROTECTED (HLA-DQ6) SUBJECTS | 202600369349100525 |
| 2025 | The Regents of the University of California San Francisco San Francisco, CA | U | $217,916 | approved, future | IDENTIFICATION AND ANALYSIS OF EXTREME FORMS OF TYPE 1 DIABETES, ESTABLISHMENT OF A DATA COMMONS | 202600369349100525 |
| 2025 | Minnesota State Colleges and Universities St Paul, MN | U | $217,428 | paid | EXPANDING RURAL SONOGRAPHY EXPERTISE IN MINNESOTA | 202600369349100525 |
| 2025 | Universite Libre de Bruxelles Brussels | U | $217,239 | approved, future | STUDYING THE SELECTIVEB CELL SENSITIVITY TO A HOMOZYGOUS PD-L1 MUTATION IN NEONATAL DIABETES | 202600369349100525 |
| 2025 | Insulin for Life USA Inc Gainesville, FL | B | $215,700 | approved, future | STRENGTHENING ORGANIZATIONAL CAPACITY II | 202600369349100525 |
| 2025 | Kaiser Foundation Health Plan of Georgia Inc Atlanta, GA | C | $213,776 | approved, future | EXPANSION OF THE T1DES PILOT TO A PUBLIC HOSPITAL | 202600369349100525 |
| 2025 | Universite Libre de Bruxelles Brussels | U | $213,602 | paid | GENERATION OF NEW ANTI- FXYD2A PROBES AND PRECLINICAL VALIDATION FOR HUMAN BETA CELL IMAGING | 202600369349100525 |
| 2025 | Universite Libre de Bruxelles Brussels | U | $213,278 | paid | STUDYING THE SELECTIVE B CELL SENSITIVITY TO A HOMOZYGOUS PD-L1 MUTATION IN NEONATAL DIABETES | 202600369349100525 |
| 2025 | University of Florida Gainesville, FL | U | $213,106 | paid | HUMAN ATLAS OF NEONATAL DEVELOPMENT AND EARLY LIFE-IMMUNITY (HANDEL-I) CONTINUATION | 202600369349100525 |
| 2025 | Universita Degli Studi Di Milano Milan | U | $213,050 | approved, future | UNRAVELING THE ROLE OF CD45RACCR7 CD4 T CELLS IN THE PATHOGENESIS OF TYPE 1 DIABETES | 202600369349100525 |
| 2025 | Cedars-Sinai Medical Center Los Angeles, CA | B | $211,815 | paid | A MULTIDISCIPLINARY PREHABILITATION PROGRAM FOR PATIENTS WITH IBD UNDERGOING ABDOMINAL SURGERY | 202600369349100525 |
| 2025 | Cardiff University Wales | U | $211,718 | paid | T1D-PLUS AN ADAPTIVE TRIAL PLATFORM FOR THE STUDY OF COMBINATION THERAPIES IN NEW-ONSET T1D | 202600369349100525 |
| 2025 | Australasian Gastro Intestinal Research Foundation Ltd Fitzroy | U | $209,377 | paid | FECAL MICROBIOTA TRANSPLANTATION (FMT) IN CROHN'S DISEASE THE MIRO (MICROBIOTA RESTORATION) STUDY. | 202600369349100525 |
| 2025 | The University of Edinburgh Edinburgh | U | $209,222 | paid | HUMAN GUT CELL ATLAS - NORMAL INTESTINE AND CROHN'S DISEASE | 202600369349100525 |
| 2025 | University of Florida Gainesville, FL | U | $208,595 | approved, future | UNDERSTANDING T1D AND INSULIN-REQUIRING DIABETES IN FEDERALLY QUALIFIED HEALTH CENTERS (FQHC) A NATIONAL NEEDS ASSESSMENT | 202600369349100525 |
| 2025 | Natural Areas Conservancy Inc New York, NY | B | $206,868 | approved, future | STRENGTHENING NYC'S URBAN FOREST PLAN NATURAL AREAS | 202600369349100525 |
| 2025 | University of Exeter Exeter | U | $206,160 | paid | EXTREMELY EARLY ONSET TYPE 1 DIABETES (EXE T1D) PHASE 2 FROM OBSERVATION TO MECHANISM | 202600369349100525 |
| 2025 | Katholieke Universiteit Te Leuven Leuven | U | $205,983 | approved, future | EMBODY EFFECTS OF A MINDFULNESS BASED INTERVENTION ON IBD DISABILITY | 202600369349100525 |
| 2025 | Minnesota State Colleges and Universities St Paul, MN | U | $205,285 | approved, future | EXPANDING RURAL SONOGRAPHY EXPERTISE IN MINNESOTA | 202600369349100525 |
| 2025 | University of Iowa Iowa City, IA | U | $204,566 | approved, future | SUPPORTING THE RUPRI HEALTH PANEL TO BRING RESEARCH AND EXPERTISE TO INFORM POLICY DEVELOPMENT AND IMPLEMENTATION | 202600369349100525 |
| 2025 | Chancellor Masters & Scholars of the University of Oxford Oxford | D | $202,677 | approved, future | ALPHA CELL FUNCTION IN PEOPLE WITH TYPE 1 DIABETES WITH AND WITHOUT SEVERE HYPOGLYCEMIA | 202600369349100525 |
| 2025 | Cornell University for the Joan & Sanford I Weill Medical College New York, NY | U | $202,620 | approved, future | TARGETING THE MYCOBIOME IN PATIENTS WITH CROHNS DISEASE | 202600369349100525 |
| 2025 | Board of Trustees of the Leland Stanford Junior University Stanford, CA | B | $201,490 | paid | DIABDOCS NATIONAL K12 SUPPLEMENT | 202600369349100525 |
| 2025 | University of Texas System for the University of Texas at Austin Austin, TX | U | $200,927 | approved, future | INCREASING ACCESS TO CROHNS DISEASE CLINICAL CARE FOR THE IBD CENTER AT UT HEALTH AUSTIN | 202600369349100525 |
| 2025 | University of Texas System for the University of Texas at Austin Austin, TX | U | $200,927 | paid | INCREASING ACCESS TO CROHNS DISEASE CLINICAL CARE FOR THE IBD CENTER AT UT HEALTH AUSTIN | 202600369349100525 |
| 2025 | The Regents of the University of Colorado Denver Aurora, CO | D | $200,584 | paid | EXPLORING THE GENOMIC MECHANISM BEHIND THE MATERNAL PROTECTION FROM T1D | 202600369349100525 |
| 2025 | The Max Stern Academic College of Emek Yezreel Ltd (cc) Yezreel Valley | U | $200,000 | approved, future | OPPORTUNITY FOR SUCCESS SCHOLARSHIPS FOR ETHIOPIAN ISRAELIS PURSUING NURSING DEGREES | 202600369349100525 |
| 2025 | For Inspiration and Recognition of Science and Technology (first) Manchester, NH | B | $200,000 | approved, future | FIRST SENIOR MENTOR PROGRAM | 202600369349100525 |
| 2025 | The Trustees of Columbia University in the City of New York New York, NY | U | $200,000 | paid | SUPPORT FOR T1D TRANSITION PROGRAMS | 202600369349100525 |
| 2025 | The Max Stern Academic College of Emek Yezreel Ltd Yezreel Valley | U | $200,000 | paid | OPPORTUNITY FOR SUCCESS SCHOLARSHIPS FOR ETHIOPIAN ISRAELIS PURSUING NURSING DEGREES | 202600369349100525 |
| 2025 | Shatterproof a Nonprofit Corp Norwalk, CT | U | $200,000 | paid | GENERAL OPERATING SUPPORT | 202600369349100525 |
| 2025 | Youth Development Organization Inc Lawrence, MA | B | $200,000 | approved, future | CAPACITY BUILDING PROJECT SUPPORT 2024-2026 | 202600369349100525 |
| 2025 | Breakthrough T1d New York, NY | B | $200,000 | paid | CO-FUNDED DEVELOPMENT OF A 3-B-HYDROXYBUTYRATE BINDING PROTEIN BASED CONTINUOUS KETONE MONITORING MICROSENSOR | 202600369349100525 |
| 2025 | For Inspiration and Recognition of Science and Technology (first) Manchester, NH | B | $200,000 | paid | FIRST SENIOR MENTOR PROGRAM | 202600369349100525 |
| 2025 | The Max Stern Academic College of Emek Yezreel Ltd (cc) Yezreel Valley | U | $200,000 | approved, future | OPPORTUNITY FOR SUCCESS SCHOLARSHIPS FOR ETHIOPIAN ISRAELIS PURSUING NURSING DEGREES | 202600369349100525 |
| 2025 | Youth Development Organization Inc Lawrence, MA | B | $200,000 | paid | CAPACITY BUILDING PROJECT SUPPORT 2024-2026 | 202600369349100525 |
| 2025 | University of Iowa Iowa City, IA | U | $199,968 | paid | SUPPORTING THE RUPRI HEALTH PANEL TO BRING RESEARCH AND EXPERTISE TO INFORM POLICY DEVELOPMENT AND IMPLEMENTATION | 202600369349100525 |
| 2025 | Katholieke Universiteit Te Leuven Leuven | U | $199,460 | approved, future | EMBODY EFFECTS OF A MINDFULNESS BASED INTERVENTION ON IBD DISABILITY | 202600369349100525 |
| 2025 | University of Texas System for the University of Texas at Austin Austin, TX | U | $198,646 | paid | INCREASING ACCESS TO CROHNS DISEASE CLINICAL CARE FOR THE IBD CENTER AT UT HEALTH AUSTIN | 202600369349100525 |
| 2025 | Board of Regents Nevada System of Higher Education Reno, NV | B | $197,208 | paid | ULTRASOUND TRAINING INITIATIVE IN NEVADA | 202600369349100525 |
| 2025 | Jaeb Center for Health Research Foundation Inc Tampa, FL | C | $194,126 | paid | VIRTUAL DIABETES SPECIALTY CLINIC (VDISC) - A STUDY EVALUATING REMOTE INITIATION OF CONTINUOUS GLUCOSE MONITORING | 202600369349100525 |
| 2025 | New York Restoration Project New York, NY | B | $193,536 | paid | NYC URBAN REFORESTATION & EXPANSION | 202600369349100525 |
| 2025 | University of Hawaii Honolulu, HI | B | $193,410 | approved, future | IMPROVING HEALTH ACROSS RURAL HAWAII THROUGH RESEARCH AND POLICY | 202600369349100525 |
| 2025 | Natural Areas Conservancy Inc New York, NY | B | $193,132 | paid | STRENGTHENING NYC'S URBAN FOREST PLAN NATURAL AREAS | 202600369349100525 |
| 2025 | Jaeb Center for Health Research Foundation Inc Tampa, FL | C | $191,816 | approved, future | TRIAL EVALUATING THE EFFECT OF INHALED TECHNOSPHERE INSULIN VERSUS RAPID ACTING ANALOGUE INSULIN ON EXERCISE-INDUCED HYPOGLYCEMIA IN ADULTS WITH T1D | 202600369349100525 |
| 2025 | African Mission Healthcare Foundation Deland, FL | B | $191,802 | paid | ST. FRANCIS HOSPITAL MATERNITY CENTER | 202600369349100525 |
| 2025 | University of Hawaii Honolulu, HI | B | $190,434 | approved, future | IMPROVING HEALTH ACROSS RURAL HAWAII THROUGH RESEARCH AND POLICY | 202600369349100525 |
| 2025 | The Royal Institution for the Advancement of Learningmcgill Univ Montreal | U | $190,336 | paid | DATA GOVERNANCE RESOURCE | 202600369349100525 |
| 2025 | Reachanother Foundation Bend, OR | U | $190,186 | approved, future | EXPANDING PEDIATRIC NEUROSURGERY CAPACITY IN ETHIOPIA | 202600369349100525 |
| 2025 | University of Exeter Exeter | U | $189,671 | approved, future | UNCOVERING NEW GENETIC MECHANISMS UNDERLYING EXTREME EARLY-ONSET TYPE 1 DIABETES | 202600369349100525 |
| 2025 | City Parks Foundation Inc New York, NY | B | $188,595 | approved, future | STRENGTHENING NYCS URBAN FOREST PLAN PUBLIC PARK LANDS | 202600369349100525 |
| 2025 | University of Notre Dame du Lac Notre Dame, ID | U | $188,155 | paid | GLUCOSE-BINDING MOTIFS FROM DYNAMIC COMBINATORIAL LANDSCAPES | 202600369349100525 |
| 2025 | The Sheba Fund for Health Services and Research (ra) Ramat Gan | U | $188,118 | approved, future | ISRAEL IBD RESEARCH NUCLEUS (IIRN) CONSORTIUM CAPSULE & OMICS FOR PREDICTING EXACERBATION OF CROHNS DISEASE (CORE-CD) | 202600369349100525 |
| 2025 | Genome Research Limited for the Wellcome Sanger Institute Cambridge | U | $187,672 | paid | SCIBD-RESPONSE MASSIVE-SCALE SINGLE-CELL RNA-SEQUENCING TO IDENTIFY TRANSCRIPTOMIC PREDICTORS OF RESPONSE TO BIOLOGIC THERAPIES IN CROHNS DISEASE | 202600369349100525 |
| 2025 | Institut National de la Sante Et de la Recherche Medicale Paris | U | $186,090 | approved, future | FROM BENIGN ISLET AUTOIMMUNITY TO TYPE 1 DIABETES HLA-A- VS. HLA-B-RESTRICTED CD8 T-CELL BIOMARKERS OF PROGRESSION | 202600369349100525 |
| 2025 | The Royal Institution for the Advancement of Learningmcgill Univ Montreal | U | $185,694 | approved, future | DATA GOVERNANCE RESOURCE | 202600369349100525 |
| 2025 | New Destiny Housing Corporation New York, NY | B | $183,350 | paid | PILOTING AFTERCARE INTERVENTION TO IMPROVE HOUSING AND HEALTH STABILITY FOR FORMERLY HOMELESS DOMESTIC VIOLENCE SURVIVORS | 202600369349100525 |
| 2025 | The Royal Institution for the Advancement of Learningmcgill Univ Montreal | U | $182,394 | approved, future | DATA GOVERNANCE RESOURCE | 202600369349100525 |
| 2025 | Vanderbilt University Medical Center Nashville, TN | C | $182,168 | approved, future | ADAPTING FAMS TO OPTIMIZE CGM USE AMONG EMERGING ADULTS WITH TYPE 1 DIABETES | 202600369349100525 |
| 2025 | Jaeb Center for Health Research Foundation Inc Tampa, FL | C | $180,800 | paid | EVALUATION OF THE RELATIONSHIP OF GLUCOSE METRICS VIA CONTINUOUS GLUCOSE MONITORING WITH DIABETIC RETINOPATHY | 202600369349100525 |
| 2025 | University of Glasgow Court Glasgow | U | $176,239 | paid | COMBINATION THERAPY WITH BIOLOGICS AND PARTIAL ENTERAL NUTRITION IN ADULTS WITH ACTIVE ILEOCOLONIC CROHNS DISEASE THE BIOPIC STUDY | 202600369349100525 |
| 2025 | Sustainable Coastlines Hawaii Honolulu, HI | B | $176,000 | approved, future | SCALING SUSTAINABLE COASTLINES HAWAII BUILDING LEADERSHIP FOR LONG-TERM GROWTH AND IMPACT | 202600369349100525 |
| 2025 | Albert Einstein College of Medicine Bronx, NY | B | $173,613 | paid | PROMOTE DIABETES TECHNOLOGY USE IN YOUNG ADULTS FROM UNDERREPRESENTED MINORITY GROUPS WITH T1D | 202600369349100525 |
| 2025 | St Rose Dominican Health Foundation Henderson, NV | U | $172,840 | approved, future | DIGNITY HEALTH-ST. ROSE DOMINICAN - SIENA CAMPUS CATH LAB REVITALIZATION PROJECT | 202600369349100525 |
| 2025 | Family Healthcare Center Fargo, ND | B | $172,160 | paid | FAMILY HEALTHCARE CENTER ULTRASOUND INITIATIVE | 202600369349100525 |
| 2025 | Albert Einstein College of Medicine Bronx, NY | B | $171,150 | approved, future | ENHANCING THE COMMUNITY HEALTH WORKER (CHW) MODEL TO PROMOTE DIABETES TECHNOLOGY USE IN YOUNG ADULTS FROM UNDERREPRESENTED MINORITY GROUPS WITH T1D | 202600369349100525 |
| 2025 | Crohn's and Colitis Uk Hatfield | U | $170,782 | approved, future | IMPLEMENTATION OF A LOWER GI DIAGNOSTIC PATHWAY IN PRIMARY HEALTHCARE AND DEVELOPMENT AND DISSEMINATION OF A LOWER GI PATIENT TOOLKIT | 202600369349100525 |
| 2025 | Shatterproof a Nonprofit Corp Norwalk, CT | U | $170,000 | approved, future | GENERAL OPERATING SUPPORT | 202600369349100525 |
| 2025 | International Bowel Ultrasound Group Ev Munster | U | $169,420 | paid | POINT-OF-CARE INTESTINAL ULTRASOUND TRAINING IN THE UNITED STATES INTRODUCTION TO INTESTINAL ULTRASONOGRAPHY | 202600369349100525 |
| 2025 | American Pharmacists Association Foundation Washington, DC | B | $167,500 | paid | PROJECT IMPACT CGM EXPANDING ACCESS TO CGM THROUGH COMMUNITY PHARMACIES | 202600369349100525 |
| 2025 | Regents of the University of Minnesota Minneapolis, MN | U | $166,880 | approved, future | THERAPEUTIC USE OF PEPTIDEMHC MABS FOR T1D | 202600369349100525 |
| 2025 | Insulin for Life USA Inc Gainesville, FL | B | $165,700 | approved, future | STRENGTHENING ORGANIZATIONAL CAPACITY II | 202600369349100525 |
| 2025 | Healing Hands of Joy Charlotte, NC | B | $165,000 | approved, future | ELIMINATION OF OBSTETRIC FISTULA | 202600369349100525 |
| 2025 | St Mark's Hospital Foundation London | U | $164,712 | approved, future | PERIANAL CROHNS DISEASE (PCD) EDUCATIONAL MEETING AND TOPCLASS CONSORTIUM MEMBER CONFERENCE | 202600369349100525 |
| 2025 | Vanderbilt University Medical Center Nashville, TN | C | $163,405 | paid | ISOLATING ISLETS TO UNDERSTAND HYPOGLYCEMIA IN TYPE 1 DIABETES | 202600369349100525 |
| 2025 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $162,877 | paid | GPPAD DRIED BLOOD SPOT OMICS TO PREDICT HEALTH AND AUTOIMMUNITY OUTCOMES IN CHILDREN | 202600369349100525 |
| 2025 | City Parks Foundation Inc New York, NY | B | $161,100 | paid | CATALYST SUSTAINABILITY THE IMPORTANCE OF COMMUNITY ENGAGEMENT IN PARKS | 202600369349100525 |
| 2025 | Mayo Clinic Rochester, MN | U | $160,940 | paid | MILITARY SCIENCES MEDICAL TRAINING 2024-2026 | 202600369349100525 |
| 2025 | Trustees of Indiana University Bloomington, ID | U | $160,875 | paid | THE FINDING IMMUNE NASCENT DIABETES (FIND-T1D) | 202600369349100525 |
| 2025 | Institut Integrated Biobank of Luxembourg Dudelange | U | $160,613 | approved, future | GPPAD BIOBANK - SINT1A | 202600369349100525 |
| 2025 | Jaeb Center for Health Research Foundation Inc Tampa, FL | C | $159,838 | approved, future | EXERCISE IN DIABETES INITIATIVE LARGE ADULT STUDY | 202600369349100525 |
| 2025 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $158,504 | paid | EUROPEAN PRE-T1D REGISTRY | 202600369349100525 |
| 2025 | Mayo Clinic Rochester, MN | U | $157,469 | paid | STENOSIS THERAPY AND ANTI-FIBROTIC RESEARCH (STAR) CONSORTIUM | 202600369349100525 |
| 2025 | Breakthrough T1d New York, NY | B | $157,366 | approved, future | HELMSLEY AND JDRF CO-FUNDED WORKSHOPS | 202600369349100525 |
| 2025 | The Imperial College of Science Technology and Medicine London | U | $156,358 | paid | IMMUNOLOGICAL MECHANISMS UNDERLYING THE GENETIC BASIS FOR NATURAL T1D PROTECTION | 202600369349100525 |
| 2025 | Nelson County Health System Mcville, ND | B | $153,546 | paid | NELSON COUNTY HEALTH SYSTEM ULTRASOUND INITIATIVE | 202600369349100525 |
| 2025 | Children's Hospital Los Angeles Los Angeles, CA | U | $153,056 | paid | BEYOND COYOT1 EXPANSION OF PATIENT-CENTERED VIRTUAL CARE | 202600369349100525 |
| 2025 | University of Birmingham Birmingham | U | $152,801 | paid | DEFINING THE EFFICACY AND MECHANISMS OF PEPTIDE IMMUNOTHERAPY FOR TYPE 1 DIABETES AN EXPERIMENTAL MEDICINE STUDY | 202600369349100525 |
| 2025 | Universite Catholique de Louvain Louvainlaneuve | U | $152,546 | approved, future | SEARCH FOR MECHANISMS RESPONSIBLE FOR THE IMPAIRED GLUCAGON SECRETION IN T1D AND FOR STRATEGIES TO CORRECT THEM | 202600369349100525 |
| 2025 | Technische Universitaet Muenchen Munchen | U | $151,947 | paid | COST-EFFECTIVENESS OF PUBLIC HEALTH SCREENING FOR PRE-SYMPTOMATIC TYPE 1 DIABETES WITH AND WITHOUT TREATMENT FOR PREVENTION OF TYPE 1 DIABETES | 202600369349100525 |
| 2025 | Mayo Clinic Rochester, MN | U | $151,705 | paid | DEVELOPMENT OF A NEXT-GENERATION BIOMARKER TOOL TO ACCELERATE THE DEVELOPMENT OF EFFECTIVE ANTI-FIBROTIC THERAPIES | 202600369349100525 |
| 2025 | Villages of Hope Africa Society Mississauga | D | $151,152 | paid | INFRASTRUCTURE IMPROVEMENTS AND EXPANSION | 202600369349100525 |
| 2025 | The Regents of the University of Colorado Denver Aurora, CO | D | $150,914 | paid | EPIGENOMIC BIOMARKERS OF THE INCOMPLETE MATERNAL PROTECTION IN TYPE 1 DIABETES | 202600369349100525 |
| 2025 | The Trustees of Columbia University in the City of New York New York, NY | U | $150,000 | approved, future | SUPPORT FOR T1D TRANSITION PROGRAMS | 202600369349100525 |
| 2025 | City Futures Inc New York, NY | B | $150,000 | paid | NYC GREENSPACE POLICY REPORTS FOCUSED ON PROMOTING RECREATION, AND IMPROVING ACCESS TO GREENSPACE | 202600369349100525 |
| 2025 | Impact-Se Inst for Monitoring Peace & Cultural Tolerance in School Ed Ramat Gan | U | $150,000 | paid | TRANSFORMING EDUCATION FOR PEACE A NATIONWIDE AWARENESS CAMPAIGN ON INCITEMENT IN PALESTINIAN/UNRWA TEXTBOOKS. | 202600369349100525 |
| 2025 | National Academy of Sciences Washington, DC | C | $150,000 | approved, future | STRENGTHENING MINORITY SERVING INSTITUTIONS | 202600369349100525 |
| 2025 | University of North Carolina at Chapel Hill Chapel Hill, NC | B | $149,796 | paid | GENOMIC AND MICROBIAL SIGNATURES PREDICT POST-OPERATIVE CROHNS DISEASE OUTCOMES | 202600369349100525 |
| 2025 | Center for Health Care Strategies Inc Hamilton, NJ | B | $149,672 | paid | IDENTIFYING OPPORTUNITIES TO SUPPORT T1D AUTOANTIBODY SCREENING IN MEDICAID PROGRAMS AND HEALTH CARE SYSTEMS THAT SERVE MEDICAID BENEFICIARIES | 202600369349100525 |
| 2025 | Vanderbilt University Medical Center Nashville, TN | C | $149,050 | approved, future | EXPANSION OF PANCREATLAS CONNECTIVITY PLATFORM AND PHENOTYPING OF HANDEL SAMPLES BY CUTTING-EDGE SINGLE CELL MULTIOME TECHNOLOGY | 202600369349100525 |
| 2025 | The Trustees of Columbia University in the City of New York New York, NY | U | $146,689 | paid | ADDING HEALTH QUESTIONS TO THE POVERTY TRACKER TO SURVEY THE HEALTHCARE NEEDS AND UTILIZATION PREFERENCES OF LOW-INCOME NEW YORKERS | 202600369349100525 |
| 2025 | Sanford World Clinics Sioux Falls, SD | C | $145,752 | approved, future | PROGRAM DETEKTA DETECTING TYPE 1 DIABETES AND PREVENTING DIABETIC KETOACIDOSIS (DKA) | 202600369349100525 |
| 2025 | Clalit Health Services Tel Aviv | U | $145,605 | paid | ISRAELI IBD RESEARCH NUCLEUS (IIRN) CONSORTIUM MANAGEMENT | 202600369349100525 |
| 2025 | Genome Research Limited for the Wellcome Sanger Institute Cambridge | U | $143,892 | approved, future | SCIBD-RESPONSE MASSIVE-SCALE SINGLE-CELL RNA-SEQUENCING TO IDENTIFY TRANSCRIPTOMIC PREDICTORS OF RESPONSE TO BIOLOGIC THERAPIES IN CROHNS DISEASE | 202600369349100525 |
| 2025 | Center for Health Care Strategies Inc Hamilton, NJ | B | $141,530 | paid | EXPANDING ACCESS TO AID DEVICES IN MEDICAID | 202600369349100525 |
| 2025 | Herlev Og Gentofte Hospital Herlev | U | $140,000 | approved, future | TARGETING GIP/GLP-2 RECEPTORS TO PREVENT HYPOGLYCEMIA IN T1D | 202600369349100525 |
| 2025 | City Parks Foundation Inc New York, NY | B | $139,790 | approved, future | CATALYST SUSTAINABILITY THE IMPORTANCE OF COMMUNITY ENGAGEMENT IN PARKS | 202600369349100525 |
| 2025 | The Governors of the University of Calgary Calgary | D | $137,417 | paid | INTERLEUKIN-4 ACTIVATED MACROPHAGES (M(IL4)) FOR PERSONALIZED CELLULAR IMMUNOTHERAPY TO TREAT IBD | 202600369349100525 |
| 2025 | Board of Regents Nevada System of Higher Education Reno, NV | B | $137,345 | paid | CARDIORESPIRATORY CARE SCIENCE DEGREE PROGRAM | 202600369349100525 |
| 2025 | Herlev Og Gentofte Hospital Herlev | U | $135,722 | paid | INTERACTION BETWEEN AMINO ACIDS AND GLUCOSE-DEPENDENT INSULINOTROPIC POLYPEPTIDE IN PANCREATIC ALPHA CELLS | 202600369349100525 |
| 2025 | University of Oulu Oulu | U | $135,549 | approved, future | MATERNAL AND PATERNAL TYPE 1 DIABETES MECHANISMS FOR THE DISTINCT RECURRENCE RISK IN THE OFFSPRING | 202600369349100525 |
| 2025 | State University of Iowa Foundation Iowa City, IA | B | $135,000 | approved, future | SIMULATION IN MOTION-IOWA ENDOWMENT | 202600369349100525 |
| 2025 | State University of Iowa Foundation Iowa City, IA | B | $135,000 | approved, future | SIMULATION IN MOTION-IOWA ENDOWMENT | 202600369349100525 |
| 2025 | University of Dundee Dundee | U | $133,804 | paid | HYPO-RESOLVE - UNDERSTANDING ORGAN SPECIFIC CONSEQUENCES OF HYPOGLYCEMIA | 202600369349100525 |
| 2025 | Breakthrough T1d New York, NY | B | $133,334 | approved, future | CO-FUNDED DEVELOPMENT OF A MICRONEEDLE SENSOR FOR SIMULTANEOUS CONTINUOUS MONITORING OF KETONES AND GLUCOSE | 202600369349100525 |
| 2025 | Breakthrough T1d New York, NY | B | $133,332 | paid | CO-FUNDED DEVELOPMENT OF A MICRONEEDLE SENSOR FOR SIMULTANEOUS CONTINUOUS MONITORING OF KETONES AND GLUCOSE | 202600369349100525 |
| 2025 | Community Health Service Inc Moorhead, MN | B | $132,287 | paid | COMMUNITY HEALTH SERVICE INC ULTRASOUND INITIATIVE | 202600369349100525 |
| 2025 | Stiftelsen for Utbildning (ioibd) Orebro | U | $132,000 | approved, future | THE IOIBD CLINICAL EXPERIENCE EXCHANGE TO FOSTER INVESTIGATIVE CAREERS IN IBD | 202600369349100525 |
| 2025 | Stiftelsen for Utbildning (ioibd) Orebro | U | $132,000 | paid | THE IOIBD CLINICAL EXPERIENCE EXCHANGE TO FOSTER INVESTIGATIVE CAREERS IN IBD | 202600369349100525 |
| 2025 | State University of Iowa Foundation Iowa City, IA | B | $130,000 | approved, future | SIMULATION IN MOTION-IOWA ENDOWMENT | 202600369349100525 |
| 2025 | The Regents of the University of California Los Angeles Los Angeles, CA | U | $128,649 | paid | GLUCOSE RESPONSIVE GLUCAGON (GRG) FOR THE REDUCTION OF HYPOGLYCEMIA FOR PEOPLE WITH T1D | 202600369349100525 |
| 2025 | Boston Medical Center Corporation Boston, MA | B | $128,527 | paid | SUPPLEMENTAL FUNDING FOR AN EFFECTIVENESS TRIAL TO SUPPORT ADOPTION OF AID IN UNDERSERVED ADULTS WITH T1D | 202600369349100525 |
| 2025 | The Governors of the University of Calgary Calgary | D | $127,077 | paid | INTERLEUKIN-4 ACTIVATED MACROPHAGES (M(IL4)) FOR PERSONALIZED CELLULAR IMMUNOTHERAPY TO TREAT IBD | 202600369349100525 |
| 2025 | St Rose Dominican Health Foundation Henderson, NV | U | $124,981 | paid | DIGNITY HEALTH - ST. ROSE DOMINICAN - SIENA CAMPUS ECMO PROGRAM | 202600369349100525 |
| 2025 | The Regents of the University of Colorado Denver Aurora, CO | D | $124,200 | paid | COMPLEMENT SYSTEM IN THE INITIATION AND PROGRESSION OF ISLET AUTOIMMUNITY | 202600369349100525 |
| 2025 | Mass General Brigham for the Massachusetts General Hospital Boston, MA | U | $123,922 | approved, future | VALIDATION OF WIRELESS THERMAL AND MICROSCOPIC IMAGING TECHNOLOGY FOR QUANTIFYING INFLAMMATION AND FIBROSIS IN CROHNS DISEASE | 202600369349100525 |
| 2025 | Reachanother Foundation Bend, OR | U | $122,978 | approved, future | TRANSFORMING PEDIATRIC NEUROSURGERY SERVICES | 202600369349100525 |
| 2025 | Vanderbilt University Medical Center Nashville, TN | C | $121,999 | paid | ADAPTING FAMS TO OPTIMIZE CGM USE AMONG EMERGING ADULTS WITH TYPE 1 DIABETES | 202600369349100525 |
| 2025 | Children's Hospital of Philadelphia Philadelphia, PA | C | $121,207 | approved, future | LEVERAGING HLA PROTECTION AND HUMORAL IMMUNITY TO DEVELOP MICROBIAL THERAPEUTICS THAT PREVENT T1D | 202600369349100525 |
| 2025 | The Sheba Fund for Health Services and Research Ramat Gan | U | $118,210 | paid | THE UTILITY OF HAND-HELD ULTRASOUND DEVICES TO DETECT BOWEL WALL INFLAMMATORY ACTIVITY IN CROHN'S DISEASE | 202600369349100525 |
| 2025 | University at Buffalo Pediatric Associates P C Buffalo, NY | D | $118,038 | paid | FINANCIAL VIABILITY OF TELEHEALTH SERVICES FOR UNDERSERVED T1D PEDIATRIC POPULATIONS | 202600369349100525 |
| 2025 | Institut Integrated Biobank of Luxembourg Dudelange | U | $116,852 | approved, future | GPPAD BIOBANK - SINT1A | 202600369349100525 |
| 2025 | The Rector and Visitors of the University of Virginia Charlottesville, VA | C | $115,896 | paid | TYPE 1 DIABETES RISK PREDICTION INTEGRATION OF PHYSIOLOGY WITH GENETICS | 202600369349100525 |
| 2025 | Cedars-Sinai Medical Center Los Angeles, CA | B | $115,500 | paid | VERY EARLY ONSET INFLAMMATORY BOWEL DISEASE (VEOIBD) PRECISION MOLECULAR DIAGNOSES TO TARGETED THERAPIES CEDARS-SINAI | 202600369349100525 |
| 2025 | King's College London London | U | $115,097 | approved, future | T CELL RECEPTOR SEQUENCING IN TYPE 1 DIABETES - BIOMARKER DISCOVERY AND TECHNOLOGY DEVELOPMENT | 202600369349100525 |
| 2025 | Region Hovedstaden Hillerod | U | $113,358 | approved, future | CAN MICROCHIMERISM EXPLAIN DIFFERENCES IN PARENTAL TYPE 1 DIABETES CONFERRED RISK OF OFFSPRING TYPE 1 DIABETES? | 202600369349100525 |
| 2025 | Sanford World Clinics Sioux Falls, SD | C | $112,523 | approved, future | PROGRAM DETEKTA DETECTING TYPE 1 DIABETES AND PREVENTING DIABETIC KETOACIDOSIS (DKA) | 202600369349100525 |
| 2025 | Institut Integrated Biobank of Luxembourg Dudelange | U | $108,058 | approved, future | GPPAD BIOBANK - SINT1A | 202600369349100525 |
| 2025 | Children's Hospital of Philadelphia Philadelphia, PA | C | $107,168 | paid | LEVERAGING HLA PROTECTION AND HUMORAL IMMUNITY TO DEVELOP MICROBIAL THERAPEUTICS THAT PREVENT T1D | 202600369349100525 |
| 2025 | Vanderbilt University Medical Center Nashville, TN | C | $104,599 | approved, future | DEFINING MOLECULAR MECHANISMS OF CELL DYSFUNCTION IN TYPE 1 DIABETES TO DEVELOP NEW APPROACHES TO PREVENT HYPOGLYCEMIA | 202600369349100525 |
| 2025 | St Rose Dominican Health Foundation Henderson, NV | U | $101,195 | approved, future | DIGNITY HEALTH - ST. ROSE DOMINICAN - SIENA CAMPUS ECMO PROGRAM | 202600369349100525 |
| 2025 | New York University New York, NY | B | $100,307 | approved, future | ANALYSIS OF MEDICAID AND RELATED DATA ON CARE TO HOMELESS SHELTER PATIENTS | 202600369349100525 |
| 2025 | Simulation in Motion Montana Inc Helena, MT | B | $100,000 | approved, future | SIM-MT BUSINESS DEVELOPMENT AND SUSTAINABILITY | 202600369349100525 |
| 2025 | Institute for Community Living Inc New York City, NY | B | $100,000 | paid | COLLABORATIVE ON HOUSING FOR HEALTH (CH4H) STEERING COMMITTEE | 202600369349100525 |
| 2025 | Urban Pathways Inc New York, NY | U | $100,000 | paid | COLLABORATIVE ON HOUSING FOR HEALTH (CH4H) STEERING COMMITTEE | 202600369349100525 |
| 2025 | Jewish Board of Family & Children's Services Inc New York, NY | B | $100,000 | approved, future | COLLABORATIVE ON HOUSING FOR HEALTH (CH4H) STEERING COMMITTEE | 202600369349100525 |
| 2025 | Urban Pathways Inc New York, NY | U | $100,000 | approved, future | COLLABORATIVE ON HOUSING FOR HEALTH (CH4H) STEERING COMMITTEE | 202600369349100525 |
| 2025 | Simulation in Motion Montana Inc Helena, MT | B | $100,000 | paid | SIM-MT BUSINESS DEVELOPMENT AND SUSTAINABILITY | 202600369349100525 |
| 2025 | Jewish Board of Family & Children's Services Inc New York, NY | B | $100,000 | approved, future | COLLABORATIVE ON HOUSING FOR HEALTH (CH4H) STEERING COMMITTEE | 202600369349100525 |
| 2025 | Institute for Community Living Inc New York City, NY | B | $100,000 | approved, future | COLLABORATIVE ON HOUSING FOR HEALTH (CH4H) STEERING COMMITTEE | 202600369349100525 |
| 2025 | Center for Urban Community Services Inc New York, NY | U | $100,000 | approved, future | COLLABORATIVE ON HOUSING FOR HEALTH (CH4H) STEERING COMMITTEE | 202600369349100525 |
| 2025 | State University of Iowa Foundation Iowa City, IA | B | $100,000 | paid | SIMULATION IN MOTION-IOWA ENDOWMENT | 202600369349100525 |
| 2025 | Insulin for Life USA Inc Gainesville, FL | B | $100,000 | approved, future | STRENGTHENING ORGANIZATIONAL CAPACITY II | 202600369349100525 |
| 2025 | Urban Pathways Inc New York, NY | U | $100,000 | approved, future | COLLABORATIVE ON HOUSING FOR HEALTH (CH4H) STEERING COMMITTEE | 202600369349100525 |
| 2025 | Simulation in Motion Montana Inc Helena, MT | B | $100,000 | paid | SIM-MT BUSINESS DEVELOPMENT AND SUSTAINABILITY | 202600369349100525 |
| 2025 | Institute for Community Living Inc New York City, NY | B | $100,000 | approved, future | COLLABORATIVE ON HOUSING FOR HEALTH (CH4H) STEERING COMMITTEE | 202600369349100525 |
| 2025 | Center for Urban Community Services Inc New York, NY | U | $100,000 | approved, future | COLLABORATIVE ON HOUSING FOR HEALTH (CH4H) STEERING COMMITTEE | 202600369349100525 |
| 2025 | Center for Urban Community Services Inc New York, NY | U | $100,000 | paid | COLLABORATIVE ON HOUSING FOR HEALTH (CH4H) STEERING COMMITTEE | 202600369349100525 |
| 2025 | Jewish Board of Family & Children's Services Inc New York, NY | B | $100,000 | paid | COLLABORATIVE ON HOUSING FOR HEALTH (CH4H) STEERING COMMITTEE | 202600369349100525 |
| 2025 | Jerusalem College of Technology Jerusalem | U | $100,000 | paid | EMERGENCY SUPPORT FOR STUDENTS AT THE JERUSALEM COLLEGE OF TECHNOLOGY. | 202600369349100525 |
| 2025 | North Dakota State University Fargo, ND | B | $99,500 | paid | EXPANDING RURAL SONOGRAPHY EXPERTISE IN NORTH DAKOTA | 202600369349100525 |
| 2025 | University of Exeter Exeter | U | $95,777 | paid | STIMULATED GLUCAGON LEVELS AS A BIOMARKER OF HYPOGLYCEMIA RISK IN TYPE 1 DIABETES | 202600369349100525 |
| 2025 | Institut Integrated Biobank of Luxembourg Dudelange | U | $95,213 | paid | GPPAD BIOBANK - SINT1A | 202600369349100525 |
| 2025 | Northwood Deaconess Health Center Northwood, ND | B | $95,182 | paid | NORTHWOOD DEACONESS HEALTH CENTER (ND) ULTRASOUND INITIATIVE | 202600369349100525 |
| 2025 | Centre Hospitalier Regional de Nancy Nancy | U | $94,386 | paid | PREVENTION OF EXTRA-INTESTINAL MANIFESTATIONS AND COMORBIDITIES IN CROHNS DISEASE THE NEMO PROJECT | 202600369349100525 |
| 2025 | Chancellor Masters & Scholars of the University of Oxford Oxford | D | $93,443 | approved, future | INTERROGATING THE MECHANISM OF HYPERSENSITIVITY TO ANTIBODY-BASED DRUGS FOR DEVELOPMENT OF A NOVEL ANTI-TNF BIOLOGIC FOR CROHNS DISEASE | 202600369349100525 |
| 2025 | Breakthrough T1d New York, NY | B | $93,442 | paid | HELMSLEY AND JDRF CO-FUNDED WORKSHOPS | 202600369349100525 |
| 2025 | P R Health Corporation Park River, ND | B | $93,347 | paid | FIRST CARE HEALTH CENTER ULTRASOUND INITIATIVE | 202600369349100525 |
| 2025 | Academisch Ziekenhuis Leiden Leiden | U | $93,238 | approved, future | SAFETY AND EFFICACY OF IMMUNE INTERVENTION WITH TOLEROGENIC DENDRITIC CELLS IN PATIENTS WITH EARLY T1D (D-SENSE II) | 202600369349100525 |
| 2025 | Regents of the University of Michigan Ann Arbor, MI | C | $92,033 | paid | EVALUATION OF A GUT-SPECIFIC ANTIFIBROTIC THERAPEUTIC IN PRE-CLINICAL MODELS OF CROHNS DISEASE | 202600369349100525 |
| 2025 | Regents of the University of Michigan Ann Arbor, MI | C | $92,033 | paid | EVALUATION OF A GUT-SPECIFIC ANTIFIBROTIC THERAPEUTIC IN PRE-CLINICAL MODELS OF CROHNS DISEASE | 202600369349100525 |
| 2025 | Engineering Ministries International USA Colorado Springs, CO | B | $89,417 | paid | EVALUATING RURAL HEALTH CARE FACILITIES | 202600369349100525 |
| 2025 | Hazen Memorial Hospital Association Hazen, ND | B | $88,179 | paid | SAKAKAWEA MEDICAL CENTER (ND) ULTRASOUND INITIATIVE | 202600369349100525 |
| 2025 | St Rose Dominican Health Foundation Henderson, NV | U | $87,671 | approved, future | DIGNITY HEALTH-ST. ROSE DOMINICAN - SIENA CAMPUS CATH LAB REVITALIZATION PROJECT | 202600369349100525 |
| 2025 | Institut Integrated Biobank of Luxembourg Dudelange | U | $85,150 | approved, future | BIOBANKING FOR THE PRIMARY ORAL INSULIN TRIAL | 202600369349100525 |
| 2025 | University Medical Center of Southern Nevada Las Vegas, NV | U | $84,783 | approved, future | DEVELOPMENT OF AN EXTRACORPOREAL LIFE SUPPORT (ECLS) PROGRAM AT UNIVERSITY MEDICAL CENTER OF SOUTHERN NEVADA | 202600369349100525 |
| 2025 | The Sheba Fund for Health Services and Research (ra) Ramat Gan | U | $84,659 | approved, future | THE UTILITY OF HAND-HELD ULTRASOUND DEVICES TO DETECT BOWEL WALL INFLAMMATORY ACTIVITY IN CROHN'S DISEASE | 202600369349100525 |
| 2025 | Wishek Hospital Clinic Association Wishek, ND | B | $83,657 | paid | SOUTH CENTRAL HEALTH ULTRASOUND INITIATIVE | 202600369349100525 |
| 2025 | Institut Integrated Biobank of Luxembourg Dudelange | U | $79,723 | paid | BIOBANKING FOR THE PRIMARY ORAL INSULIN TRIAL | 202600369349100525 |
| 2025 | Institut Integrated Biobank of Luxembourg Dudelange | U | $77,919 | approved, future | GPPAD BIOBANK - SINT1A | 202600369349100525 |
| 2025 | Jacobson Memorial Hospital Care Center Elgin, ND | B | $77,620 | paid | JACOBSON MEMORIAL HOSPITAL ULTRASOUND INITIATIVE | 202600369349100525 |
| 2025 | Linton Hospital Linton, ND | B | $76,961 | paid | LINTON HOSPITAL (ND) ULTRASOUND INITIATIVE | 202600369349100525 |
| 2025 | Ashley Medical Center Ashley, ND | D | $76,961 | paid | ASHLEY MEDICAL CENTER (ND) ULTRASOUND INITIATIVE | 202600369349100525 |
| 2025 | Sage Bionetworks Seattle, WA | B | $75,165 | paid | EXTENSION OF VEOIBD DATA COORDINATION TO ACCELERATE DISCOVERY OF PRECISION MOLECULAR DIAGNOSES TO TARGETED THERAPIES | 202600369349100525 |
| 2025 | University of Virginia Law School Foundation Charlottesville, VA | B | $75,000 | paid | GENERAL OPERATING SUPPORT FOR THE CATHERINE MURPHY KEATING '87 RESTRICTED FUND | 202600369349100525 |
| 2025 | City Futures Inc New York, NY | B | $75,000 | approved, future | NYC GREENSPACE POLICY REPORTS FOCUSED ON PROMOTING RECREATION, AND IMPROVING ACCESS TO GREENSPACE | 202600369349100525 |
| 2025 | City Futures Inc New York, NY | B | $75,000 | approved, future | NYC GREENSPACE POLICY REPORTS FOCUSED ON PROMOTING RECREATION, AND IMPROVING ACCESS TO GREENSPACE | 202600369349100525 |
| 2025 | St Luke's Hospital Crosby, ND | B | $74,770 | paid | ST. LUKE'S MEDICAL CENTER ULTRASOUND INITIATIVE | 202600369349100525 |
| 2025 | Vivli Inc Burlington, MA | B | $74,348 | paid | DATA SHARING PLATFORM FOR T1-DEXI DATASETS | 202600369349100525 |
| 2025 | St Andrew's Hospital Bottineau, ND | B | $74,293 | paid | ST. ANDREW'S HOSPITAL ULTRASOUND INITIATIVE | 202600369349100525 |
| 2025 | University of North Carolina at Chapel Hill Chapel Hill, NC | B | $71,233 | approved, future | FREQUENCY AND TITER OF GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR AUTO-ANTIBODIES IN PATIENTS WITH CD-LIKE DISEASE OF THE POUCH | 202600369349100525 |
| 2025 | University of Exeter Exeter | U | $70,533 | approved, future | ADVANCINGB-CELL SPECIFIC THERAPY BY IDENTIFYINGB-CELL REACTIVE HIGH AFFINITY T CELL RECEPTORS | 202600369349100525 |
| 2025 | The University of Queensland Brisbane | D | $69,271 | paid | GUT MICROBIAL METABOLITES DURING EARLY-LIFE DEVELOPMENT AS PREDICTORS OF ISLET AUTOIMMUNITY | 202600369349100525 |
| 2025 | Presentation Medical Center Rolla, ND | B | $68,957 | paid | ST. KATERI ULTRASOUND INITIATIVE | 202600369349100525 |
| 2025 | West River Health Services Foundation Hettinger, ND | B | $68,591 | paid | NORTH DAKOTA US REVITALIZATION PROJECT | 202600369349100525 |
| 2025 | American Camping Association Inc Martinsville, IN | B | $65,258 | approved, future | ACA PROFESSIONAL DEVELOPMENT 2024-2027 | 202600369349100525 |
| 2025 | Mass General Brigham for the Massachusetts General Hospital Boston, MA | U | $65,218 | approved, future | VALIDATION OF WIRELESS THERMAL AND MICROSCOPIC IMAGING TECHNOLOGY FOR QUANTIFYING INFLAMMATION AND FIBROSIS IN CROHNS DISEASE | 202600369349100525 |
| 2025 | American Gastroenterological Association Institute Bethesda, MD | B | $64,189 | paid | AMPLIFYING LEARNING FROM THE CEDARS-SINAI ADVANCED DIETARY IBD EDUCATION AND TRAINING (DIET) PROGRAM BEYOND MALNUTRITION | 202600369349100525 |
| 2025 | Philanthropy New York Inc New York, NY | B | $63,750 | paid | GENERAL OPERATING SUPPORT FOR 2025 MEMBERSHIP | 202600369349100525 |
| 2025 | Universite Catholique de Louvain Louvainlaneuve | U | $62,567 | paid | LONGITUDINAL STUDY OF THE GLUCAGON RESPONSE TO HYPOGLYCEMIA IN CHILDREN AND ADOLESCENTS WITH NEW-ONSET TYPE 1 DIABETES | 202600369349100525 |
| 2025 | Insulin for Life USA Inc Gainesville, FL | B | $60,700 | paid | STRENGTHENING ORGANIZATIONAL CAPACITY | 202600369349100525 |
| 2025 | Nevada Department of Health and Human Services Carson City, NV | U | $60,670 | approved, future | NEVADA FIRST RESPONDER AED PROJECT | 202600369349100525 |
| 2025 | American Camping Association Inc Martinsville, IN | B | $60,221 | approved, future | ACA PROFESSIONAL DEVELOPMENT 2024-2027 | 202600369349100525 |
| 2025 | Sanford World Clinics Sioux Falls, SD | C | $59,605 | paid | PROGRAM DETEKTA DETECTING TYPE 1 DIABETES AND PREVENTING DIABETIC KETOACIDOSIS (DKA) | 202600369349100525 |
| 2025 | Trustees of Indiana University Bloomington, ID | U | $58,372 | paid | TARGETING METABOLIC DRIVERS OF B CELL DIFFERENTIATION IN TYPE 1 DIABETES | 202600369349100525 |
| 2025 | Alimentiv Inc London | U | $55,930 | approved, future | VALIDATION OF THE PRO SYMPTOMS AND IMPACTS QUESTIONNAIRE FOR CROHNS DISEASE | 202600369349100525 |
| 2025 | University of Exeter Exeter | U | $55,571 | paid | ADVANCING B-CELL SPECIFIC THERAPY BY IDENTIFYING B-CELL REACTIVE HIGH AFFINITY T CELL RECEPTORS | 202600369349100525 |
| 2025 | New York University New York, NY | B | $55,372 | approved, future | ANALYSIS OF MEDICAID AND RELATED DATA ON CARE TO HOMELESS SHELTER PATIENTS | 202600369349100525 |
| 2025 | American Camping Association Inc Martinsville, IN | B | $55,330 | paid | ACA PROFESSIONAL DEVELOPMENT 2024-2027 | 202600369349100525 |
| 2025 | The University of Adelaide Adelaide | U | $55,260 | paid | PANCREATIC EXOCRINE FUNCTION AND THE PROGRESSION TO TYPE 1 DIABETES IN YOUNG CHILDREN | 202600369349100525 |
| 2025 | Israel Center On Addiction Ra Netanya | U | $55,000 | paid | ICA'S EMERGENCY MENTAL HEALTH SUPPORT | 202600369349100525 |
| 2025 | The Center for Effective Philanthropy Inc Cambridge, MA | B | $54,780 | paid | GENERAL OPERATING SUPPORT FOR 2024 | 202600369349100525 |
| 2025 | University of North Dakota Grand Forks, ND | B | $54,673 | approved, future | SIMULATION IN MOTION (SIM) CONSORTIUM | 202600369349100525 |
| 2025 | Human Cell Atlas Incorporated Cambridge, MA | B | $50,000 | paid | 2024 HUMAN CELL ATLAS GENERAL MEETING | 202600369349100525 |
| 2025 | Katholieke Universiteit Te Leuven Leuven | U | $50,000 | paid | IDS 2024 BRUGES | 202600369349100525 |
| 2025 | Society for the Preservation of New England Antiquities Haverhill, MA | U | $50,000 | paid | GENERAL OPERATING SUPPORT | 202600369349100525 |
| 2025 | Acumen America LLC New York, NY | U | $50,000 | paid | SUPPLEMENTAL SUPPORT TO ADDRESS SOCIAL DETERMINANTS OF HEALTH FOR PEOPLE WITH INSULIN REQUIRING DIABETES | 202600369349100525 |
| 2025 | Insulin for Life USA Inc Gainesville, FL | B | $50,000 | approved, future | STRENGTHENING ORGANIZATIONAL CAPACITY II | 202600369349100525 |
| 2025 | The University of Edinburgh Edinburgh | U | $47,977 | paid | BUILDING A CROSS-DISCIPLINE SCIENTIFIC APPROACH TOWARDS UNDERSTANDING CROHNS DISEASE - LEVERAGING UK HELMSLEY STUDIES | 202600369349100525 |
| 2025 | Jaeb Center for Health Research Foundation Inc Tampa, FL | C | $47,712 | paid | EVALUATION OF THE RELATIONSHIP OF GLUCOSE METRICS VIA CONTINUOUS GLUCOSE MONITORING WITH DIABETIC RETINOPATHY | 202600369349100525 |
| 2025 | University of North Dakota Grand Forks, ND | B | $46,976 | paid | SIMULATION IN MOTION (SIM) CONSORTIUM | 202600369349100525 |
| 2025 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $46,760 | paid | FR1DA ORAL INSULIN INTERVENTION TRIAL AMENDMENT | 202600369349100525 |
| 2025 | Mckenzie County Healthcare Systems Inc Watford City, ND | B | $46,052 | paid | MCKENZIE HEALTH ULTRASOUND INITIATIVE | 202600369349100525 |
| 2025 | Barbara's House Greenwich, CT | B | $45,000 | paid | GENERAL OPERATING SUPPORT | 202600369349100525 |
| 2025 | Ida County Iowa Community Hospital Ida Grove, IA | B | $44,685 | paid | TELE-EMERGENCY SERVICES AT HORN MEMORIAL HOSPITAL | 202600369349100525 |
| 2025 | The University of Adelaide Adelaide | U | $43,631 | approved, future | PANCREATIC EXOCRINE FUNCTION AND THE PROGRESSION TO TYPE 1 DIABETES IN YOUNG CHILDREN | 202600369349100525 |
| 2025 | Ncd Alliance Geneva | U | $42,500 | paid | GENERAL OPERATING SUPPORT - NCD ALLIANCE SUPPORTERS GROUP | 202600369349100525 |
| 2025 | Kaiser Foundation Health Plan of Georgia Inc Atlanta, GA | C | $41,911 | paid | EXPANSION OF THE T1DES PILOT TO A PUBLIC HOSPITAL | 202600369349100525 |
| 2025 | Oregon Health & Science University Portland, OR | U | $41,318 | paid | DISSEMINATION PILOT THE IMPLEMENTATION OF NOVEL INTERVENTIONS IN CHILDREN'S HEALTHCARE (NICH) IN ANOTHER HEALTHCARE SYSTEM | 202600369349100525 |
| 2025 | University of Exeter Exeter | U | $40,825 | approved, future | B CELL SIGNATURES IN TYPE 1 DIABETES | 202600369349100525 |
| 2025 | New York University New York, NY | B | $40,419 | approved, future | ANALYSIS OF MEDICAID AND RELATED DATA ON CARE TO HOMELESS SHELTER PATIENTS | 202600369349100525 |
| 2025 | Humboldt County Memorial Hospital Humboldt, IA | C | $39,438 | paid | TELE-EMERGENCY SERVICES AT HUMBOLDT COUNTY MEMORIAL HOSPITAL | 202600369349100525 |
| 2025 | Philanthropy New York Inc New York, NY | B | $39,250 | paid | GENERAL OPERATING SUPPORT | 202600369349100525 |
| 2025 | Helmholtz Zentrum Munchen (gmbh) Neuherberg | U | $37,585 | approved, future | EUROPEAN PRE-T1D REGISTRY | 202600369349100525 |
| 2025 | University of Florida Gainesville, FL | U | $36,272 | paid | GENERATING AUTOANTIGEN-SPECIFIC ANTIBODY-PRODUCING HYBRIDOMAS AS A RENEWABLE SOURCE OF ISLET AUTOANTIBODIES | 202600369349100525 |
| 2025 | The University of Western Australia Crawley | U | $35,866 | paid | CGM ASSESSMENTS OF ENDIA CHILDREN | 202600369349100525 |
| 2025 | Cozad Hospital District No 2 Cozad, NE | D | $35,283 | paid | TELE-EMERGENCY AT COZAD COMMUNITY HEALTH SYSTEM | 202600369349100525 |
| 2025 | Pulitzer Center On Crisis Reporting Washington, DC | C | $34,097 | approved, future | INSIGHT AND CONNECTION THROUGH JOURNALISM AND EDUCATION | 202600369349100525 |
| 2025 | Council On Foundations Inc Washington, DC | B | $34,000 | paid | GENERAL OPERATING SUPPORT FOR ONE YEAR MEMBERSHIP | 202600369349100525 |
| 2025 | Council On Foundations Inc Washington, DC | B | $34,000 | approved, future | GENERAL OPERATING SUPPORT | 202600369349100525 |
| 2025 | The Communications Network Naperville, IL | C | $30,000 | paid | GENERAL OPERATING SUPPORT FOR 2025-27 MEMBERSHIP | 202600369349100525 |
| 2025 | Candid New York, NY | B | $28,749 | paid | GENERAL OPERATING SUPPORT | 202600369349100525 |
Match tier: A Reported EIN · B Exact name and place · C Strong name match · D Probable name match · U Unresolved. Tiers C and D are inferred, not reported; see how matching works.
Recipient matching for this dataset version has not yet completed its independent precision check. Tier A rows carry the EIN the filer reported; tiers B–D are the matcher's inference and should be read as leads until the check is published on the methodology page.
Derived from IRS Form 990-PF e-file XML. Dataset version 2026.09.0, built 2026-09-03. All years for this funder.
The same organization elsewhere in the program: exempt status and filing health · federal awards · grant guidance · open opportunities.
This is informational only, derived from public data on the dates shown. It is not an eligibility determination, and not legal, tax, or accounting advice. Verify against the official source before relying on it.